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PREFACE
Exfoliation syndrome and exfoliation glaucoma are common in 
patients in Northern Greece with cataract, or open angle 
glaucoma. The management of these patients is problematic.
This has prompted the author's interest in the disorder 
providing the motivation for this investigation.
This thesis is presented in two parts. Part I deals with 
morphological studies on the exfoliation syndrome. First, 
a critical review of the history, pathology, nature, origin, 
pathogenesis, epidemiology, clinical features and management of 
the disorder is presented. This is followed by the description 
and discussion of conventional morphological and 
immunocytochemical studies.
In Part II two clinical studies have been conducted. First, 
Scottish surgical patients were investigated prospectively, 
both clinically and morphologically, in order to ascertain the 
"true” prevalence of exfoliation glaucoma in this population 
and highlight differences between this disorder and primary 
open angle glaucoma. Second, a prospective randomised study 
has investigated the effect of varying the position of the 
trabeculectomy fistula on the incidence of postoperative 
hyphaema. The results are discussed and suggestions for future 
studies are outlined.
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SUMMARY
Exfoliation syndrome may be defined as a condition in which 
there is a characteristic clinical pattern of deposition of 
fine white granular material upon and within ocular and orbital 
tissues. Morphologically, exfoliation material comprises 
randomly orientated fibrillar aggregates with the staining and 
ultrastructural characteristics of a protein. The origin and 
structure of this protein (exfoliation material) are uncertain. 
Exfoliation syndrome is a common, but poorly understood cause 
of glaucoma worldwide.
Iris tissue samples from 100 patients operated upon for open 
angle glaucoma and 31 control subjects with closed angle 
glaucoma have been subjected to light and electron microscopy. 
This aimed at establishing a definitive diagnosis for the 
clinical study described below. Ostensibly normal iris vessels 
were found close to other vessels with intense perivascular 
aggregation of exfoliation material. Foci of exfoliation 
material in the iris stroma exhibited a pattern consistent with 
'ghost vessels'. A diffuse distribution would have been 
anticipated if passive deposition of exfoliation material had 
taken place.
Collagen types I-V and laminin were sought in 16 normal and 20 
exfoliative specimens of iris and/or trabecular meshwork, by 
means of ultrastructural immunogold localisation. Collagen 
types I-V were not present in the exfoliation material. In 
this study the glycoprotein laminin has been identified, for 
the first time, as an integral component of the exfoliation 
material. The vascular matrices of exfoliative iris exhibited
XIII
increased amounts of collagen types I and IV in less affected 
vessels. Depletion of collagen types I, IV and laminin was 
noted in severely affected vessels.
In part II of this thesis the results of two prospective 
studies are presented. The first investigated the prevalence 
and clinical characteristics of exfoliation glaucoma. Surgical 
patients with open angle glaucoma were divided by clinical 
examination into 3 groups: definite exfoliation (22)? possible
exfoliation (18) and no exfoliation (60). Subsequent
morphological assessment delineated two definitive groups: 
exfoliation glaucoma (26) and primary open angle glaucoma (74). 
Exfoliation glaucoma patients more frequently had higher 
untreated IOP at diagnosis, shorter duration of medical 
therapy, higher treated IOP before surgery and were operated 
upon more often for high IOP. They also exhibited 
significantly lower IOP postoperatively compared with age- 
matched primary open angle glaucoma patients.
The second study was performed upon 78 patients and
studied the effect of varying the position of a surgical 
fistula upon the incidence of postoperative hyphaema. This 
study confirmed that by fashioning the fistula entirely in 
corneal tissue the incidence and severity of postoperative 
bleeding is reduced resulting in shorter hospital stay. The 
incidence of postoperative hyphaema was lower in the 
exfoliation glaucoma group, but not significantly so. Neither 
the type of dissection, nor the occurence of hyphaema 
influenced the IOP at 4 months following surgery.
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PART I MORPHOLOGICAL STUDIES ON THE EXFOLIATION SYNDROME
CHAPTER 1 LITERATURE REVIEW ON THE EXFOLIATION SYNDROME 
General introduction
Exfoliation syndrome may be defined as a discrete clinical 
entity characterised by the production and deposition of 
fine white granular material, (exfoliation material), upon 
and within ocular and orbital tissues. The clinical 
diagnosis of exfoliation syndrome is based on the incidental 
finding of 'dandruff-like' material upon the pupillary 
margin, or 'sugar frosting' of the anterior lens capsule. 
Sight threatening glaucoma and the development of cataract 
are common (Bertelsen 1966, Jerndal 1986). The socio­
economic importance of this age-related disorder is likely to 
increase due to the increasing life expectancy in Western 
societies where the disease is most prevalent.
1.1 History and nomenclature
1.1.1 History
The early literature has been reviewed by Sunde (1956) and 
Tarkkanen (1962). The following description outlines the 
various stages of development in the understanding of the 
disorder.
Differences of opinion on the disorder
From the historical point of view, exfoliation syndrome is 
one of the most controversial subjects in ophthalmic
1
literature. In their review article in 1973, Layden &
Shaffer asserted that 'exfoliation syndrome is a leader 
amongst the topics in ophthalmology that undergo constant 
appraisal as to terminology, pathogenesis and clinical 
implications'. From the clinical standpoint, controversy has 
arisen concerning both the epidemiological and the clinical 
features of the condition (Jerndal 1986, Forsius 1988). Even 
the nomenclature of exfoliation syndrome remains debatable. 
Another problem has been that anecdotal findings reported by 
eminent ophthalmologists have been accorded undue weight.
The first accounts
The Finnish ophthalmologist Lindberg is credited as having 
been the first author to describe the clinical presence of 
exfoliation material. In 1917 he found 'small greyish-white, 
or bluish-grey flakes which originate from the edge of the 
pupillary margin' in the iris of 30 out of 60 patients with 
glaucoma, examined as part of his doctoral thesis work in 
Petersburg. Lindberg thought these flakes were 'old 
inflammatory exudates'. In 1923, the Norwegian, Mailing 
observed 33 cases with 'greyish-white formations on the 
anterior surface of the lens' and assumed that these arose as 
a 'membrane-like exudate on the surface of the lens'.
In 1925, Vogt provided the first detailed clinical 
description of the disorder and accorded the name 
'superficial exfoliation of the anterior capsule of the 
lens'. He was the first to implicate exfoliation material as 
the underlying cause for a secondary glaucoma and to suggest 
that exfoliation glaucoma had a worse prognosis than primary
2
open angle glaucoma (POAG), (Vogt 1930a).
Busacca (1927) was the first author to provide a 
morphological account and exfoliation material was 
subsequently referred to by some authors as 'Busacca's 
deposits' (Sobhy Bey 1932, Sunde 1956). Trantas (1929) was 
the first to suggest that the condition was a more 
generalised disorder affecting all the 'hyaline membranes' of 
the eye. Mailing (1938) proposed a vascular aetiology for 
the 'atrophic exfoliative-depigmentation phenomenon'.
The first British cases of exfoliation syndrome and glaucoma 
were reported by Goulden (1925) and Foster (1933). Goulden 
(1925) presented a 63 year old female with 'rupture of the 
zonular lamella complicating ordinary senile cataract'.
Further developments
The publication of an important paper by Dvorak-Theobald 
(1954) revised the views of many ophthalmologists that 
exfoliation syndrome is a disorder of the lens capsule. 
Dvorak-Theobald provided histological evidence that 
contradicted Vogt's theory and came to the conclusion that 
exfoliation material was a deposit on the lens. She 
introduced the term 'pseudoexfoliation of the lens capsule' 
to stress the unknown origin of the exfoliative aggregates 
and to differentiate the condition from 'true exfoliation of 
the lens capsule'. The latter may rarely be found in 
patients exposed to prolonged and excessive heat (i.e. 
glass-blowers). Blackstad and coworkers (1960) conducted the 
first ultrastructural study of the exfoliation material.
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Detailed accounts of the clinical picture of the condition 
have been provided, among others, by Horven (1937), orgen 
(1949), Horven (1966) and Sugar (1984). Barkan (1936) first 
identified flakes of exfoliation material by gonioscopy. 
Gradle & Sugar (1940) were the first to draw attention to the 
pigmentary changes in the disorder. Irvine (1940) was the 
first to study two different ethnic populations and to 
recognise varied ethnic prevalences. Tarkkanen (1962) 
carried out the first clinical study on 418 patients with 
exfoliation syndrome/glaucoma. He established that 
dilatation of the pupil, using mydriatics, is essential for 
the diagnosis of the condition. A characteristic gonioscopic 
feature of the exfoliation syndrome, termed Sampaolesi's line 
(defined in section 1.9), has been documented by Sampaolesi 
(1959). Vannas (1969) first demonstrated striking vascular 
abnormalities in affected eyes by employing fluorescein 
angiography of the iris. Bartholomew (1971) demonstrated an 
early 'pre-granular' stage in the evolution of the disorder.
1.1.2 Nomenclature
The condition was first referred to both as senile 
exfoliation of the lens capsule and as 'exfoliatio 
superficialis capsulae anterioris' by Vogt (1925). The term 
pseudoexfoliation syndrome has somehow evolved from this term 
to accommodate the full clinical picture of the condition. 
Bertelsen and coworkers (1964) have proposed the term 
fibrillopathia epitheliocapsularis. The term exfoliation 
syndrome was originally put forward by Sunde (1956). 
Pseudoexfoliative fibrillopathy (Streeten et al 1990) is yet
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another term which has recently been coined. Nowadays, as 
there is evidence of multifocal aggregation and possibly 
origin, a retreat to the simple designation exfoliation 
syndrome is gaining popularity (Garner 1990).
None of the terms used in the literature is satisfactory 
because they each simply describe a specific pathological 
feature of the condition and, on the basis of current 
information, are obsolete. The terms exfoliation 
syndrome/glaucoma are used throughout this thesis in 
preference to the terms pseudoexfoliation syndrome/glaucoma 
because there is no current need to distinguish the condition 
from 'true exfoliation of the lens', a condition which is 
rare and does not cause glaucoma. It has also been shown 
that true exfoliation of the lens capsule does occur in a 
number of patients with the condition (Jerndal 1986).
Clearly there is a need for a uniform terminology for this 
condition.
1.2 Pathology of exfoliation syndrome
The motivation for the morphological studies was to identify 
the nature and source of exfoliation substance. The 
appropriate literature is discussed in section 1.4.
1.2.1 Macroscopic appearance
Exfoliation syndrome may be difficult to recognize 
macroscopically. It is seen on the anterior lens capsule in 
two areas, a central disc (Figs 1.1 & 1.2) in the pupillary
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Figure 1.1: Slit-lamp photograph of a patient with exfoliation 
glaucoma to illustrate the central disc (arrows), 
discrete flecks of exfoliation material can be 
discerned in the centre of the disc.
Figure 1.2: Slit-lamp photograph of a patient with exfoliation 
glaucoma. The edge of central disc 
appears more prominent.
region and a band around the periphery, referred to as the 
granular zone, (see section 1.7.2). The central disc 
possesses a flat grey-whitish uniform appearance, which 
sometimes is difficult to distinguish from the lens capsule. 
In some cases the central disc may be conspicuous with a 
clearly defined edge which is sometimes curled inwards (Fig 
1.2). A far more reliable indicator for the presence of 
exfoliation is the granular zone (Figs 1.3 & 1.4).
Feathery excrescences of exfoliation material are commonly 
found along the posterior and less frequently along the 
anterior surface of the iris (Vogt 1938a, Horven 1966), (Fig 
1.5). The ciliary processes (Fig 1.6) and the zonular fibres 
are similarly coated (Trantas 1929, Horven 1936). The 
trabecular meshwork in affected eyes exhibits dense 
pigmentation (Fig 1.7). The 'frosting' of the ciliary body 
and the zonules in the exfoliation syndrome is helpful in 
establishing the diagnosis (Figs 1.6 & 1.8).
1.2.2 Light microscopic appearance
Exfoliation material is described as fluffy, fibrillar, or 
fibrillogranular, eosinophilic, extracellular material, 
forming tree-like structures (Sunde 1956, Tarkkanen 1962, 
Larsen 1969, Duke-Elder 1969, Morrison & Green 1988), (Figs
1.9 & 1.10). The best descriptions offered in the literature 
for the light microscopic (LM) appearance of exfoliation 
aggregates are 'iron filings lining up on a magnet' (Yanoff & 
Fine 1989) and 'bush shaped' accretions (Ringvold 1970a, 
Morrison & Green 1988). Exfoliation aggregates on the
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Figure 1.3: Slit-lamp photograph of an eye with exfoliation syndrome. 
Note the granular zone extending from 
the pupil margin to the arrows. The inset shows 
this zone with a frosted appearance.
Figure 1.4: Slit-lamp photograph of an eye with exfoliation 
glaucoma and cataract. The granular zone 
extends from the pupil margin to the arrows and 
its inner edge is curled.
Figure 1.5: Macroscopic appearance of a globe with exfoliation glaucoma.
Exfoliation material is deposited on the posterior surface of the 
pupillary region (arrow), ciliary body (CB) and zonules (arrowheads). 
Subluxation of the lens is a sectioning artefact.
Figure 1.6 Colour photograph of anterior segment of an eye with
exfoliation glaucoma. Note uneven deposition of white granular 
material (exfoliation material) upon the zonules (arrow) and 
ciliary body (arrowheads).
Figure 1.7 Macroscopic appearance of the anterior chamber angle
in a globe with exfoliation glaucoma. Note dense pigmentation 
of the trabecular meshwork (arrows). C:cornea; l:iris; CB: 
ciliary body; LC: lens capsule; zonules are arrowed.
Figure 1.8: Macroscopic photograph of exfoliation material 
deposition upon the ciliary processes (arrows), 
which occurs in bands. OS: ora serrata.
central disc of the anterior lens capsule appear as sparse, 
short 'vegetations' whereas, on the granular zone they have a 
tall broad bush-shaped appearance (Fig 1.10). Exfoliation 
material has been shown to be loosely attached to the 
anterior lens capsule, zonules and anterior vitreous face and 
firmly adherent to the equatorial lens capsule, pigment 
epithelium of the iris and the non-pigmented ciliary 
epithelium (reviewed by Morrison & Green 1988).
Conjunctiva and cornea
LM has not revealed exfoliation material in the conjunctiva 
(Layden & Shaffer 1974). Exfoliation material has been 
reported to adhere to and even to be endocytosed by the 
corneal endothelium (Dvorak-Theobald 1954). However, Sunde 
(1956) did not detect exfoliation material on the cornea.
Trabecular meshwork
Dvorak-Theobald (1954) studied 3 enucleated eyes and found 
exfoliation material both on the inner surface of the 
trabecular meshwork and amongst the intertrabecular spaces. 
Another study demonstrated exfoliation material around 
Schlemm's canal in all 4 cases of advanced exfoliation 
glaucoma (Kurosawa et al 1983).
The iris
Sunde (1956) found exfoliation deposits in all 23 cases he 
studied. The LM appearance of exfoliation deposits in the 
iris (Fig 1.9) is similar to that in other affected tissues 
and comprises aggregation of exfoliation material principally 
in association with blood vessels (Ringvold 1969; 1970a?
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1970c) and upon the pigment epithelium (Horven 1937, Gifford 
1957) and sporadically, within iris crypts in the anterior 
border layer (Vogt 1925, Sunde 1956). Ringvold (1970c) 
demonstrated exfoliation material in 113 out of 499 iris 
vessels in 8 iridectomy specimens. The affected vessels 
showed, in toluidine blue stained sections, exfoliation 
material as a light blue material, unevenly distributed in 
the normally unstained vascular matrix outside the vascular 
cells).
Ciliary processes
Exfoliation material deposition on the ciliary processes has 
been described in a number of studies (Bussaca 1928, Dvorak- 
Theobald 1954, Larsen 1969, Sugar et al 1976, Morrison & 
Green 1988). The ciliary processes are frequently coated 
with feathery eosinophilic excrescences, which adhere firmly 
to the underlying non-pigmented epithelium and its limiting 
membrane (Fig 1.8).
Zonules
Zonular involvement in the exfoliation syndrome was 
established in 1937 by Horven, who felt that the 'zonular 
changes are of constant nature and form an integral part of 
the clinical picture of exfoliation'. Gradle & Sugar (1940) 
and Dvorak-Theobald (1954) confirmed Horven's observations. 
Gifford (1957) found an intimate association between 
exfoliation material and the zonules whereas, the lens 
capsule was ostensibly normal.
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Figure 1.9: Histological section of exfoliative iris. Exfoliation material (arrows) 
covers the posterior surface of the pigmented epithelium, which is 
serrated. S:iris stroma; D:dilator muscle; vessels are arrowheaded. 
The anterior border layer is bounded by a neovascular membrane(nv).
Figure 1.10: Histological section of anterior exfoliative lens capsule (LC).
Exfoliation aggregates present on its surface are ‘bushy’ in 
appearance. E:lens epithelium.
The lens
Bussaca (1928) described vacuoles in the superficial and deep 
layers of the lens capsule. Dvorak-Theobald (1954) and 
others (Sunde 1956, Gifford 1957, Horven 1966) have noted 
that in enucleated eyes exfoliation deposits can easily be 
removed mechanically leaving behind a 'normal' lens capsule. 
However, other investigators have provided evidence of 
underlying alterations in the lens capsule in association 
with the exfoliation syndrome namely an amorphous layer close 
to the lens epithelium, which was not present in normal 
controls (Bertelsen et al 1964, Dark et al 1969). Larsen 
(1969) studied 100 autopsy eyes and found this amorphous 
layer in all 12 eyes with the exfoliation syndrome and in 
none amongst the controls. Gifford (1957) demonstrated 
thickening of the anterior lens capsule in 2 out of 6 lenses. 
'True exfoliation' (peeling off) of the anterior layer of the 
lens has also been observed (Gifford 1957, Dark et al 1977, 
Morrison & Green 1988).
Other tissues
The anterior vitreous face may contain exfoliation deposits, 
which appear as radial stripes (Sunde 1956, Larsen 1969). 
Exfoliation material has not been detected by LM beyond the 
boundaries of structures bathed by the aqueous.
1.2.3 Ultrastructural appearance
Electron microscopy (EM) has made it feasible to examine 
exfoliation material in greater detail (Figs 1.11 & 1.12).
In the first transmission electron microscopic (TEM) study
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Blackstad and coworkers (1960) described exfoliation material 
as 'heterogeneous deposits consisting of numerous fibres of 
varying form and size that most often lie in accumulations 
with ill-defined outlines'.
Several investigations have described exfoliation material 
since Blackstad's early study (including Ringvold 1969;
1970b, Rohen & Witmer 1972, Witmer & Rohen 1976, Dark et al 
1977, Harnisch 1977, Davanger 1978; 1980, and Dark & Streeten 
1990). The dominant ultrastructural feature of exfoliation 
material is the presence of straight, or slightly bent 
exfoliation fibres with blunt (Ringvold 1970b, Dark &
Streeten 1982), or split (Harnisch 1977) ends. The fibres 
are randomly orientated (Ringvold 1969; 1970a, Seland 1988) 
and electron-dense in nature (Dark et al 1977, Harnisch 
1977). Their width has been reported to vary between 20-80 
nm (Nishi et al 1976, Harnisch 1977, Takei & Mizuno 1978, 
Seland 1979; 1988, Davanger 1980). Their length ranges 
between 100 and 700 nm (Harnisch 1977, Shimizu 1985), but has 
been reported to vary up to 5 microns (Davanger 1975). 
Exfoliation fibres are most often identified by a distinctive 
aggregation pattern resembling 'meshwork' of randomly 
distributed, incompletely separated fibres. Davanger (1980) 
has suggested that the fibres may enlarge by the accumulation 
of new material on their surface. To date, there is no 
information in the literature concerning the effects of 
conventional processing on the morphology of exfoliation 
fibres. It is conceivable that fixation and osmication of 
exfoliative tissues may influence considerably the morphology 
and dimensions of exfoliation material.
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Figure 1.11: Transmission electron micrograph of exfoliation material aggregates(ex) 
on the basal surface of the iris posterior pigmented epithelium 
(PPE). The basement membrane is absent and exfoliation material is 
present between cells (arrows).
Figure 1.12: Transmission electron micrograph of exfoliation material in the 
trabecular meshwork of a patient with exfoliation glaucoma.
An aggregate of exfoliation material (ex) 
lies in the intertrabecular space (ITS).
Periodicity
There is a lack of agreement as to the precise periodicity of 
exfoliation material. Overall, exfoliation fibres have been 
shown to display a major banding between 17-56 nm (Blackstad 
et al 1960, Bertelsen et al 1964, Ringvold 1969, Davanger 
1980, Garner & Alexander 1984, Dark & Streeten 1982, Roh et 
al 1987) and a more inconsistent micro-periodicity of 
approximately 4-10 nm (Takei & Mizuno 1978, Dark & Streeten 
1982). Streeten and coworkers (1990) found considerable 
variation in the structure of exfoliation fibres in different 
ocular and extraocular sites. Exfoliation fibres were 
divided into type A fibres (long, thin fibres up to 0.6 
microns long) and type B fibres (short, thicker with 
unspecified length). A periodicity of 20-25 nm was more 
prominent on type A fibres, whereas type B fibres appeared to 
contain an increased amount of densely osmiophilic coating. 
Streeten and coworkers (1990) also observed that in the iris 
stroma exfoliation fibres tended to be shorter and less 
clearly banded, in comparison with the lenticular aggregates.
Other structural components
Two other structural components of exfoliation material have 
been described (Davanger & Pedersen 1975, Davanger 1978; 
1980a? 1980b). A filament with a uniform width of 10 nm and 
a length up to 1 micron and an amorphous interfibrillar 
matrix in which exfoliation fibres and filaments are 
embedded. Davanger (1980a) employed lanthanum to enhance the 
structural features. He hypothesised that the basic unit of 
exfoliation material, the exfoliation fibril (fibre), may be 
formed by lateral aggregation of these filaments.
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Ultrastructural distribution of exfoliation material
The distribution of exfoliation material and the associated 
matrix changes are described in relation to the tissue 
involved:
a) Conjunctiva
Exfoliation material was first localised in the conjunctival 
stroma by Ringvold (1972). Subsequent reports have shown 
that the involvement of the conjunctiva is a distinct feature 
(Ringvold 1973c, Speakman & Ghosh 1976, Roh et al 1987,
Prince et al 1987, Streeten et al 1987; 1990). Ringvold 
(1972? 1973c) observed exfoliation material as densely packed 
aggregates which measured up to 22 microns across, consisted 
of irregularly arranged exfoliative fibres and contained 
elastic elements, collagen and some granular material. 
Abundant exfoliation material deposits adjacent to 
multilayered vascular basement membranes were also observed 
(Ringvold 1972).
Speakman & Ghosh (1976) found exfoliation material in the 
loose connective tissue of the conjunctiva, adjacent to the 
endothelium of thin-walled lymphatics and occasionally in 
close apposition to the walls of blood vessels. Roh and 
coworkers (1987) found no evidence of exfoliation material 
deposition near blood vessels but found 'poorly orientated 
microfibrils in close proximity to fibroblasts and 
elastic/collagen fibres'. Streeten and coworkers (1987) 
established a close relationship between exfoliation 
aggregates and stromal fibroblasts and elastosis. In 
contrast with previous studies they stated that 'exfoliative
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fibres did not appear to be specifically related to collagen 
and exfoliative clumps did not contain visible collagen'.
The conflicting evidence on the exfoliative conjunctiva may 
be attributable to a difference in the material employed; 
Ringvold (1972) studied enucleated eyes, whereas, Roh et al
(1987) and Streeten et al (1987) studied small tissue samples 
(i.e. conjunctival biopsies). Alternatively, the appearance 
of exfoliation material within and adjacent to conjunctival 
vascular basement membranes established by Ringvold (1972; 
1973c) and Speakman & Ghosh (1976) may be a late phenomenon 
in the evolution of the disease.
b) Cornea
In a study on the cornea from eyes with exfoliation syndrome 
Sampaolesi and coworkers (1988) studied the accumulation of 
pigment upon the corneal endothelium. They suggested that 
the pigment seen biomicroscopically consisted of melanin 
granules located close to the cell nucleus within the 
endothelial cells.
c) Trabecular meshwork
In the first investigation on the exfoliation outflow system 
Ringvold & Vegge (1971) noted exfoliation material in the 
outflow system of 3 enucleated eyes. In the first eye with 
normal intraocular pressure (IOP), exfoliation material was 
present only in the inner intertrabecular spaces as clumps of 
varying size and density, often touching the trabecular 
endothelial cells. In the second eye, (with ocular 
hypertension), exfoliation material was also found in
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asymmetric vacuoles inside the endothelial lining of 
Schlemm's canal; within the cribriform layer and in the outer 
walls of Schlemm's canal. Most giant vacuoles appeared 
empty, but significantly, some were filled with exfoliation 
material. In the third eye, (which had exfoliation glaucoma 
with bullous keratopathy), the amount of exfoliation material 
was greater than in the other two eyes. The trabecular beams 
were disorganised often lacking endothelial cells. In that 
eye the endothelial lining of Schlemm's canal showed areas of 
marked thinning and the cribriform layer was packed with 
exfoliation material. No giant vacuoles were seen.
Subsequent reports have demonstrated exfoliation material in 
the uveal meshwork (Sampaolesi & Argento 1977, Kurosawa 1981, 
Richardson & Epstein 1981) , within the cribriform layer 
(Benedikt & Roll 1979, Shimizu et al 1980, Kurosawa et al 
1983, Ito & Inomata 1985, Lutjen-Drecoll et al 1986, Rohen & 
Jikihara 1988) and in the outer wall of Schlemm's canal 
(Benedikt & Roll 1979, Kurosawa 1981, Kurosawa et al 1983). 
Some, but not all, published studies have found that some of 
the giant vacuoles in the lining endothelium of Schlemm's 
canal contain exfoliation material (Ringvold & Vegge 1971, 
Benedikt & Roll 1979, Kurosawa 1981, Richardson & Epstein 
1981, Dark & Streeten 1982). To date, only one study has 
localised exfoliation material in the external collector 
channels (Kurosawa et al 1983). Figure 1.12 illustrates an 
aggregate of exfoliation material in the trabecular meshwork.
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d) iris
There are 14 TEM studies which report the ultrastructural 
features of the exfoliative iris (Shakib et al 1965, Ringvold 
1969? 1970a? 1970c? 1973a, Anastasi et al 1974, Ghosh & 
Speakman 1974, Shimizu et al 1980, Ringvold & Davanger 1981, 
Shimizu & Futa 1985, Shimizu 1985, Ito & Inomata 1985, 
Spinelli et al 1985, Sugino 1990)? (Fig 1.11). The 
ultrastructural features of the exfoliative iris are the 
subject of the first part of this thesis and the relevant 
literature is discussed in sections 5.2.4 and 6.4.
e) Ciliary body
Shakib and coworkers (1965) were the first to describe the 
ultrastructural changes of the exfoliative ciliary body based 
on their observations in one enucleated eye. They found 
exfoliation material in the surface convolutions and within 
the basement membrane (internal limiting membrane) of the 
non-pigmented ciliary epithelium. Exfoliation material was 
not observed in the cytoplasm, or nuclei of intact cells. It 
is interesting to note that in that study the pigmented and 
the non-pigmented epithelial cells and the blood vessels (no 
location given) were normal? no evidence of exfoliation 
material was found in the perivascular tissue or stroma.
In a subsequent investigation Ghosh & Speakman (1973) studied 
an eye enucleated for painful absolute glaucoma. They found 
similar features, but also noted marked localised thickening 
of the basement membrane of the non-pigmented ciliary 
epithelium in places where exfoliation material had 
accumulated. There were numerous uninvolved portions of the
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basement membrane of the non-pigmented ciliary epithelium, 
with abrupt transitions between diseased and exfoliation free 
basement membrane. In their study the thickest most heavily 
stained exfoliation fibres were located in the middle third 
of the basement membrane. The inner third (i.e. the one in 
direct communication with the posterior chamber) contained 
only a few exfoliative fibres. This finding implies that 
exfoliation material may be actively synthesised by the non- 
pigmented epithelium of the ciliary body.
Davanger (1975) has provided the only SEM study of the 
exfoliative ciliary body to date. He examined 3 enucleated 
eyes to visualise 'plaques' of exfoliation material attached 
to parts of the ciliary body, particularly to the surface of 
the ridges of the ciliary processes.
f) Zonules
There are four studies of the zonular fibres at the site of 
their attachment to the lens (Ashton et al 1965, Takei & 
Mizuno 1978, Futa & Furuyoshi 1989, Chijiiwa et al 1989). 
These studies have shown the zonules to be encrusted with 
accumulations of exfoliation material (Ashton et al 1965, 
Takei & Mizuno 1978) and degeneration of the zonular fibres 
in association with heavy deposition of exfoliation material 
(Futa & Furuyoshi 1989, Chijiiwa et al 1989). The latter 
feature was observed in zonules of lenses obtained from 
exfoliation glaucoma patients with clinical evidence of 
phakodonesis.
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g) Lens
The literature on the fine structure of the exfoliative lens 
has recently been reviewed by Seland (1988). In the surface 
layer of the anterior lens capsule exfoliation material is 
often mixed with degraded cell products, of which iris 
pigment granules are the most frequent (Bertelsen et al 1964, 
Dark et al 1977, Takei & Mizuno 1978). In a recent study, 
Dark & Streeten (1990) have suggested that the presence of a 
'precapsular film' on the ageing lens capsule is a 
conceivable precursor of the exfoliation syndrome development 
on the lens. By SEM, this film appeared as a friable 
incomplete fibrillar layer, with rolling of the edges 
suggesting loose attachment. However, the importance of this 
finding was limited by the observation of some degree of 
precapsular film in control tissue.
The description of the lenticular features of the disease are 
conflicting. For example, the 'amorphous layer' observed by 
Bertelsen and coworkers (1964) could not be confirmed by 
Benedikt (1973). Seland (1979; 1988) documented an increased 
thickness of the exfoliative capsule. However, another study 
on 105 cataractous lenses showed no statistical difference in 
the capsular thickness between exfoliation-positive and 
exfoliation-negative lenses (Ruotsalainen & Tarkkanen 1987). 
Previous published work has stressed the importance of 
numerous fibrillogranular lenticular inclusions (Dark et al 
1969, Bertelsen & Seland 1971) and lens epithelial pits 
(Bertelsen et al 1964, Dark et al 1969, Ueno et al 1987) in 
the evolution of exfoliation syndrome. However, all these 
features have been documented in clinically normal elderly
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patients (Ghosh & Speakman 1972, Dickson & Ramsey 1979,
Seland 1988). From the information available, only long term 
follow up of the development and progression of the 
lenticular changes in the exfoliation syndrome could 
delineate the complete spectrum and specificity of the 
pathological features that relate to the disease alone, as 
contrasted to those attributable to ageing, or cataract.
h) Vitreous body
Only one SEM study has documented the involvement of the 
vitreous cavity in the exfoliation syndrome (Davanger 1975b). 
Exfoliation material accumulated in an unspecified number of 
cases upon the anterior vitreous face of aphakic eyes in the 
form of radial stripes, presumably as a consequence of 
deposition from the aqueous humour.
i) Orbital sites
Formerly, exfoliation syndrome was considered principally a 
disease of the anterior segment of the eye. In the last two 
years however, two studies have identified exfoliation 
material, (or material morphologically similar to exfoliation 
material), in a number of previously unrecognised extraocular 
sites. First, Kiichle and coworkers (1991) reported 
involvement of the recti muscles, vortex veins, and optic 
nerve sheath in a single case. Schlotzer-Schrehardt and 
coworkers (1991a) reported the presence of exfoliation 
material in the orbital connective tissue septae and central 
retinal vessels. These authors found unevenly distributed 
deposits of exfoliation material among normal connective- 
tissue components such as elastic fibres, collagen fibres and
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Figure .13: Summary diagram indicating the various sites 
(red circles) in which exfoliation material has 
been documented by transmission electron
mirrnsrnnu
fibroblasts. In all 5 eyes exfoliation material aggregates 
were not evident in extrabulbar locations by LM, but could 
only be discerned by TEM examination of serial sections. 
Schlotzer-Schrehardt and coworkers (1991a; 1991b) have stated 
that in 2 cases exfoliation material localised in extrabulbar 
locations by TEM, could not be identified in intraocular 
locations (ciliary body and iris). The authors have 
speculated that the development of extraocular exfoliation 
syndrome may precede its intraocular appearance.
1.2.4 Is exfoliation syndrome a systemic disease?
In a recent study Sugino (1990) has reported typical 
exfoliation material in the dermis of the lateral canthus in 
3 out of 9 cases of exfoliation positive patients. He 
confirmed the diagnosis in all 9 patients by examination of 
the iris. He also noted 'immature' forms of exfoliation 
material in the other 6 cases and suggested that exfoliation 
syndrome may be a systemic degenerative disease of the body. 
In an attempt to resolve the question of whether exfoliation 
syndrome is a local, or systemic disorder Streeten and 
coworkers (1990) carried out an ultrastructural examination 
of skin biopsy specimens from one to three areas in 13 
patients with ocular signs of exfoliation syndrome. A 
'fibrillopathy' closely resembling that seen in the affected 
eye was found in 11 out of 13 patients. Exfoliation material 
occurred primarily along elastic fibres. The authors 
concluded that exfoliation syndrome is a systemic disorder.
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Figure 1.13 summarises the ocular and extraocular locations 
in which exfoliation material has been documented by TEM. 
Although recent evidence suggests that exfoliation material, 
or material which morphologically resembles exfoliation 
material, can be found in the skin of patients with 
exfoliation syndrome uncertainties remain about the 
significance of these findings. As conceded by Streeten and 
coworkers (1990) the diagnostic criteria employed in their 
study for the detection of exfoliation material must be 
supported by immunocytochemical, or biochemical data.
1.3 Nature of exfoliation material
The nature of exfoliation material has been extensively 
investigated, but remains obscure (reviewed by Dickson & 
Ramsey 1979, Jerndal 1986, Morrison & Green 1988, Ringvold 
1988). Published work has indicated that exfoliation 
material is a complex compound (Davanger & Pedersen 1975, 
Dark et al 1977, Baba 1983, Streeten et al 1984, Ringvold 
1988), which may even vary in its morphology in different 
regions of the eye (Streeten et al 1987? 1990).
1.3.1 Histochemical studies
The first histochemical description of exfoliation material 
was included in Dvorak-Theobald's paper (1954). The author 
states that 'since exfoliation material is moderately 
positive with PAS and Millon tests it may be assumed that 
mucopolysaccharides (glycosaminoglycans) and tyrosine are 
present'. In a subsequent study, Arnesen and coworkers
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(1963) digested paraffin sections of enucleated eyes with 
exfoliation glaucoma with collagenase. It was found that 
although the lens capsule disappeared, exfoliation deposits 
remained unaltered. They suggested that the exfoliation 
deposits are chemically different from the lens capsule and 
probably do not consist of collagen. They also found faint 
staining with Alcian Blue and therefore lent their support to 
Dvorak-Theobald's hypothesis that glycosaminoglycans are 
present in the exfoliation material.
Bertelsen and coworkers (1964) found these reports 
unconvincing because 'glycosaminoglycans are PAS negative and 
if they were present in large quantity then the Alcian Blue 
reaction should have been strongly blue'. On the other hand, 
they asserted 'mucoproteins and glycoproteins stain weakly 
blue with Alcian Blue'. Bertelsen & Ehlers (1969) 
investigated the histochemical properties of exfoliation 
material aggregates on the lens surface of 7 lenses from 
patients with exfoliation syndrome, who had undergone 
intracapsular cataract extraction. In their study the 
abnormal material stained lightly with toluidine blue 
and was completely negative with Sudan black B (stain for 
lipids), Congo-red (for amyloid), Alcian blue (for 
glycosaminoglycans), and elastin/Weigert reticulin stain (for 
elastic fibres). The excrescences were positive with Millon 
stain (for tyrosine), Acid fuchscin -van Gieson- stain (for 
collagen) and reticulin stain (for reticulin fibres). The 
same authors carried out a number of enzyme digestion 
experiments in 5 exfoliative lenses fixed in a mixture of 
acetic acid and ethanol. Exfoliation aggregates and
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fibrillogranular inclusions within the lens were resistant to 
proteolytic enzymes: pepsin, trypsin, chymotrypsin, 
collagenase and papain (Bertelsen & Ehlers 1969).
Periodic acid-Schiff stain
Periodic acid-Schiff stain (PAS), which demonstrates the 
presence of mucoproteins, glycoproteins and lipoproteins has 
reacted positively with exfoliation material in some studies, 
but the PAS reaction has not been uniformly reported.
Although initial studies reported it to be positive (Dvorak- 
Theobald 1954, Horven 1966), Bertelsen and coworkers (1964) 
found it to be 'mostly negative'. In an ensuing study 
Bertelsen & Ehlers (1969) reported that the excrescences on 
the surface of the lens capsule were weakly positive (red) 
with PAS staining. Dark and coworkers (1969) reported 
exfoliation material to be PAS positive, Alcian blue negative 
and strongly positive with Chrome haematoxylin. They noted 
variable colouration with their tests which they attributed 
to the compound nature of the abnormal substance.
Exfoliation material and amyloid
Ringvold & Husby (1973) reported positive staining of 
exfoliation aggregates on the ciliary body and on the 
posterior iris surface after staining with Sirius red and 
Congo red. Ringvold & Husby (1973) have argued that 
exfoliation material should be classified amongst the 
amyloid-like substances. Indeed, in an TEM investigation 
Meretoja & Tarkkanen (1977) demonstrated amyloid-like 
deposits in 19 selected specimens (17 enucleated eyes, one 
autopsy, one iridectomy) from eyes with exfoliation syndrome.
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Amyloid material is difficult to distinguish histologically, 
but can be histochemically differentiated from exfoliation 
material (Schwartz et al 1982). Subsequent reports have been 
unable to confirm the previous positive histochemical results 
for amyloid in the exfoliation material. Dark and coworkers 
(1977) studied sections from 3 cataractous lenses with 
exfoliation syndrome and reported that Congo red dichroism, 
the most critical histochemical test for amyloid, was not 
present. Several studies since have confirmed that 
exfoliation aggregates do not stain with Congo red (Garner & 
Alexander 1984, Streeten et al 1984; Li et al 1989). Thus 
today, there is little support for the view that exfoliation 
syndrome is a type of amyloidosis. Nevertheless, it is 
conceivable that exfoliation material is an amyloid-like 
substance which does not stain with Congo red.
1.3.2 Biochemical and tissue culture studies
Amino acid analysis
A preliminary amino acid analysis of exfoliation material was 
performed by Ringvold in 1973. The author collected 
exfoliation material from the anterior surface of 18 lenses 
with demonstrable deposits. The amino acid analysis 
according to this study showed that exfoliation material was 
rich in glutamic acid and aspartic acid. It contained 
glycine, proline, serine and alanine; and was deficient in 4- 
hydroxyproline. Ringvold (1973) suggested that this profile 
was consistent with the presence of proteins and made it 
unlikely that collagen was a significant component of 
exfoliation material (as collagen is rich in
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4-hydroxyproline). He was of the opinion that exfoliation 
material had a similar amino acid profile to amyloid, the 
microfibrillar component of elastic fibres and the non- 
collagenous proteins of the basement membranes.
Aqueous humour studies
Baba (1983) provided evidence of an abnormal electrophoretic 
pattern (peculiar tailing and a biphasic pattern in albumin) 
in 3 aqueous samples from eyes with exfoliation syndrome.
The author speculated that his observations indicated an 
abnormal overproduction of glycosaminoglycans in the 
exfoliation syndrome. Hannappel and coworkers (1985) studied 
the amino acid pattern in the aqueous humour of 5 patients 
with exfoliation syndrome, in comparison with 27 POAG 
patients and 30 controls (cataract patients). All 21 amino 
acids studied showed higher levels in POAG than in 
exfoliation, or control patients. Ringvold and coworkers 
(1989) have studied 4 exfoliative lens capsules with SDS-PAGE 
electrophoresis and established the presence of two 
polypeptides (molecular weight estimated between 14,400 and 
20,000), not present in their controls. The significance of 
these findings was difficult to assess, but the authors have 
speculated that either exfoliation syndrome generated unknown 
products, or these polypeptides represented fragments from 
established proteins. In the same study, 15 pooled aqueous 
samples collected during cataract surgery from patients with 
exfoliation syndrome were analysed. No definitive 
differences with the controls could be obtained.
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Tissue culture studies
Only one tissue culture study has been performed to date on 
the exfoliation syndrome. Ringvold & Nicolaissen (1990) 
studied by TEM samples of iris tissue from 8 exfoliation 
positive patients and 6 normal controls. The iridectomy 
specimens were cultured on tissue culture plastic and on 
biological basement membranes. Extracellular fibrillar 
material closely resembling exfoliation material appeared to 
originate from the newly divided cells in the exfoliation- 
positive iris tissue after four weeks.
1.3.3 Immunohistochemical studies
Immunooeroxidase studies
Harnisch and coworkers (1981), employed the indirect 
immunoperoxidase technique to study 3 lenses from patients 
with the exfoliation syndrome. The authors treated semi-thin 
frozen sections with antibodies against basement membrane 
proteoglycans (BM^ P^G isolated from EHS-sarcoma) and found 
positive staining for basement membrane proteoglycans. The 
authors considered that their findings supported the 
hypothesis that the disorder is caused by a disturbance in 
the biosynthesis of basement membranes.
Streeten and coworkers (1986), employed indirect LM and EM 
peroxidase techniques with polyclonal and monoclonal 
antibodies to study 10 lenses with the clinical diagnosis of 
exfoliation syndrome. Exfoliation aggregates stained with 
zonular antisera (most intense staining, mainly in the outer 
portions of large exfoliation fibres), bovine elastic
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microfibrillar protein (less diffuse staining, less 
penetration) and monoclonal fibrillin antibody (diffuse 
stain). Streeten and coworkers (1986) offer evidence which 
indicates that the ocular zonules share similar histochemical 
properties and some component, or components with the 
exfoliation material. The significance of these results 
however, remains uncertain. Firstly, the peroxidase method 
results in a diffuse aggregate which makes the precise 
localisation of the antibody difficult. Secondly, as 
conceded in the paper, the antibodies employed may have 
labelled more than one antigen. Finally, in support of their 
hypothesis, the authors claim that 'we have found no cross­
reactivity (unpublished work) between exfoliation material 
and three basement membrane components: type IV collagen, 
laminin and basement membrane proteoglycan'. Since at that 
time, the distribution of these three important ECM 
components in the normal ocular tissues was unknown, their 
comment is surprising. It is reasonable to assume that the 
specific immunohistochemical localisation of collagen type 
IV, laminin and basement membrane proteoglycan would have 
been of considerable interest to the scientific community.
On the other hand, failure to establish the distribution of 
these three basement membrane components in the normal ocular 
tissues invalidates the negative results obtained for 
exfoliation material.
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1.3.4 Immunocytochemical studies
Elastin and exfoliation material
In the first immunogold study, to investigate the nature of 
exfoliation material, Li and coworkers (1988) have shown the 
presence of elastin and tropoelastin in exfoliation material. 
Specimens were examined from 12 patients with exfoliation 
syndrome/glaucoma diagnosed clinically and histologically. 
Evidence for elastin and tropoelastin-associated epitopes in 
exfoliation material was seen in both the intraocular and 
conjunctival sites. Some variability in binding affinity was 
seen in the different ocular sites and immunogold labelling 
was seen more often on the periphery than in the centre of 
the exfoliation fibres.
Neither elastin, nor the elastic microfibrillar protein are 
known to be circulating proteins. Indeed, the secretion of 
these molecules in the extracellular space is rapidly 
followed by cross-linking and insolubility (Ruggeri & Motta 
1984, Ringvold 1992 personal communication). Therefore, this 
observation implies secretion of these molecules by local 
ocular cells, especially basement membrane-producing cells.
As the authors concede, 'all of the cells in juxtaposition to 
exfoliation material in the posterior chamber are epithelial 
cells, not known to engage in elastogenesis normally' (Li et 
al 1988). To substantiate this hypothesis Li and coworkers
(1988) quote three lines of evidence. First, unpublished 
observations of elastin epitopes in cultured ciliary non- 
pigmented epithelial cells. Second, the likelihood that 
zonular fibres are synthesised by the non-pigmented
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epithelium of the ciliary body. Thirdly, the appearance of 
microfibrils resembling elastic microfibrils, or oxytalan in 
proximity to basement membranes (e.g. Descemet's membrane) in 
some unspecified disorders. These authors have concluded 
that exfoliation syndrome arises from abnormal regulation of 
extracellular matrix (ECM) synthesis (Li et al 1988).
Amvloid P and exfoliation material
In a recent review article Ringvold (1988) has suggested that 
in retrospect, the observed cross-reaction between anti­
amyloid serum and exfoliation material could have been 
attributable to the presence of amyloid-P, a less prominent 
component of all types of amyloid which constitutes 5-10% of 
the dry weight of amyloid substance. In addition, Ringvold 
states that 'the same substance is part of the normal 
basement membrane and it may be part of the exfoliation 
material if this is an abnormal basement membrane product'.
Indeed, Li and coworkers (1989) have recently demonstrated by 
immunoelectron microscopy the presence of amyloid P protein 
in exfoliation aggregates from 14 ocular and conjunctival 
specimens from patients with exfoliation syndrome. In their 
study amyloid was not found by Congo red stain, or 
ultrastructural examination. Moreover, immunostaining of 
exfoliation material for other common amyloid proteins, 
including amyloid A, prealbumin and immunoglobulin light 
chains was negative in most cases. Immunoelectron microscopy 
on Lowicryl sections revealed weak labelling for amyloid P 
mostly on the edges of exfoliation fibres. No labelling for 
amyloid P was seen on oxytalan fibres, in the zonules and in
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the lens capsule. The authors were of the opinion that the 
consistent presence of amyloid P, a minor serum component, 
within exfoliation aggregates indicated a specific 
association. They proposed that there may be similar binding 
sites on exfoliation fibres with those on elastic fibres. 
However, no direct data was obtained in any of their 
specimens to support this hypothesis.
There are two limitations to the study by Li and coworkers
(1989). First, as the authors themselves point out, it is 
well documented that a varied degree of iris vasculopathy is 
a common feature of the exfoliation syndrome. This increased 
permeability of the walls of iris vessels and the consequent 
leakage of protein could account for the presence and binding 
of amyloid P. Second, amyloid P is present in basement 
membranes. The authors refute this possible source of 
amyloid P since 'they did not find it in the lens capsule'. 
However, lens capsule is a highly specialised basement 
membrane with a unique ECM composition (Marshall et al 
199Id). It is the vascular basement membranes that are the 
likely sites of amyloid P, but there is no mention of these 
in the paper.
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1.4 Origin of exfoliation material
Several anatomical sites have been proposed for the origin of 
exfoliation material, but the published reports to date have 
not established the principal source(s) with any certainty.
The lens
Bertelsen and coworkers (1964) and Dark and Streeten (1969) 
supported the exclusive lenticular origin of exfoliation 
material with the fine structural observation of 
fibrillogranular inclusions apparently emanating from the 
diseased epithelium. The morphological similarity between 
these inclusions and exfoliation fibrils prompted these 
investigators to suggest a lenticular origin for exfoliation 
material. The supporters of the lens epithelial origin 
believed that exfoliation material originates from a 
metabolically abnormal lens epithelium and subsequently 
migrates through the lens capsule.
The uvea
In 1951, Weekers and coworkers proposed that the primary 
change in exfoliation syndrome was an atrophy of the 
the pigmented epithelium of the iris and thus exfoliation 
material was depigmented iris tissue. Sunde (1956) 
highlighted the importance of the close proximity of the iris 
in the formation of the peripheral band of exfoliation 
material on the lens. He showed that patients with an iris 
coloboma and exfoliation syndrome exhibited a discontinuous 
band of 'lenticular' exfoliation material at the site of the 
iris coloboma.
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Sugar in a series of publications (Sugar et al 1976, Sugar 
1976? 1980? 1984) provided evidence suggesting that the iris 
may be the source of exfoliation material. He pointed out 
that the pattern of exfoliation deposition upon the lens was 
dependent upon the configuration of the iris. In a case 
report he demonstrated changes in the typical circular 
pattern of exfoliation material deposition on the lens 
capsule of a patient with post-traumatic alteration of the 
iris shape (Sugar 1976). He considered that exfoliation 
material could not originate from the lens as it could not 
pass through the thick lens capsule. Most investigators in 
the subsequent literature appear to have tacitly accepted 
that the iris may be an additional source of exfoliation 
material (reviewed by Morrison & Green 1988). The ciliary 
epithelium has also been considered a source of exfoliation 
material, although the evidence for this is more tentative 
(section 1.2.3).
The morphological evidence put forward by the supporters of 
the uveal origin of the exfoliation material had one inherent 
weakness. It does not exclude the possibility of exfoliation 
material originating from the lens epithelium subsequently 
being transferred to uveal locations via the aqueous 
circulation. The exclusive lenticular origin of the 
exfoliation material started to lose favour only when 
clinical and ultrastructural studies supplied comprehensive 
evidence of exfoliation material synthesis in the absence of 
the lens. Exfoliation material synthesis was shown to 
commence (Fellner & Benedikt 1971) and continue (Radian & 
Radian 1975, Sugar 1980, Caccamise 1981) long after removal
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of the lens by intracapsular cataract extraction. In a case 
report, Ghosh & Speakman (1983) confirmed, by TEM examination 
the absence of exfoliation material from the lens removed 
from the uninvolved eye of a patient with unilateral 
exfoliation syndrome. Five years later, the patient 
developed exfoliation syndrome in the originally uninvolved 
eye. Nine years later, when the eye was removed at autopsy, 
typical exfoliation fibres were found in the iris, the 
ciliary body and the anterior vitreous. Furthermore, in a 
recent iris tissue culture study, Ringvold & Nicolaissen
(1990) provided evidence to suggest in vitro synthesis of 
exfoliation material in the iris.
A comparable pattern of exfoliation material distribution to 
that found on the human lens has been shown to arise on the 
surface of plastic intraocular lenses following extracapsular 
cataract surgery (Ringvold & Bore 1990). Published evidence 
thus favours the synthesis of exfoliation material in the 
iris, but the precise pathway remains uncertain. The 
plausible role of the ciliary epithelium in the synthesis of 
exfoliation material requires further elucidation.
Other sites of synthesis
Ringvold & Vegge (1971) proposed that the trabecular meshwork 
may be an independent source of exfoliation material. The 
case for local synthesis of exfoliation material in the 
trabecular meshwork has not been substantiated since that 
study. Ringvold (1972; 1973) provided TEM evidence for the 
presence of exfoliation material in the limbal (1972) and 
palpebral (1973) conjunctiva. He considered it unlikely that
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exfoliation material was transported to the palpebral 
conjunctiva, as this tissue is neither exposed to the aqueous 
humour, nor to the blood supply of the anterior segment. He 
proposed that the conjunctiva is an additional source of 
exfoliation material. Indeed, Prince and coworkers (1987) 
have proposed that the synthesis of exfoliation material in 
the conjunctiva may precede the clinically obvious disease.
A recent report by Schlotzer-Schrehardt and coworkers (1991a) 
has provided evidence of exfoliation material in a number of 
extrabulbar locations including the orbit (section 1.2.3). 
They have proposed that synthesis of exfoliation material 
outside the globe may precede its intraocular appearance.
On reviewing the literature on the origin of exfoliation 
material, Dark & Streeten (1982) highlighted a potential 
complicating factor: exfoliation material may aggregate in 
locations remote from the original site of synthesis. This 
question can only be resolved when accurate biochemical data 
are obtained on the composition of exfoliation material in a 
variety of anatomical locations.
1•5 Pathogenesis
1.5.1 Pathogenesis of exfoliation syndrome
The theories concerning the pathogenesis of exfoliation 
syndrome have been extensively reviewed (Horven 1937, Dickson 
& Ramsey 1979, Dark & Streeten 1982, Jerndal 1986, Ringvold 
1988, Morrison & Green 1988). Although there are no known 
published studies on animals, exfoliation syndrome is
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considered to be a disease peculiar to man. On the basis of 
studies published on the subject, the risk to individuals is 
related to ageing (section 1.6.8).
The basement membrane disorder theory
Anomalous basement membrane synthesis may well underly the 
pathogenesis of exfoliation syndrome (Bertelsen et al 1964, 
Anastasi et al 1974, Sugar et al 1976, Seland 1988, Morrison 
& Green 1988). Vascular basement membrane abnormalities 
accompany the perivascular accumulation of exfoliation 
material (Ringvold 1969? 1970a? 1988, Ringvold & Vegge 1971, 
Harnisch 1977, Eagle et al 1979, Garner 1990) and basement 
membrane proteoglycan components have been identified in such 
material (Harnisch et al 1981). However, morphologically 
only specific basement membranes are involved (e.g. vascular 
basement membranes) but the basement membrane of the cornea 
and retina have never been implicated (Seland 1985).
To summarise, most workers in the field still favour the 
hypothesis that exfoliation syndrome is a form of basement 
membrane disorder (Ringvold 1969? 1988, Layden & Shaffer 
1973, Sugar et al 1976, Dickson & Ramsey 1979, Harnisch et al 
1981, Layden 1982, Seland 1985, Yanoff & Fine 1989, Garner 
1990), but the evidence for this is still circumstantial.
The elastosis theory
Streeten and coworkers (Streeten et al 1984? 1986a? 1987 & Li 
et al 1988) have postulated that the exfoliation process is a 
type of elastosis with elastic microfibrils, or an abnormal 
related fibril, forming the basis for the exfoliative fibres.
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These authors have proposed that exfoliation material derives 
from abnormal polymerisation of glycoproteins associated with 
the zonular-elastic microfibrillar system. This theory 
relied upon histochemical and immunohistochemical 
similarities between exfoliation material, the ocular zonules 
(Streeten et al 1986a; 1986b) and elastic components (Li et 
al 1988). With regard to the theory that exfoliation 
syndrome is a basement membrane disorder, Streeten and 
coworkers (1986) have stated that 'the proximity between 
unhealthy basement membranes and exfoliation material appears 
to implicate the basement membrane-producing cells in the 
pathogenesis of exfoliation syndrome, but does not 
necessarily mean that exfoliation material is composed of 
basement membrane in any usual sense'. Thus, although there 
is no unified concept concerning the pathogenesis of 
exfoliation syndrome, there is at least general agreement on 
the involvement of local basement membrane cells in the 
pathogenesis of the disorder.
Other theories on the pathogenesis of the disease 
Schlotzer-Schrehardt and coworkers (1991a) have suggested 
that exfoliation syndrome may result from a disordered 
synthesis and\or assembly of connective-tissue microfibrils. 
Their theory was based on the observed association between 
connective tissue components and exfoliation material. There 
is some evidence that exfoliation syndrome may be an 
environmental disease (Taylor 1979), or that at least 
environmental factors may influence its pathogenesis (Taylor 
1979? 1980, Khanzada 1985, Johnson et al 1989). Taylor 
(1979) found a strong occupational association, with
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Australian Aborigine stockmen exhibiting a significantly 
higher prevalence of the disorder when compared with an age 
matched control Aboriginal population. He also established 
that exfoliation syndrome increased at lower latitudes and 
higher levels of solar radiation. He suggested that solar 
ultraviolet irradiation may induce protein denaturation or 
synthesis of abnormal basement membrane precursors (Taylor 
1979? 1980).
Genetic factors (Teikari 1987), a traumatic cause (Sugar
1976), a vascular aetiology (Anastasi et al 1974, Spinelli et 
al 1985) and an unspecified immunological background 
(Krishnan et al 1986) have also been implicated in the 
pathogenesis of the disease. The evidence offered for these 
theories remains unconvincing. To date, it appears that the 
triggering mechanism for the development of exfoliation 
syndrome and the pathway by which exfoliation material is 
synthesised remains as obscure as when the condition was 
discovered seventy-four years ago by Lindberg (1917).
1.5.2 Pathogenesis of exfoliation glaucoma
It has been established that aqueous outflow may be 
obstructed by cells and particulate matter carried into the 
trabecular meshwork along with the aqueous (Spencer 1985). 
What remains uncertain, however, is the precise role of 
exfoliation material in exfoliation glaucoma and why a 
significant number of patients with exfoliation syndrome do 
not ultimately develop exfoliation glaucoma (Tarkkanen 1986).
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Some authors (Trantas 1929, Cebon & Smith 1976, Tarkkanen 
1984, Wollensak et al 1992), are convinced that exfoliation 
syndrome does not cause glaucoma? that either it is a 
coincidental feature of ageing, or its presence merely 
aggravates pre-existing POAG. However, the majority of 
workers in the field support the view that exfoliation 
glaucoma is a true secondary open-angle glaucoma (Vogt 1930, 
Dvorak-Theobald 1954, Ringvold & Vegge 1971, Rohen & Witmer 
1972, Linner & Rohen 1974, Harnisch 1977, Rohen 1983, Lutjen- 
Drecoll et al 1986).
Liitjen-Drecoll and coworkers (1986) have shown a significant 
difference between the ultrastructural appearance of the 
outflow system in POAG and exfoliation glaucoma. By 
quantitative analysis of the 'plaque material' in the 
cribriform layer and outer wall of Schlemm's canal (38 and 26 
specimens respectively) they established disease-related 
differences. In exfoliation glaucoma, the total amount of 
'plaque material' was significantly less than that detected 
in POAG and comparable to that found in normal autopsy 
control eyes.
An important question in the pathogenesis of exfoliation 
glaucoma is whether the increased resistance is due to 
trabecular endothelial phagocytosis. As stated previously, 
Dvorak-Theobald (1954) considered that the endothelium of the 
trabecular meshwork phagocytosed exfoliation material. With 
one exception (Ringvold & Vegge 1971), her observation, was 
not confirmed by subsequent studies, which indicated that 
unlike pigment, exfoliation material is not phagocytosed by
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the trabecular endothelial cells (reviewed by Spencer 1985). 
Richardson & Epstein (1981) employed TEM and SEM to study two 
autopsy eyes from a patient with exfoliation glaucoma. In 
both eyes the intertrabecular spaces were open and relatively 
free from exfoliation material, but massive deposits of 
exfoliation material accumulated in the cribriform layer and 
obstructed Schlemm's canal.
Ringvold & Vegge (1971) found a close relationship between 
the degree of exfoliation material deposition within the 
outflow system and the disease stage. Extrapolating from 
their findings the authors have suggested that the 
accumulation of exfoliation material within the outflow 
system is the principal mechanism underlying the development 
of exfoliation glaucoma. Kurosawa (1981) was in broad 
agreement with Ringvold & Vegge. He considered that 
exfoliation material may occlude the outflow system at 
various anatomical levels.
On the other hand, Benedikt & Roll (1979) in a TEM study of 
the outflow system of a non-glaucomatous eye with exfoliation 
syndrome, found that extensive infiltration with exfoliation 
material had not caused glaucoma. They endorsed the view 
that exfoliation material does not play any significant role 
in the pathogenesis of exfoliation glaucoma. Their 
observations on this single case however, stand in isolation 
from those of other investigators who consider that 
exfoliation material deposition within the cribriform layer 
obstructs the outflow system (Ringvold & Vegge 1971, Kurosawa 
1981, Richardson & Epstein 1981, Lutjen-Drecoll et al 1986).
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1•6 Epidemiology
In the early literature, the reported prevalence of 
exfoliation syndrome varied greatly in different ethnic 
groups. Early authors, such as Busacca (1927), Trantas 
(1929), Rehsteiner (1929), Baumgart (1933), Horven (1937), 
Irvine (1940), Lemoine (1950), Leydhecker (1960), Forsius & 
Eriksson (1961), Joannides and coworkers (1961) and Clements 
(1968) considered the condition to be common in some 
countries (Finland, Norway, Aland Islands, Isle of Man, 
Russia, Greece, Italy and India) and rare in other countries 
(Sweden, Denmark, Britain, France, Germany and the United 
States).
In a retrospective study, Lemoine (1950) found 29 patients 
with exfoliation glaucoma in Boston, USA, out of a total of 
816 glaucomatous patients (4%). Leydhecker (1960) has 
claimed that he could not find one single case of exfoliation 
glaucoma amongst 500 German glaucoma patients in Bonn. In 
contrast, the reported proportions of exfoliation glaucoma in 
Scandinavian, Greek and Indian studies ranged between 24% and 
79% (Lindberg 1917, Mailing 1923, Trantas 1929, Irvine 1940, 
Thomassen 1949, Joannides et al 1961, Klouman 1967, Krause 
1973). Thomassen (1949) studied two cohorts of glaucoma 
patients (including operated cases) after dilatation of the 
pupil and gonioscopy. In the University Department of 
Ophthalmology in Oslo, Norway, 45 out of 57 cases (79%) had 
exfoliation glaucoma. In Moorfields Hospital, London, 
England, only one out of 50 cases (2%) was reported as 
showing evidence of exfoliation (Thomassen 1949) .
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Differences of opinion
In the literature of the late sixties and early seventies, 
the notion that exfoliation syndrome varied greatly between 
different countries came under close scrutiny, especially by 
the Norwegian ophthalmologist Aasved. Bertelsen (1966) first 
succinctly pointed out that 'the opinion regarding the 
frequency of the disease in Sweden depends largely on the 
interest which the particular ophthalmologist takes in the 
entity'. To further demonstrate this point, Bertelsen gave 
as an example the first report on the prevalence of the 
disorder in Sweden by Stromberg (1962). He found 22 patients 
with the condition among 213 individuals with ocular 
hypertension detected in mass screening of the population 
over the age of 40 in a Swedish town. Another ophthalmic 
surgeon working in the same area was of the opinion that 
exfoliation syndrome did not exist in that district, until he 
became acquainted with Stromberg's report (Bertelsen 1966). 
Aasved (1969, 1971) challenged the prevailing concept that 
exfoliation syndrome showed considerable geographic 
variation. First, he refuted the evidence presented to that 
date on the prevalence of exfoliation syndrome as 
unrepresentative, since it was not based on random population 
samples. Writing in 1971, Aasved suggested that he could 
find only 7 population studies in the literature? of these 
only 2 (Bertelsen et al 1965, Hollows & Graham 1966) had 
screened more than 600 individuals.
Motivated by disbelief in the reported differences in the 
prevalence of exfoliation syndrome in neighbouring European 
countries, Aasved carried out a prospective personal survey
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of the prevalence of exfoliation syndrome in three cohorts 
over the age of 60 in Bergen, Norway; Bonn, Germany and 
Birmingham, England. He established that the prevalence of 
exfoliation syndrome was similar in the three ethnic groups- 
Bergen 6.3%, Bonn 4.7%, Birmingham 4.0%- (Aasved et al 1969, 
Aasved 197Id; 1979b).
Thus, Aasved provided convincing epidemiological evidence to 
suggest that the prevalence of the disorder in population 
groups is first, much higher than previously thought and 
second, similar in all geographic areas. Subsequent studies, 
mostly in ophthalmic cohorts, in various ethnic groups have 
either supported (Sood 1968, Sveinsson 1974, Kinoshita 1979, 
Hiller et al 1982, Krause et al 1988), or contradicted 
(Forsius 1979; 1988, Ringvold et al 1988, Cashwell & Shields 
1988, Aine 1988, Stefaniotou 1990) Aasved's view. The most 
recent literature does suggest that the prevalence of the 
condition may vary significantly even within the same country 
and remarkable differences exist within and between various 
ethnic groups. However, none of these studies is strictly 
comparable, or of similar scale to those of Aasved. Thus, 
Tarkkanen (1986) has asserted that 'the prevalence of 
exfoliation syndrome is similar in those countries that 
population-based surveys have been conducted'.
Geographic distribution
Worldwide, the reported prevalence of exfoliation syndrome 
varies from 16% in a Greek population cohort (700) over the 
age of 50 years (Stefaniotou 1989), to 0% amongst 96 Eskimos 
of similar age (Forsius 1979). Forsius (1988) has reviewed
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the epidemiological data available and has highlighted some 
inconsistencies and factors that may give rise to regional 
and geographic variations. Significantly, little is known 
about the prevalence of the disorder in many countries 
worldwide. Moreover, many published reports are 
unsatisfactory. Extrapolating the true prevalence of 
exfoliation syndrome from retrospective studies on selected 
ophthalmic patients is a tenuous exercise. The following 
review focuses on the most relevant studies and emphasises 
up-to-date published reports on the subject.
In a population based study in Middle-Norway, Ringvold and 
coworkers (1987; 1988) found the prevalence of exfoliation 
syndrome in individuals over the age of 64 to be different in 
three separate municipalities. They established a marked 
variation in the geographic distribution of exfoliation 
syndrome between coastal (10.2%) and inland areas (21% and 
19.6%). Hollows & Graham (1966) investigated a defined 
population of 4,231 individuals in Wales, 40-75 years old.
The overall prevalence rate for exfoliation syndrome in the 
total population was 0.22% (10 out of 4,231). Bartholomew 
(1979) investigated specifically the prevalence of 
exfoliation syndrome/glaucoma in three Scottish cohorts in 
Edinburgh. The prevalence of exfoliation syndrome in a 
consecutive in-patient population with cataract was 2.5% (6 
out of 247 patients)? the prevalence of exfoliation syndrome 
in a consecutive out-patient cohort was 1.5% (18 out of 1,200 
patients) and the prevalence of exfoliation glaucoma in a 
newly diagnosed glaucoma cohort was 5% (number unspecified).
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Forsius (1979) has documented a high prevalence of 
exfoliation syndrome in four different populations above 60 
years of age in Oulu, Finland, Reykjavik, Iceland, Aland 
Islands and Novosibirsk, Russia. The prevalence of 
exfoliation syndrome in this study varied between 29.8% in 
Finland and 12.4% in Russia. In a subsequent study in a 
Russian glaucoma group it was found that 37.7% of patients 
below the age of 70 years and 70% above that age suffered 
from exfoliation glaucoma (Forsius 1979). Frolova &
Khamitova (1984) screened 3,400 Russians over the age of 40 
years, engaged in sedentary work, during the course of a 
regular medical check-up. They detected exfoliation syndrome 
in 200 individuals (5.9%) and recommended obligatory 
screening for exfoliation syndrome in regular medical check­
ups of subjects over the age of 40 years.
In a prospective study conducted by 30 ophthalmologists in 
private practice in France the total prevalence among 4,042 
ophthalmic patients older than 50 years was 5.5% (Colin et al 
1988). Significant regional differences were observed within 
two regions (Brittany and South-East France showing higher 
prevalences of 16.3% and 8% respectively). Montanes and 
coworkers (1990) documented in a prospective study a high 
prevalence for exfoliation glaucoma in the North-West of 
Spain (44.5% of the open angle glaucoma cohort).
In a population study in South Africa, Bartholomew (1971) 
examined 2,584 Pondos, a Bantu tribe, over the age of 30. He 
found typical exfoliation syndrome in 132 individuals (5.1%) 
and early changes (termed pregranular exfoliation) in 76,
43
predominantly younger individuals (2.9%). In another study 
the same author (1973) studied 9 rural black tribes (Bantus 
and Swahilis) on field tours and found exfoliation syndrome 
to be present to a varied extent in 8 of these tribes (total 
prevalence in 4,156 individuals of all ages was 0.55%).
More recently, Shiose and coworkers (1991) carried out a 
prospective population survey to establish the prevalence of 
the glaucomas in seven districts throughout Japan (8,126 
persons over the age of 40). Exfoliation glaucoma was found 
in 13 individuals (0.16%) whereas, POAG was detected in 47 
individuals (0.58%).
In the only American population study to date, conducted in 
Framingham, United States, 1,906 patients age between 52 and 
85 were screened for the presence of exfoliation syndrome.
The overall prevalence of the disorder was 1.8% (36 out of 
1,906 individuals screened). In the age group 75-85 the 
prevalence of the condition was 5.0%. As the ophthalmic 
examination in this study was conducted by residents in 
ophthalmology, presumably with little expertise, or special 
interest in the condition, it is conceivable that the true 
figure in that population may have been higher.
Controversy concerning geographic variation 
Exfoliation syndrome is a common condition, but its true 
prevalence is particularly difficult to assess because of the 
insidious onset and subtle signs (Gifford 1958, Tarkkanen 
1962). The diagnostic sensitivity increases when the 
condition is actively sought by an experienced observer
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(Aasved 1969, Jerndal 1986). Although the clinical 
description of advanced exfoliation syndrome is well 
established, little clinical data exist as to the early 
changes of the disorder (Jerndal 1985? 1986, Dark & Streeten
1990). These have not been adequately documented, but may be 
particularly subtle and confined to the mid-periphery of the 
lens (Bartholomew 1971 Jerndal 1985, Dark & Streeten 1990). 
Exfoliation syndrome and the ensuing exfoliation glaucoma 
have a worldwide prevalence and an age related incidence.
The prevalence of the disorder is generally underestimated.
A clear geographic variation within and between various 
ethnic groups is possible, but further large prospective 
population studies employing similar methodology are required 
to prove this hypothesis. Several reports have indicated 
that, as yet, unidentified genetic, ethnic, or environmental 
factors may contribute to the varied prevalence of the 
condition.
Other epidemiological features 
Age
It is well established that exfoliation syndrome is age- 
dependent (Aasved 1969; 1971, Tarkkanen 1986, Forsius 1988). 
The youngest patients recorded in the world literature have 
been 22 (Sugar 1976); 27 (Aminisarduei & Ferkrat 1986)? 31 
(Horven & Huchinson 1967, Kuchle & Naumann 1992)? 32 
(Khanzada 1985)? 35 (Horven & Huchinson 1967, Taylor et al
1977) and 39 (Joannides et al 1961).
In 25 published reports in the Western and Japanese 
literature the youngest patient was over the age of 50 years.
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On the other hand, a distinctly younger pattern exists in 
some racial groups. In the Pondo tribe of South African 
Bantu, Bartholomew (1973) documented an overall prevalence of 
6.4% in the 30 to 39 age group (10 out of 157 persons), 
principally due to the inclusion of a pre-granular stage in 
the evolution of the disorder (8 out of 157 cases? 5%).
Along with the Australian Aboriginal cohort reported by 
Taylor and coworkers (1977) and an Icelandic cohort reported 
by Als (1980) an 'earlier involvement pattern' possibly 
influenced by genetic, or environmental factors has been 
documented.
Sex
The reported series on the relationship between exfoliation 
syndrome and sex are often irreconcilable. Some authors have 
shown a higher prevalence for females (for example, Aasved 
1979, Ekstrom 1987, Esmail 1991). Two studies where the data 
were population corrected and subsequently compared with age 
matched controls, show females being affected by the disorder 
more frequently than males (Aasved 1969, Hiller et al 1982). 
However, this preponderance of females has not been confirmed 
in other populations (Bartholomew 1973, Taylor 1979, Forsius 
1979, Heriot et al 1983, Summanen & Asbjorn 1988) and large 
ophthalmic cohorts (Colin et al 1988, Montanes et al 1989).
In some clinical reports a marked preponderance of males with 
the condition has been reported (orgen 1949, Zlatar 1965,
Sood 1968, Bartholomew 1979, Khanzada 1985, Mohammad & Kazmi 
1986). More specifically, Sood (1968) reported a prevalence 
of 1.2% in female patients and 2.1% in males in his 
ophthalmic clinic in India. In Pakistan, males were affected
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YOUNGEST PATIENTS WITH EXFOLIATION REPORTED IN THE LITERATURE
tAbi.s 1'1
diagnosis
AUTHOR COUNTRY RELEVANT OCULAR HISTORY
22
27
31
32 
35 
35
37
38
39
30-39 
10 cases)
<40
2 cases) 
40
41
42
43
Sugar 1976 U.S.A.
Aminisarduei 1986 Iran
Horven et al 1967
Khanzada 1985 
Taylor et al 1977 
Horven et al 1967
Kiichle et al 1992
U.S.A.
Pakistan
Australia
U.S.A.
Germany
11 months old corneal 
injury; iris prolapse 
excised
No data provided
Juvenile glaucoma; 
iridencleisis
No data provided
No data provided
Keratoconus; corneal 
graft at the age of 24
Keratoconus; corneal 
graft
Summanen et al 1988 Saudi Arabia No data provided
Ioannides et al 1961 Greece
Bartholomew 1973 
Als 1980
Forsius et al 1974
Sugar et al 1976 
Kiichle et al 1992
Konstas 1992
South Africa
Iceland
Iceland
U.S.A 
Germany
Scotland
No data provided
No data provided
No data provided
No data provided
No data provided
Keratoconus; corneal 
graft
Keratoconus; corneal 
graft; heterochromia
three times more frequently than females (Mohammad & Kazmi 
1986). Cultural and social factors influencing the 
proportions of males and females presenting to 
ophthalmologists were not discussed by these authors.
1.7 Diagnosis
1.7.1 Symptoms
Exfoliation syndrome is usually characterised by the lack of 
symptoms, for throughout its long and insidious course the 
condition is clinically silent (Duke-Elder 1969). Symptoms 
may only arise with the development of cataract, or when 
exfoliation glaucoma ensues. Cataract will give rise to 
blurring of vision. Exfoliation glaucoma, in a similar 
fashion to the other glaucomas, may remain asymptomatic and 
undetected until serious visual disability occurs. However, 
in a number of cases it may give rise to subjective symptoms: 
dull eye ache, or 'tension' (due to high IOP); difficulty in 
reading, diminished peripheral or night vision and ultimately 
failure of vision due to advanced glaucomatous atrophy of the 
optic nerve head. In a small proportion of cases exfoliation 
glaucoma may present in a more dramatic fashion with headache 
or pain owing to the development of 'acute open angle 
glaucoma' with an IOP in excess of 50 mm Hg (Jerndal 1986, 
Brooks & Gillies 1988).
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1.7.2 The classic diagnostic signs
Pupil
The objective diagnostic signs of exfoliation syndrome are 
diagramatically shown in Figures 1.14 & 1.15. The pupillary 
margin is encrusted with 'dandruff-like' discrete particles 
of exfoliation material (Figs 1.14 & 1.16). In the advanced 
stage, exfoliation aggregates may be seen upon the anterior 
iris surface and within the iris crypts. Exfoliation 
material on the lens surface is the most commonly recognised 
feature of the disorder. Three distinct zones have been 
documented (reviewed by Sugar et al 1976). In the centre of 
the anterior lens surface a white, ring-shaped, subtle 
opacification resembling a cellophane-like membrane termed 
the central disc is seen (cf Figs 1.1 & 1.2).
Biomicroscopically, the central disc ranges in size between 
1-2.5 mm (Prince & Ritch 1986) and is best visualised with 
bright illumination after dilatation of the pupil since its 
border may be hidden under the iris. In many cases the 
border of the central disc appears well-demarcated and in 
some cases it may be curled inwards (Jerndal & Svedbergh
1978); (Fig 1.15). On the edge, or the surface of the 
central disc minute exfoliation material particles may be 
seen (cf Fig 1.1). It has been suggested that the size and 
shape of the central disc depend upon the size of the pupil 
i.e. a miosed pupil would have a smaller central disc whereas 
distortion in the shape of the pupillary rim would change the 
shape of the central disc (Sunde 1956, Sugar 1984, Prince & 
Ritch 1986). The central disc may be absent in some 10 to 18
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CLINICAL SIGNS IN EXS
□  Transillumination defects
□  Exfoliation material 
■ Pigment
Figure 1.14: Diagramatical representation of clinical signs in exfoliation syndrome prior 
to dilation of the pupil. Transillumination defects (orange) are observed in 
pupillary ruff(1), peripupillary(2) and mid-peripheral iris(3). Pigment deposit 
(arrows) and exfoliation material(arrowheads) are also shown.
IILATED PUPIL IN EXS.
“P '■*L- i - .— III i--- II I I .  I ill I..Mil I - 1 ~ '
Figure1.15: Diagramatical representation of clinical signs on the exfoliative lens 
(dilated pupil). CD:central disc; ^intermediate zone; GZ:granular zone; 
•)f:rolled edge of GZ; long arrowrpeeling of lens capsule; 
thick arrow:radial striae; short arrow:pigment.
per cent of cases (Joannides et al 1961, Tarkkanen 1962, Sood 
1968, Aasved 1971b; 1971d, Kinoshita 1979, Sugar 1984).
The periphery of the lens capsule exhibits a granulated 
circular band of variable width resembling 'sugar frosting', 
called the granular zone (Figs 1.3, 1.4 & 1.15). This zone 
may exhibit holes and occasionally communicates with the 
central disc via bridges of exfoliation material (Fig 1.15). 
Several suggestions have been made to explain the development 
of the granular zone (for example Sunde 1956, Gifford 1957, 
Bertelsen 1966, Sugar et al 1976, Dark et al 1977, Ringvold & 
Bore 1990). None of these, however, is entirely convincing.
A clear intermediate zone of normal lens capsule separates 
the central disc from the peripheral granular zone (Fig 
1.15). It is thought that the clear zone is formed by the 
'cleaning' action of the iris which constantly moves from the 
dilated to the constricted position (Sugar et al 1976) .
1.7.3 Pigmentary signs
A close relationship exists between the development of 
exfoliation material deposition and progressive atrophy of 
the posterior pigmented layer of the affected iris. This 
process is more pronounced in the pigment epithelium of the 
pupillary and peripupillary iris (Aasved 1973), (Fig 1.17) 
but recently it has been shown that the peripheral iris may 
also be involved (Repo et al 1990).
The precise mechanism of the pigment release remains obscure.
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Figure1.16: Biomicroscopical appearance of an eye with 
exfoliation syndrome. Note deposition of 
exfoliation material upon the pupillary margin 
(arrows).
Figure 1.17: A slit-lamp photograph of an eye with exfoliation 
syndrome to illustrate subtle deposition of 
exfoliation material (arrow). A section of loss 
of the pupillary ruff is shown (arrowheads).
It has been suggested that pigmentary liberation is caused by 
a primary vascular disturbance in the iris (Vannas 1969), or 
increased mechanical friction between the 'defective', uneven 
anterior lens surface and the affected pigment epithelium 
(Aasved 1973). In any case, the pigment granules released, 
move along with the aqueous humour and subsequently some of 
them adhere to and within various ocular structures, e.g. 
anterior iris surface, corneal endothelium, filtration angle 
(Wishart et al 1985, Prince & Ritch 1986, Jerndal 1986,
Prince et al 1987). Krause and coworkers (1973) were the 
first to provide controlled data on the subject of pigment 
liberation from the iris. It has now become well recognised 
that this process gives rise to a number of characteristic 
diagnostic features (Madden & Crowley 1982, Prince & Ritch 
1986, Prince et al 1987, Montanes et al 1990b, Repo et al 
1990, Konstas & Dutton 1991).
Pigmentary signs in the iris
The pigment deposition upon the surface of the iris consists 
either of distinctly particulate large granules, localised to 
the iris sphincter (Figs 1.14 & 1.15), or diffuse small 
pigment particles scattered all over the peripheral iris. 
Occasionally, a discrete cluster of pigment may be noted at 
the 6 o' clock position at the inferior border of the iris 
(Jerndal & Svedbergh 1978)? (Fig 1.14).
A variable degree of iris atrophy is a consistent feature in 
the exfoliation syndrome. This atrophy involves initially 
the pupillary ruff (Fig 1.17). Aasved (1973) demonstrated a 
higher prevalence of pupillary ruff defects in individuals
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with exfoliation syndrome (74%) when compared with normal 
controls (6.1%). However, the significance of these findings 
was diminished by the fact that in his study the results for 
the normal population were not age-corrected; the exfoliation 
group was older (Aasved 1973).
In a more advanced stage of the disorder, the iris sphincter 
becomes visible and the entire circumference of the pupillary 
margin transilluminates in a characteristic fashion (Jerndal 
1986). In most cases, the 'moth eaten' pattern is confined 
to the iris sphicter area. However, in a recent prospective 
study, Repo and coworkers (1990) found that 45% of cases with 
the condition demonstrated generalised peripheral iris 
transilluminance; this compared with 18% in an age matched 
control population (Repo et al 1990).
Pigment in the anterior chamber
After dilatation of the pupil a shower of loose pigment may 
be seen in the anterior chamber of affected eyes. Writing in 
1965, Kristensen described a mydriasis-induced excessive 
pigment liberation with a concurrent rise in IOP in two 
patients with exfoliation glaucoma. This phenomenon may also 
occur in normal aged individuals, but it has been shown that 
in the exfoliation syndrome the incidence and volume of 
pigment released following pupillary dilatation, is much 
greater (Kristensen 1965, Aasved 1973, Valle 1976, Roth & 
Epstein 1980, Mapstone 1981).
Pigmentary signs in the cornea
A characteristic deposition of fine pigment granules may
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occur upon the central region of the corneal endothelium 
(Sugar et al 1976, Brooks et al 1988, Montanes et al 1990b). 
Although, the pattern seen is usually diffuse, a Krukenberg 
spindle pattern may also develop in a few cases (Tarkkanen 
1962, Jerndal & Svedbergh 1978, Prince & Ritch 1986). 
Tarkkanen (1962) studied 418 patients with the condition and 
found a Krukenberg spindle pattern in between 4 and 16% of 
the various subgroups with exfoliation.
Importance of pigmentary signs
Historically, the diagnosis of the condition has always been 
made on the basis of the typical appearance of exfoliation 
material upon the pupillary margin and/or the lens surface. 
Krause and coworkers (1973) have shown that patients with the 
condition exhibit significantly more dense pigmentation 
gonioscopically, compared with normals. On the other hand, 
no such difference was noted by these authors between the two 
eyes of patients with unilateral exfoliation syndrome. They 
interpreted the latter finding to be consistent with 
increased pigmentation being the first stage of the disorder 
(Krause et al 1973). Recently, these more subtle signs have 
been stressed as important early cinical features which 
should alert the ophthalmologist to search for the condition 
(Jerndal 1986; 1989, Prince & Ritch 1986, Rouhiainen & 
Terasvirta 1990). It has now been suggested that the 
pigmentary signs not only accompany, but precede the fully 
established condition (Wishart et al 1985, Jerndal 1986? 
Prince et al 1987, Konstas & Dutton 1991).
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Importance of earlv diagnosis
There are four reasons why early diagnosis is optimal 
for clinical practice. First, the early recognition of 
exfoliation syndrome is important because these individuals 
may develop exfoliation glaucoma (Hansen & Sellevold 1969, 
Odland & Aasved 1971, Jerndal 1986, Slagsvold 1986, Henry et 
al 1987). Documenting the presence of exfoliation syndrome 
early in these patients will determine their subsequent 
management. Second, the distinction between exfoliation 
glaucoma and POAG will influence treatment since exfoliation 
glaucoma is different from POAG with regard to treatment, 
prognosis and follow-up (see sections 1.12.1, 10.1 & 10.3). 
Third, the distinction between exfoliation glaucoma and POAG 
is essential prior to research into the pathogenesis, or the 
clinical features of glaucoma. Many published studies fail 
to make this important distinction. Finally, a strong 
association exists between the development of lens opacities 
and the exfoliation syndrome. It has been shown that the 
rate of peroperative and postoperative complications in 
cataract surgery is significantly higher in the presence of 
exfoliation syndrome (section 1.11).
1.8 Development of the disorder
The evolution of the exfoliation syndrome is still poorly 
understood. Evidently, it evolves slowly, over many years 
(Gifford 1957; 1958, Duke-Elder 1969, Jerndal 1986). Gifford 
(1957) has postulated that the entire development of 
exfoliation syndrome was 'a matter of 10 to 20 years rather 
than 3 to 5 years'. Individuals with bilateral involvement
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are on average 2 to 7 years older than those with unilateral 
involvement (Aasved 1971b, Madden & Crowley 1982, Slagsvold 
1986). Similarly, it has been shown that a significant 
proportion of individuals with long-standing exfoliation 
syndrome develop exfoliation glaucoma. Whether exfoliation 
glaucoma can occur without an interval of 'normality', i.e. 
without the initial development of the exfoliation syndrome, 
is not known.
Theories on earlv development
The biomicroscopic changes, which describe the early stages 
of the disorder, remain ill defined and only few studies have 
dealt with this subject (Bartholomew 1971, Jerndal 1985, Dark 
& Streeten 1990). In 1971, Bartholomew first provided clues 
of an early stage in the development of the condition.
Whilst studying the condition among the Bantu in South 
Africa, he noticed grey, radial striations on the peripheral, 
anterior lens capsule of some young Bantu patients. 
Subsequently, in a few of these cases he noted that these 
lines became more confluent and eventually merged into the 
classic granular zone of exfoliation material. Bartholomew 
considered these lines to comprise a prodromal stage, so 
called 'pregranular stage', in the evolution towards the 
fully established condition (i.e. presence of exfoliation 
material, 'granular stage'). In his view, these early 
changes were 'imprints' created by the corresponding iris 
folds and were pathognomonic, superseded later in life by the 
'granular' stage. Bartholomew (1973) documented 8 patients 
with 'pregranular exfoliation', in the 30-39 age group among 
the Pondo tribe in South Africa. Later, in support of this
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theory, he observed identical striations in a small number of 
Scottish patients (Bartholomew 1979). Significantly, similar 
striations were recently noted in Caucasians at an early 
stage of the condition by Dark & Streeten (1990).
An alternative hypothesis for the early development of the 
condition has been suggested by Jerndal (1985; 1986? 1989). 
According to his theory, in stage 1, the posterior layer of 
the iris epithelium begins to lose pigment and tiny dots of 
pigment appear in radial clusters upon the lens capsule.
Stage 2 is characterised by progressive loss of the pupillary 
ruff, transillumination, and an incomplete granular zone 
with the first aggregates of exfoliation material often 
intermingled with pigment. Stage 3 shows the completed 
granular zone and advanced transillumination of the iris.
Preclinical stage
A number of workers have recently shown that further insight 
into the development of the disorder might be gained by 
ultrastructural studies on tissues from exfoliation patients 
who do not demonstrate clinical evidence of exfoliation 
material on biomicroscopy. First, Speakman & Ghosh (1976) 
found exfoliation material in conjunctival biopsy specimens 
from both eyes in 7 patients with clinical evidence of 
unilateral exfoliation syndrome. Similar evidence was 
obtained from ultrastructural studies in conjunctival 
specimens from patients who only exhibited pigmentary signs 
(these are described in section 1.7.3). Thus, the concept 
that there is a preclinical (histological) stage in some 
patients is now firmly established. Employing specular
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microscopy, Miyake and coworkers (1989) demonstrated 
comparable morphological alterations (polymegethism and 
pleomorphism) in the corneal endothelium of both eyes in 
patients who clinically demonstrated only unilateral 
exfoliation. This study concluded that corneal endothelial 
changes are consistent with early manifestations of the 
condition and that the fellow 'normal' eye is in fact at a 
preclinical stage of the disorder.
1.9 Gonioscopic features
The gonioscopic features in exfoliation syndrome/glaucoma 
(Figs 1.18 & 1.19) are important in the early diagnosis of 
the disorder (Gradle & Sugar 1940) and gonioscopy is 
considered of value in assessing the risk of IOP elevation 
(Sampaolesi 1959, Jerndal 1986, Montanes et al 1990b).
Sampaolesi's line
Sampaolesi's line is defined as a single wavy pigmented line, 
superior to Schwalbe's line and situated between 4 and 8 o' 
clock position in the angle (Sampaolesi 1959); (Fig 1.19). 
This line may extend onto the posterior face of the inferior 
corneal endothelium. Occasionally, more than one line of 
pigment, each parallel to the other, are observed (Sampaolesi 
et al 1988). Sampaolesi's line is found in between 63 and 
98% of patients with the condition (Mizuno & Muroi 1979, 
Konstas & Allan 1989, Montanes et al 1990b, Konstas & Dutton
1991). A significant correlation between increased IOP and 
Sampaolesi's line has recently been confirmed in a study of 
263 cases (Montanes et al 1990b).
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Pigment in the angle
It has been suggested that increased pigmentation may be the 
earliest detectable sign of the exfoliation syndrome (Wishart 
et al 1985). Although few published studies actually record 
their assessment of pigmentation, a densely pigmented 
trabecular band has been consistently reported (Gradle &
Sugar 1940, Rouhiainen & Terasvirta 1990). In appearance the 
angle in exfoliation syndrome is characterised by diffuse, 
brown/black pigmentation of heterogeneous distribution 
(Jerndal & Svedbergh 1978, Montanes et al 1990b).
Considerably more pigmentation is seen upon the inferior 
angle (Prince & Ritch 1986, Sampaolesi et al 1988), with 
maximum pigmentation localised at the 6 o' clock position 
(Wishart et al 1985); (Figs 1.18 & 1.20). The intensity of 
angle pigmentation correlates well with the severity of 
exfoliation glaucoma (Montanes et al 1990b, Rouhiainen & 
Terasvirta 1990). Whether increased angle pigmentation is 
attributable to enhanced shedding of pigment cells, or 
reflects ineffective pigment removal is not known.
Exfoliation material in the angle
Exfoliation material may be seen gonioscopically in the 
angle (Barkan 1936, Gradle & Sugar 1940) in between 5.6 and 
50% of cases (Thomassen 1949, Joannides et al 1961, Tarkkanen 
1962, Konstas & Dutton 1991). Exfoliation material in the 
angle is not pathognomonic for raised IOP, since it is as 
commonly found in normotensive patients with exfoliation 
syndrome. When present, it has no typical pattern of 
appearance, but is usually observed in the inferior angle 
sometimes mingled with pigment (Sampaolesi et al 1988).
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Figure 1.18: Typical gonioscopic appearance of the inferior 
angle in a patient with exfoliation glaucoma.
The angle exhibits moderate pigmentation(arrow). 
Sampaolesi's line is present(arrowhead).
Figure 1.19: Gonioscopic photograph of the inferior angle in 
an eye with exfoliation glaucoma. Note 
exfoliation material in the angle (arrow) and 
Sampaolesi’s line (arrowhead).
1.10 Other clinical features
Fluorescein angiographic studies
Vannas (1969) was the first to use fluorescein angiography to 
describe the anterior segment changes of exfoliation 
syndrome/glaucoma. He documented extensive vascular changes 
in the iris of 15 out of 20 cases with exfoliation syndrome 
and 40 out of 41 cases with exfoliation glaucoma. In the 15 
cases with exfoliation syndrome, the findings comprised 1) 
early and pronounced fluorescence at the pupillary border, 2) 
the presence of numerous, thin, tortuous new vessels in the 
pupillary and ciliary portion of the iris and 3) profuse 
leakage of fluorescein from these newly formed neovascular 
'whorls' (Vannas 1969). In cases with exfoliation glaucoma 
the angiographic findings were even more pronounced with 
vascular changes being more widespread, often involving both 
the pupillary and ciliary portion of the iris. In 33 
exfoliation glaucoma cases, Vannas (1969) was impressed with 
the profuse leakage of fluorescein from the iris vasculature, 
the presence of a rich neovascular network, the occurence of 
microaneurysm-like buds, the phenomenon of venous stasis and 
the absence of radial veins. Although fluorescein 
extravasation was also noted at the pupillary margin of 33% 
of the normal control eyes, none of the controls showed 
evidence of neovascularisation, or leakage of stain at the 
ciliary portion of the iris (Vannas 1969).
In a more recent study, Brooks & Gillies (1987) confirmed 
Vannas' findings. They performed iris angiography in 25 
patients with exfoliation syndrome and found a varied degree
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of microneovascularisation (defined as a more subtle degree 
of neovascularisation than that seen in neovascular glaucoma) 
in 87% of their patients. This was accompanied by diminished 
iris perfusion. The authors concluded that these features 
are specifically related to the condition (Brooks & Gillies
1987). Furthermore, they described the development of 
hypoperfusion and microneovascularisation in two previously 
unaffected eyes after the clinical appearance of exfoliation 
syndrome (Brooks & Gillies 1987).
1.11 Exfoliation syndrome and cataract
Presence of cataract
Most published reports have suggested a consistent yet 
unexplained relationship between exfoliation syndrome and 
cataract (Gradle & Sugar 1940, Horven 1966, Taylor et al 
1977, Roth & Epstein 1980, Madden & Crowley 1982, Forsius 
1988, Konstas 1989, Ayed et al 1990). The reported clinical 
figures for the prevalence of the condition in cataract 
cohorts vary between 2.5 and 44% (Lindberg 1917, Horven 1937, 
Irvine 1940, Bartholomew 1979, Guzek et al 1987, Forsius 
1988, Olivius et al 1989, Walinder et al 1989). Similarly, 
the prevalence of lens opacities in selected exfoliation 
cohorts differs according to the study between 20 and 93% 
(Trantas 1929, Tarkkanen 1962, Horven 1966, Layden & Shaffer 
1974, Taylor 1980, Madden & Crowley 1982, Khanzada 1985, 
Konstas & Allan 1989, Stefaniotou 1989, Montanes et al 1989).
Taylor (1980) believed that exfoliation syndrome was 
positively associated with the development of cataract and
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suggested a radiation effect linkage. Seland & Chylack 
(1982) have offered some evidence suggesting a link between 
exfoliation syndrome and the pattern of cataract formation. 
They analysed the type of cataract seen in 431 lenses with 
the disorder and 1,776 senile cataract controls. In patients 
with exfoliation, cortical cataracts were significantly less 
common, and nuclear cataracts more common.
1.11.1 Cataract surgery and the exfoliation syndrome
Surgical removal of a cataract may be indicated in patients 
with exfoliation syndrome for improved visual acuity.
Lens subluxation
Published work has indicated that patients with exfoliation 
syndrome may have spontaneous, or intraoperative lens 
dislocation (Bartholomew 1970, Sood et al 1973). This 
complication may occur as a consequence of increased 
friability of the zonules, or may be due to their weakened 
attachment to the ciliary body. Horven & Hutchinson (1967) 
documented 9 cases with lens displacement out of 635 cases 
(1.4%) in the United States.
The first to draw attention to the common occurence of 
phakodonesis in exfoliation patients was Bartholomew (1970), 
who pointed out that phakodonesis was an important sign of 
incipient lens displacement. He reported zonular fragility, 
phakodonesis and spontaneous rupture leading to subluxation 
of the lens in 6 Bantu patients with exfoliation. In India 
Sood and coworkers (1973) found 11 cases with phakodonesis
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out of 17 cases with exfoliation detected in the course of 6 
months. In two of these cases the lens had dislocated into 
the vitreous cavity (Sood et al 1973). More recently, Jofe
(1988) has suggested that in many exfoliation patients with 
cataract only a slight degree of phakodonesis may be seen. 
Detection in these cases is facilitated with biomicroscopic 
examination for lens movements prior to pupillary dilatation.
ICCE and exfoliation syndrome
Gillies (1973) reviewed 30 cases with exfoliation and stated 
that 'cataract extraction was difficult in these patients; 
the lens capsule seemed very liable to break and large 
hyphaemas frequently occured'. Krause & Tarkkanen (1978) 
observed 'remnants of posterior synechiae' in 5 out of 100 
extracted cataractous lenses with the condition. Dark (1979) 
described clinically and histologically, adhesions involving 
the pigment epithelium of the iris and the peripheral 
anterior lens capsule in 6 cases with exfoliation glaucoma.
In that study, extended bonding of the iris pigment 
epithelium to the pre-equatorial lens capsule by exfoliation 
fibres was confirmed ultrastructurally (Dark 1979).
ECCE and exfoliation syndrome
Currently, ECCE is the most popular technique of cataract 
extraction. There are several reports that indicate that 
exfoliation syndrome may adversely influence ECCE (Raita & 
Setala 1986, Hovding 1988, Carpel 1988, Pedersen et al 1990, 
Ruusuvaara et al 1990, Assia et al 1991). However, in the 
current literature, there are few controlled observations on 
the surgical complications in elderly patients with
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exfoliation syndrome. In a prospective consecutive study of 
1,000 ECCE cases in Saudi Arabia, Guzek and coworkers (1987) 
found a four-fold increase in the risk of zonular breaks when 
exfoliation syndrome was present (25% of their patients). 
Naumann and coworkers (1988) reported a five-fold increase in 
the incidence of vitreous loss in ECCE performed in patients 
with exfoliation syndrome (4 out of 46 cases in the 
exfoliation group, (9%), versus 23 out of of 1,205 in senile 
cataract controls, (1.8%). Similarly, Kuchle and coworkers
(1989) found exfoliation syndrome to be a significant risk 
factor for vitreous loss, but not for capsular breaks. In 
their study, vitreous loss was observed in 8 out of 72 cases 
with exfoliation (11.1%), and in 32 out of 1,970 controls 
(1.6%). Capsular breaks, without vitreous loss, occured in 
4.2% of the exfoliation cases and 2.8% of the control 
cataract group (Kuchle et al 1989).
Skuta and coworkers (1987) reported 5 patients with 
exfoliation glaucoma who developed extensive zonular dialyses 
during ECCE. They speculated that weakness of the lens 
zonules, or their attachments to the ciliary processes 
accounted for this complication. In a prospective study in a 
German cataract population, Konstas and coworkers (1993) have 
studied the prevalence of exfoliation syndrome and its 
influence in the surgical outcome. Out of 1,023 consecutive 
German patients 51 (5.2%) were found to have exfoliation 
syndrome. Patients with exfoliation syndrome were more 
likely to be operated upon under general anesthesia, by the 
most senior surgeon, have iris surgery and expression of the 
nucleus with a loop instead of phacoemulsification. In spite
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of these measures, they had a significantly higher chance for 
vitreous loss (5.9% versus 0.9% for the controls, p<0.01).
The increased incidence of zonular rupture and vitreous loss 
during cataract surgery in eyes with exfoliation may also be 
attributable to insufficient pupillary dilatation.
Delivering a large nucleus through a poorly dilated pupil, 
requires a significant increase in pressure applied, which in 
turn would increase the risk of zonular rupture and vitreous 
loss (Carpel 1988, Konstas et al 1992). This hypothesis is 
consistent with the information provided by Guzek and 
coworkers (1987) who found that decreasing pupil size was the 
only significant risk for vitreous loss in ECCE.
1.12 Exfoliation glaucoma
Relationship with exfoliation syndrome
The percentage of patients with exfoliation syndrome who have 
glaucoma (exfoliation glaucoma), or ocular hypertension on 
initial examination ranges from 22 to 94% (Kozart & Yanoff 
1982, Ruprecht et al 1985, Jerndal 1986, Slagsvold 1986, 
Forsius 1988, Konstas 1989). Exfoliation glaucoma may ensue 
at any time after the development of exfoliation syndrome. A 
retrospective study has shown that in patients with 
exfoliation syndrome and normal IOP, 5% developed raised IOP 
over 5 years while 15% did so over 10 years (Henry et al
1987).
Exfoliation glaucoma has uniformly been considered as a 
severe form of chronic open angle glaucoma (Smith 1979, Sugar
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1984, Tarkkanen 1984, Jerndal 1986, Thorburn 1988, Naumann et 
al 1988). Perasalo & Raitta (1987) found exfoliation 
glaucoma to be a major cause of visual impairment in an 
institutionalised geriatric Finnish cohort 66 to 100 years 
old. Raivio (1987) has estimated that the number of patients 
with glaucoma in Finland would increase by 40% by the year 
2 010 owing to the ageing population. He also calculated that 
a 40% increase of resources and glaucoma care facilities 
would be required for glaucoma patients by the year 2010.
1.12.1 Course and clinical attributes
The natural history of exfoliation glaucoma without treatment 
has not been described. This is because most patients are 
treated, which presumably influences the disease process. 
Prospective data concerning the long term outcome of treated 
exfoliation glaucoma is presently not available. Specific 
clinical attributes distinguish exfoliation glaucoma from 
POAG (Kristensen 1965, Horven 1966, Olivius & Polland 1980, 
Tarkkanen 1984, Blika et al 1984, Sugar 1984, Bertelsen 1985, 
Lutjen-Drecoll et al 1986, Repo et al 1990). Asymmetry in 
the clinical manifestations of the disorder is the rule 
rather than the exception (Johnson & Brubaker 1982).
The fellow eve in unilateral exfoliation glaucoma 
Several studies have confirmed a significant risk of the 
unaffected eye developing exfoliation glaucoma, related to 
the duration of the condition (Pohjanpelto 1973? 1986, 
Ruprecht et al 1985, Prince et al 1987, Konstas & Allan 1989, 
Streeten et al 1990, Montanes et al 1990b). A retrospective
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study has indicated that 21-26% of patients with bilateral 
exfoliation syndrome and unilateral exfoliation glaucoma may 
develop exfoliation glaucoma in the fellow eye within 5 years 
(Hansen & Sellevold 1969). In another retrospective series 
of 519 patients with exfoliation, Brooks & Gillies (1988) 
established that in unilateral exfoliation glaucoma the 
presence of exfoliation syndrome in the fellow eye was a 
serious risk factor. Raised IOP developed in approximately 
three quarters of these eyes. In addition, exfoliation 
glaucoma developed in approximately 25% of eyes with ocular 
hypertension at presentation (Brooks & Gillies 1988).
IOP and exfoliation
A consistent, yet unexplained, feature has been observed in 
patients with exfoliation syndrome. They exhibit a higher 
IOP compared with age matched control subjects (Aasved 1971c? 
1979a, Krause et al 1973, Hiller et al 1982). Whether this 
clinical feature is explained by the incomplete handling of 
the influx of pigment and/or exfoliation material by the 
self-cleaning filter mechanism of the angle, is speculative. 
It is conceivable that exfoliation syndrome increases outflow 
resistance even in 'normal' eyes.
Patients with exfoliation glaucoma typically present with 
elevated IOP, often considerably so (Tarkkanen 1965, Gillies 
& West 1977, Bertelsen 1985, Jerndal 1986? 1990). Tarkkanen 
(1965) reported that over 60% of the affected eyes in 
patients with unilateral exfoliation glaucoma exhibited an 
IOP higher than 35 mm Hg, at diagnosis. Lindblom & Thorburn 
(1984b) surveyed the hospital records of a well defined
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glaucoma population in Halsingland, Sweden. Their cohort 
consisted of 245 cases with exfoliation glaucoma and 75 cases 
with POAG (3:1 ratio). Exfoliation glaucoma patients had 
unilateral disease more often at diagnosis (31% versus 54% 
for POAG). Both glaucomas showed the same degree of visual 
field loss at diagnosis, despite the fact that the mean IOP 
at diagnosis was considerably higher in the exfoliation 
glaucoma group (42.9 mm Hg for exfoliation glaucoma compared 
to 34.8 mm for POAG). In exfoliation glaucoma the authors 
noted a significant increase in the mean IOP with every stage 
of progression in their classification for glaucomatous 
damage (Lindblom & Thorburn 1984b). This was not observed in 
the POAG cases. It is remarkable that, according to their 
findings, the mean IOP at diagnosis for patients with legal 
blindness due to advanced exfoliation glaucoma (11 patients) 
was almost 60 mm Hg.
Few cases of low tension exfoliation glaucoma have been 
reported to date (Bertelsen 1985). In one study, only 2 out 
of 245 patients with exfoliation glaucoma and visual field 
loss had an IOP below 20 mm Hg at diagnosis (Lindblom & 
Thorburn 1984a). There is nearly universal agreement in the 
literature that exfoliation glaucoma is a hypertensive 
glaucoma (reviewed by Jerndal 1986). Indeed, a number of 
studies have described an acute form of exfoliation glaucoma. 
Up to 25% of patients with exfoliation glaucoma may present 
with an acute rise in IOP, frequently in excess of 50 mm Hg, 
and a varied degree of corneal oedema (Gillies & West 1977, 
Brooks & Gillies 1988, Gillies & Brooks 1988). The majority 
of these cases have open angles, although some cases of acute
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angle closure glaucoma with exfoliation have also been 
described (Gillies 1978, Bartholomew 1981, Gillies & Brooks
1988) .
Extreme cases of so called 'absolute exfoliation glaucoma' 
can occasionally present with high IOP and no perception of 
light (Gillies & West 1977, Gillies 1978). In an Australian 
series, 5 cases of absolute exfoliation glaucoma were 
identified in a cohort of 72 cases with acute open angle 
exfoliation glaucoma (Gillies & Brooks 1988). In the same 
series, a marked preponderance of males with acute 
exfoliation glaucoma was noted. Bartholomew (1981) described 
8 cases with definite acute angle closure glaucoma in 
association with exfoliation. He suggested that the 
underlying mechanism was that of secondary angle closure due 
to the formation of iridocapsular synechiae.
Steroid response
Among the several differences between exfoliation glaucoma 
and POAG one of the most interesting is the lack of a change 
in IOP following topical steroids. Steroid-induced ocular 
hypertension occurs in approximately a third of the normal 
population, but occurs in the majority of patients with POAG 
(reviewed by Armaly 1986). It is reversible, reproducable 
and genetically determined. The trabecular meshwork is the 
site of the pathology responsible for the IOP elevation and 
the response is abolished following filtering surgery (Armaly
1986). Exfoliation glaucoma differs markedly from POAG by 
exhibiting the same frequency of steroid response as that of 
the normal population (Armaly 1986).
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Prognosis
In a retrospective study, Olivius & Thorburn (1978) reported 
that after 5 years more glaucomatous damage had occurred in 
the exfoliation glaucoma patients (102 eyes) than in the POAG 
group (58 eyes) in spite of recourse to surgery more often 
and earlier. After 5 years the exfoliation glaucoma group 
exhibited severe visual field loss in 48% of cases compared 
with only 19% in the POAG group. Pohjanpelto (1985) studied 
retrospectively the fate of visual fields in 42 eyes with 
exfoliation glaucoma and 46 eyes with POAG. At the end of 
the follow up period (mean 10 years), 71% of the eyes in the 
exfoliation glaucoma group and 82% of the eyes in the POAG 
group had deteriorated. Approximately 40% of the eyes with 
exfoliation glaucoma and 26% of the eyes with POAG had become 
legally blind.
No comment however, can be made on the prognosis of 
exfoliation glaucoma until controlled data are obtained. To 
date, no prospective comparative studies have been conducted 
comparing an age matched POAG sample with an exfoliation 
glaucoma sample of comparable severity to determine whether 
exfoliation glaucoma has a better, or worse prognosis than 
POAG.
1.12.2 Treatment of exfoliation glaucoma
Medical therapy
Eye drops have conventionally been considered the first line 
of treatment in the glaucomas (Jay 1991). Several authors 
have made the anecdotal observation that, in comparison with
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POAG, the response to medical therapy is poorer in patients 
with exfoliation glaucoma (Vogt 1930, Gradle & Sugar 1947, 
Joannides et al 1961, Horven 1966, Aasved 1971, Tarkkanen 
1965? 1984, Haydon 1986). Another feature stressed by some 
writers is that an initial good response to medical therapy 
is often followed by failure of IOP control (Gillies 1978, 
Tarkkanen 1986, Jerndal 1986; 1990, Brooks & Gillies 1988). 
However, insufficient control of the IOP with medical therapy 
and failure after initial success in controlling the IOP have 
also been documented in a significant proportion of POAG 
patients (Jay & Murray 1988, Stewart 1990, Jay 1991).
Airaksinen (1979) compared the hypotensive effect of timolol 
to that of pilocarpine in 10 patients with POAG and 5 
patients with exfoliation glaucoma. He concluded that in 
exfoliation glaucoma the hypotensive effect of timolol was 
initially 'good', but that later 'IOP increased gradually so 
miotics had to be added'. Aasved and coworkers (1979) found 
that the percentage of initial successful control (defined as 
IOP<22 mm Hg) with timolol in patients with exfoliation 
glaucoma was only 11%. Blika & Saunte (1982) reported that 
after 3 years on timolol drops alone successful control was 
obtained in 33% of the POAG cases (130 eyes) compared with 8% 
of the exfoliation glaucoma cases (50 eyes). Their material 
was age matched, but collected retrospectively, selective and 
the analysis of the results flawed by the analysis of eyes 
instead of patients.
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Granstrom (1985) documented retrospectively a greater risk of 
visual field loss in patients with exfoliation glaucoma, 
compared with POAG patients, treated with pilocarpine 4% 
three times a day. ohrstrdm & Kattstrom (1981) studied the 
interaction of timolol and adrenaline in a prospective 
double-blind randomised trial on 10 patients with POAG and 10 
patients with exfoliation glaucoma. They found a 
significantly increased hypotensive effect with adrenaline? 
in patients with exfoliation glaucoma.
Drawbacks of medical therapy
It is well recognised that between 28 and 58% of patients 
with open angle glaucoma treated with drops fail to 
administer their drops (Granstrom 1985, Kass 1985, Kass et al 
1986? 1987, Stewart 1990, Winfield et al 1990). Winfield and 
coworkers (1990) found that in elderly patients a high 
prevalence of non-compliance was compounded by physical 
inability to administer eye drops. It has also been shown 
that ophthalmologists consistently fail to predict the 
patients who will not comply with their medications (Kass et 
al 1987). Indeed the problem may be underestimated since 
data on compliance may be biased. It has been suggested that 
the inclusion of a patient in a compliance trial improves 
their compliance by 30% (Novack et al 1988).
There is no specific data on the compliance of patients with 
exfoliation glaucoma. It is reasonable to assume that the 
advanced age compounded with the presence of chronic physical 
and mental ailments would further adversely influence the 
rate of non-compliance. Drug side effects are common, often
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limit therapeutic choices and may even be life threatening, 
especially with beta blockers, or carbonic anhydrase 
inhibitors (Kass 1985, Konstas 1989, Jay 1991). It has been 
shown that troublesome side effects, especially when they 
appear suddenly, may result in poor compliance (Kass 1985, 
Kass et al 1987). Less obvious disadvantages of long term 
medical therapy have recently been identified. Sherwood and 
coworkers (1989) found increased numbers of inflammatory 
cells in conjunctival biopsies from eyes on long term medical 
therapy when compared with biopsies from eyes treated by 
early trabeculectomy. However, the greatest risk associated 
with long term medical therapy is the progressive loss of 
visual field during unsuccessful attempts to establish 
medical control (Jay & Murray 1988, Jay & Allan 1989). 
Although, the reported disadvantages of long term medical 
therapy have been identified in studies of predominantly POAG 
patients these disadvantages may be even more pertinent in 
the older patients with exfoliation glaucoma.
Laser therapy
Argon Laser Trabeculoplasty (ALT) is used in the hope of 
avoiding surgical intervention (Wise & Witter 1979, Tuulonen 
1983, Tuulonen et al 1985, Pohjanpelto 1985, Grinich et al 
1987, Hetherington 1988, Svedbergh 1988, Jerndal 1990, Reiss 
et al 1991). This technique involves placing multiple 
thermal burns, evenly spaced over part or the whole 
circumference of the trabecular meshwork (Reiss et al 1991). 
ALT is thought to lower the IOP by increasing the facility of 
outflow (Stewart 1990). Although its exact therapeutic 
mechanism is not fully understood, its success in lowering
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IOP has been confirmed by many authors (Wise & Witter 1979, 
Logan et al 1983, Svedbergh & Sherwood 1985, Lund & Zink 
1988, Ticho & Nesher 1989, Psilas et al 1989). The success 
rate has been variably defined and comparisons between 
published reports are difficult (Reiss et al 1991). In 
general the response to ALT may be described in two time 
intervals: initial (up to one year) and long-term (more than 
one year). Initial results have shown that 71 to 97% of 
phakic patients obtain an IOP of 21 mm Hg or less after ALT 
(Wise & Witter 1979, Grinich et al 1985, Ticho & Nesher 1989, 
Psilas et al 1989, Stewart 1990, Reiss et al 1991). The 
average drop in IOP is between 5 and 14 mm Hg with a greater 
reduction of IOP in patients with a higher baseline IOP.
ALT in exfoliation glaucoma
ALT in exfoliation glaucoma has certain characteristic 
attributes (Svedbergh 1988). Whilst treating the inferior 
angle, excess pigmentation often obscures the location of the 
trabecular meshwork. The most efficient treatment parameters 
for ALT in exfoliation glaucoma remain uncertain. One study 
showed a 20% decrease in the IOP using either 500, 700 or 900 
mW (Rouhiainen et al 1987). Future modifications of ALT in 
exfoliation glaucoma may reduce the complication rate while 
still providing an adequate IOP reduction.
Several studies have suggested that ALT is more successful in 
exfoliation glaucoma than POAG (Thomas et al 1984, Ticho & 
Nesher 1989). Most authors have ascribed this to the 
increased pigmentation of the trabecular meshwork (Thomas et 
al 1984, Sherwood & Svedbergh 1985, Stangos et al 1985, Ticho
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& Nesher 1989, Psilas et al 1989). For example, Ticho & 
Nescher (1989) reported four factors which favour the use of 
ALT; older age, lower pre-treatment IOP level, exfoliation 
glaucoma and pigmented meshwork. Indeed, advancing age and 
exfoliation glaucoma are factors consistently reported to 
influence positively the outcome of ALT (Tuulonen et al 1985; 
1989, Ticho & Nesher 1989). Sherwood & Svedbergh (1985) 
reported a 70% success rate in 55 eyes with exfoliation 
glaucoma and late failure only in 2 cases.
This view however, is not universally shared (Logan 
et al 1983, Higginbotham & Richardson 1986, Lund & Zink
1988). Lund & Zink (1988) did not observe a significant 
difference in the response to ALT between exfoliation 
glaucoma and POAG. Higginbotham & Richardson (1986) reported 
that despite having a large immediate IOP response to ALT 
the treatment subsequently failed at a faster rate. Another 
series reported a similar response for exfoliation glaucoma 
to that for POAG, with a one year success rate of 73%, 
decreasing to 54% after 3 years (Grinich et al 1985). 
Furthermore, a high rate of failure in exfoliation glaucoma, 
compared to POAG, has been reported with longer follow up 
periods (Higginbotham & Richardson 1986, Raitta & Setala 
1986, Svedbergh 1988). In 1988 Svedbergh conducted a 5 year 
retrospective analysis of 74 patients treated by ALT and 
found that late failures were significantly more common in 
the exfoliation glaucoma group (69% compared to 45% in POAG 
after 5 years) although the failure rate was similar at the 
end of the first year (19%).
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Primary ALT
Current interest in ALT has moved from its use as a means of 
avoiding surgery in cases escaping from medical control to 
direct comparison with medical therapy as a first line of 
treatment in newly diagnosed glaucoma cases (primary ALT). 
Thomas and coworkers (1984) reported a 97% success rate with 
primary ALT in a small number of individuals with exfoliation 
glaucoma in Egypt. They were able to taper medication in 41% 
of the exfoliation glaucoma patients and considered primary 
ALT of great benefit in certain socioeconomic circumstances 
and in cases of suspected poor compliance (Thomas et al 
1984). In a randomised prospective trial Tuulonen 
and coworkers (1989) showed, after one year of follow-up, 
better preservation of the neuroretinal rim area, but no 
significant difference in visual field loss between primary 
laser therapy and primary medical therapy.
Surgical treatment
For the purposes of this investigation surgical treatment 
refers exclusively to trabeculectomy which is currently the 
most popular surgical procedure. Drainage surgery is the 
most effective means of reducing the IOP from the initial 
level to the physiological range (Jay 1991). Controversy 
still exists over the indications for performing glaucoma 
filtration surgery. Numerous authors including Migdal & 
Hitchings (1986), Jay and Murray (1988) and Watson and 
coworkers (1990) have established the greater effectiveness 
of surgical treatment in lowering IOP. Even when medical 
therapy is judged to control the glaucomatous progression the 
mean IOP obtained is significantly higher than that after
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surgical treatment (Wilson 1977, Jay & Murray 1988, Watson & 
Barnett 1975, Watson et al 1990). Moreover, the diurnal 
variation in IOP is almost eliminated by trabeculectomy (Jay 
1991). In contrast, medical therapy has no effect on the 
diurnal variation whereas ALT has only a minimal effect 
(Migdal & Hitchings 1986, Reiss et al 1991). The indications, 
results and specific attributes of trabeculectomy in 
exfoliation glaucoma are discussed in chapter 10.
1.13 Associated conditions
Several conditions have been reported to be associated with 
exfoliation syndrome. These include Fuchs7 heterochromic 
cyclitis (Jain et al 1983), a rare corneal dystrophy with 
oculocutaneous pigment disturbance (Meretoja 1985) and 
nanophthalmos (Diehl et al 1989, Jin & Anderson 1990). It is
thought by some that exfoliation syndrome is associated with
droplet keratopathy (Taylor 1979, Johnson et al 1989), but 
this view is not universally shared (Forsius 1988). In a 
study of 33 Indian patients with Fuchs' heterochromic 
cyclitis exfoliation syndrome was seen in 2 patients (Jain et 
al 1983). The authors speculated that there could be a link 
between the two conditions namely iris pigmentary changes.
Pigmentary glaucoma
Differences and similarities exist between exfoliation 
glaucoma and pigmentary glaucoma (Sugar 1984). Similarities 
include liberation/dispersion of pigment and the trabecular 
pigment ring. Differences include the younger age of 
affliction in pigmentary glaucoma, the refractive status and
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the possibility of self-limitation in pigmentary glaucoma. 
Layden and coworkers (1990) recently described 5 patients who 
had pigment dispersion syndrome and who subsequently 
developed exfoliation. The concurrent occurence of these two 
conditions increased the difficulty of medical management of 
their IOP.
Closed angle glaucoma
The anterior chamber depth is usually found to be normal in 
exfoliation syndrome\glaucoma (Horven 1966, Forsius et al 
1974, Bartholomew 1980, Montanes et al 1990b, Stefaniotou et 
al 1990, Konstas & Dutton 1991) and concurrent angle closure 
glaucoma is probably coincidental (Gradle & Sugar 1940, 
Tarkkanen 1962, Lowe 1964, Horven 1966, Forsius et al 1974). 
However, a high prevalence of angle narrowness in association 
with the condition has been reported in two studies (Layden 
and Shaffer 1973, Wishart et al 1985).
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1.14 Plan of proposed morphological investigation
From the foregoing review of the literature, the following 
topics were selected for research and this choice was 
influenced by 1) the availability of material and 
immunocytochemical technology and 2) the surgical policy for 
the treatment of exfoliation glaucoma.
Part I of this investigation deals with the morphology of the 
iris in exfoliation glaucoma and the nature of exfoliation 
material. Part II describes two prospective clinical 
investigations in Scottish patients with exfoliation glaucoma 
and POAG. It was not considered appropriate to deal with 
conventional morphology of the normal ocular tissues.
However, in section 4.1 a brief description of the morphology 
of the normal iris has been given. The specific aims of part 
I of this investigation are:
(1) To establish a definitive diagnosis for the presence of 
exfoliation material in the open angle glaucoma population 
studied in part II.
(2) To provide more information on the conventional 
morphological changes seen in the iris of patients with 
exfoliation glaucoma.
(3) To document the fine structural distribution of collagens 
I-V in the normal and exfoliative iris.
(4) To study the distribution of the glycoprotein laminin in 
the normal and exfoliative iris.
(5) To evaluate changes in the vascular matrix of exfoliative 
iris vessels in the various stages of the disease.
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CHAPTER 2 THE NORMAL EXTRACELLULAR MATRIX
2•1 Introduction
A brief description of the current state of knowledge in the 
structure and functional role of the extracellular matrix 
(ECM) is provided in the following chapter. Due to the 
immense breadth of research on this topic a comprehensive 
review is impractical. The following description focuses on 
the ECM components investigated in this thesis (collagen 
types I-V and laminin) and highlights only functional 
features of relevance to the present study.
2.2 Definition, structure and role of the ECM
Definition
The extracellular matrix (ECM) is an intricate meshwork of 
interacting extracellular molecules that acts as a scaffold 
to which cells attach (Mecham 1986, Adair & Mecham 1990, 
Alberts et al 1991). The ECM serves as a universal 'glue', 
and is the major constituent of structures such as cartilage, 
tendons and bone. The ECM macromolecules are thought to be 
secreted by local cells, particularly fibroblasts, and 
assemble into an organised meshwork in the extracellular 
space of most tissues. In more specialized structures, ECM 
macromolecules are secreted by specific cells, such as the 
chondroblasts forming cartilage and the osteoblasts forming 
bone. Normal development and tissue repair in the higher 
animals rely on the elaboration of appropriate matrices by 
specific cell types (Majack & Bornstein 1985).
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Structure of ECM
Two of the main classes of extracellular macromolecules are 
the collagens, which strengthen and facilitate the 
organisation of the ECM and those of glycosaminoglycans,
(forms of polysaccharide), which are frequently linked to 
protein to form proteoglycans. Collagens are distinctive 
fibrous proteins which impart stiffness and a high degree of 
tensile strength to the ECM. The glycosaminoglycan molecules 
(formerly known as mucopolysaccharides) form a highly 
hydrated gel-like 'ground substance' in which collagen fibres 
are embedded. Their role is to allow diffusion of nutrients, 
metabolites and hormones between the blood and the tissue 
cells and block diffusion of large molecules, due to their 
mesh-like structure. Proteoglycans coexist with collagens 
with whom they interact (Tawara et al 1989). Indeed, 
proteoglycans have been shown to influence the assembly of 
the collagen fibrils, their growth and their three- 
dimensional arrangement (Ruggeri & Motta 1984, Adair & Mecham 
1990). Moreover, cell culture studies have shown that 
regulation of the production of specific collagen molecules 
can be influenced by glycosaminoglycans (Pratt et al 1985, 
Majack & Bornstein 1985, Streuli & Bissell 1990).
Functional role of the ECM
Until recently, ECM was considered a rather inert structural 
network that stabilised the physical structure of tissues.
It is now known that the ECM is directly involved in a number 
of critically important biological roles, influencing the 
biochemical function of cells (for reviews see Abrahamson 
1986, Mecham 1986, Adair & Mecham 1990). Though many studies
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have been designed to elucidate the complex role that ECM 
plays in regulating the behaviour of the cells it supports, 
our understanding is still incomplete. It is clear however, 
that a variety of ECM components characterise different 
tissues. Their presence and their elaborate interactions 
determine the physico-chemical characteristics of each tissue 
(Abbot 1988, Engel 1989). Determining the ECM distribution 
in different tissues is relevant to understanding the 
function of these tissues and pathological processes that may 
occur in these tissues. For example, an immunofluorescent 
study of the human optic nerve head has demonstrated that the 
lamina cribrosa contained a specialised ECM that did not 
resemble that of the sclera (Hernandez et al 1986). The 
authors suggested that this was related to the specialised 
function of the lamina cribrosa.
Similarly, in the last decade, the disciplines of cell and 
molecular biology have made great progress in the in vitro 
documentation of the influence of the ECM on cell behaviour. 
The mechanisms by which the synthetic capacity of cells can 
be modified by the subtle ECM changes and by its interaction 
with modulating and growth factors have also aroused great 
interest (Pratt et al 1985, Krieg et al 1985, Glaser 1988). 
Cell culture studies suggest that ECM components provide 
signals that the overlying cells are capable of detecting and 
responding to (Pratt et al 1985). Furthermore, it seems that 
the cells, in turn, can modify the surrounding matrix, thus 
creating dynamic interplay between cells and their enclosing 
ECM (Mecham 1986). However, it is important to realise that 
none of the in vitro assays so far described can reproduce
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the entire set of events occuring in vivo.
2.3 Glycoproteins
Glycoproteins comprise significant yet little known 
constituents of the ECM. Some are unique to basement 
membranes. Two of the best studied glycoproteins are laminin 
(dealt in detail later) and fibronectin. These high 
molecular weight glycoproteins are widely distributed and 
possess a variety of biological functions. Fibronectin is an 
ECM glycoprotein that promotes cell adhesion and exists in 
large aggregates in the extracellular space. Fibronectin, as 
well as two other lesser known macromolecules thrombospondin 
and amvloid P, have been detected in some basement membranes 
by immunofluorescence and immunoelectron microscopy and may 
be important constituents during embryonic development or 
tissue repair (Charonis & Tsilibary 1990). However, because 
of their presence in the plasma they are not considered to be 
intrinsic components of differentiated basement membranes.
2.4 Collagens
Definition
Collagen derives from the Greek words meaning 'to produce 
glue'. It comprises a family of highly characteristic 
fibrous proteins which are rich in the amino acids glycine 
and proline (Alberts et al 1991). A collagen can also be 
defined as an extracellular structural protein whose 
functional properties depend significantly upon a triple 
helical domain (Burgeson 1988). Collagens are found in all
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multicellular animals and constitute approximately 25% of the 
total protein in mammals.
Structure
Collagens are major constituents of the extracellular space 
with common properties that allow them to be regarded as a 
single class of structural proteins. The regular form of 
fibrous collagens indicates that they derive from a single 
molecular subunit, despite the fact that the banded fibres 
vary in diameter from tissue to tissue ( Mayne & Burgeson 
1987, Burgeson 1988). The basic structural unit of collagen 
consists of three polypeptide chains whose precise 
composition depends on the type of collagen. Collagen 
molecules have an unusual amino acid composition in 
comparison with other proteins. Glycine and proline are 
present in high proportions and collagens contain two amino 
acids that are found in few other proteins, namely 4- 
hydroxyproline and 5-hydroxylysine. Moreover, the amino acid 
sequence of collagens is remarkably regular: nearly every 
third residue is glycine (Stryer 1988). Glycine residues are 
of critical importance as they are small enough to fit into 
the crowded interior of the triple helix. Consequently, 
glycine allows different polypeptide strands to come 
together. Individual collagen polypeptide chains, 
synthesized by ribosomes, are injected into the lumen of the 
rough endoplasmic reticulum as pro-a-chains. Three pro-a- 
chains then wrap around each other to form a triple stranded 
helical molecule. When this tropocollagen molecule is 
secreted by the cell to the exterior, it combines with others 
to form collagen fibrils.
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Classification of collagens
Collagens can be classified by several criteria: length of 
molecule, molecular weight, flexibility of the molecule and 
ultimately by supramolecular structure. Collagens can be 
classified into three groups according to supramolecular 
structure: the fibrous collagens, the non-fibrous collagens 
and the filamentous collagens (Bailey 1987).
Fibrous Collagens
Fibrous collagens are seen with the TEM as thick fibrils with 
a characteristic 67nm periodicity (Fleischmajer et al 1990a). 
There is considerable variation in fibril diameter, being 30- 
40 nm in the cornea and up to 200nm in the sclera (Bailey
1987). Size and distribution may be uniform within a tissue 
(e.g. cornea) or highly variable (e.g. sclera).
Collagen types I, II and III show considerable homology and 
consist of a single uninterrupted helical domain, almost 300 
nm in length (Miller 1985). Data from several sources 
indicate that collagen types I, II and III are the principal 
constituents of collagen fibres (Montes et al 1984, Miller 
1985, Ben-Zvi et al 1986, Mayne & Burgeson 1987, Linsenmayer 
et al 1990a). Ultrastructurally, type I collagen fibrils 
reach full growth at about 100-500 nm in diameter, whereas 
type III collagen fibrils do not grow beyond about 60 nm 
(Keene et al 1987, Fleischmajer et al 1990a). Recently,
Keene and coworkers (1987) showed by immunoelectron 
microscopy that antibodies against type III collagen label 
all fibrils with 67 nm periodicity regardless of their 
diameter. This study and that of Fleischmajer and coworkers
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(1990a), suggest that some collagen fibrils contain both type 
I and type III collagens. The relationship between these two 
collagens was further studied by Fleischmajer and coworkers 
(1990b) who employed single and double immunoelectron 
microscopy to show that type III collagen coats the periphery 
of intact human dermal collagen fibres. In the same study, 
collagen type I was shown throughout the interior of the 
fibril? however, its demonstration required disruption of the 
collagen fibrils. The authors considered this as evidence 
that the epitopes for collagen type I in the adult human skin 
are normally masked from type I collagen antibodies 
(Fleischmajer et al 1990b).
Collagen type V occurs both in association with basement 
membranes and, quite separately, in fibrous stroma such as 
cornea ( Mayne & Burgeson 1987, Marshall et al 1991b). The 
overall impression is that collagen type V has one, or more 
functions as a connector between basement membrane and 
stroma, but may also be found in collagen fibres in intimate 
molecular association with collagen type I (Birk et al 1986, 
Birk et al 1988). It is suggested, on the basis of studies 
on the chick cornea, that type V collagen co-exists with type 
I collagen and may control fibril diameter (Linsenmayer et al 
1990). In the same study, it was hypothesised that a high 
content of type V collagen within a heterotypic fibril would 
result in a fibril of small diameter.
Increased synthesis and accumulation of collagen type I has 
been demonstrated in diet-induced rabbit atherosclerosis 
(DeLuca et al 1990). The atheroma formation and luminal
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narrowing were associated with enhanced levels of type I 
collagen mRNA and increased rates of collagen type I 
synthesis. Degradation of collagen types I, II and III in 
the ECM by collagenases may be a feature of chronic 
inflammatory disorders, such as rheumatoid arthritis. In the 
inflammatory synovium production of collagenase, (synthesised 
by fibroblasts and chondrocytes), has been shown to be 
responsible for the degradation of these collagens and 
distortion of the architecture and function of the joints 
(Krane et al 1990).
Non-Fibrous Collagens
Non-fibrous collagens comprise the principle collagens of the 
basement membranes which separate fibrous stromal tissue from 
cells. Basement membranes vary in thickness from 25nm in 
capillaries to 200 microns in the lens capsule. Only type IV 
collagen has been classified as a non-fibrous collagen and 
has been localised in all basement membranes examined so far. 
This nonfibrillar collagen has been purified from authentic 
basement membranes as well as from ECM synthesised by tumours 
and cell cultures (Abrahamson 1986, Charonis & Tsilibary
1990). Collagen type IV molecules self-assemble to form 
extended complexes that comprise the structural backbone of 
basement membranes (Timpl et al 1981).
Most immunoelectron microscopic studies localise type IV 
collagen to the lamina densa and lamina lucida, although some 
restrict it to the lamina densa (Kennedy et al 1986, 
Abrahamson 1986, Grant & Leblond 1988, Essner & Lin 1988). 
Recently, it has been reported (Timpl et al 1990) that type
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IV collagen and laminin form polymers and interact with each 
other through an entactin/nidogen bridge. The supramolecular 
architecture of type IV collagen in basement membranes is 
probably that of a fine mesh (Yurchenco 1990). Other 
components bind to type IV and this in turn places them 
closer together and narrows considerably the 'pore size' of 
the mesh.
2•5 Laminin
The glycoprotein laminin was first purified from the basement 
membrane-like matrix of the EHS sarcoma (Timpl et al 1979).
It is a major intrinsic structural basement membrane 
component, the only one, together with collagen type IV, 
which forms polymers. Structurally, laminin is composed of 
three chains designated A (molecular weight 400,000), B1 
(210,000) and B2 (200,000). These chains are held together 
by disulfide bonds to form a cruciform-like structure 
(Kleinman et al 1990). Current concepts suggest that there 
may be various molecular forms of laminin. In the developing 
embryo, the B chains are first synthesised at the two-cell 
stage, while the A chain does not appear until the 16-cell 
stage. In adult tissues, the A chain appears to be reduced 
in amount or lacking, and the ratio of the B1 to B2 chains 
varies depending on the organ studied (Kleinman et al 1990). 
As recently reviewed, there is support for the view that 
multiple forms of laminin may serve to regulate cell 
behaviour at different times during development and repair 
(Kleinman et al 1990, Charonis & Tsilibary 1990).
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Laminin has so far been found only in basement membranes 
(Yurchenko 1990). Several studies have shown that numerous 
biological functions of basement membranes depend on laminin 
(Sakashita et al 1980, Laurie et al 1982, Martin & Timpl
1987, Schittny et al 1988, Grant & Leblond 1988, Herbst et al
1988, Panayotou et al 1989, Coopman et al 1991). More 
specifically, laminin contributes to the support, binding and 
adhesion of cells, to the selective molecular sieving and to 
the regulation of cell migration, growth and differentiation. 
In addition, laminin promotes phagocytosis, the production of 
collagenase IV and enhances the metastatic phenotype of 
malignant cells (Kleinman et al 1990).
Laminin interacts with many basement membrane components 
and recent progress has been made in identifying the portions 
of laminin with which they interact (Yurchenco 1990, Kleinman 
et al 1990). Collagen type IV has been shown to bind to 
native laminin. As removal of laminin's amino-terminal 
(short arm) globules reduces collagen type IV binding, 
this implicates these regions as major sites of the 
interaction. Laminin exists as a 1:1 complex with nidogen 
(entactin), a sulphated glycoprotein which comprises an 
intrinsic basement membrane component (Martin & Timpl 1987). 
The laminin-nidogen interaction is probably the strongest 
interaction between basement membrane macromolecules 
(Charonis & Tsilibary 1990).
Laminin has been found to bind heparin and heparan sulfate 
proteoglycan (Sakashita et al 1980, Martin & Timpl 1987, 
Charonis & Tsilibary 1990, Kleinman et al 1990). Electron
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microscopic observations have suggested that the main domain 
of laminin involved in this binding is the globule of the 
long arm (Charonis & Tsilibary 1990). Heparin was shown to 
induce a specific alteration of laminin polymerisation in 
which self-assemply was accelerated (Yurchenco 1990).
Various other molecules, including plasminogen, sulphatides 
and integrin receptors have been found to bind laminin? the 
binding sites and the functional significance remain obscure 
(reviewed by Kleinman et al 1990).
Laminin exhibits many biological activities. Published work 
has stressed the importance of laminin in the adhesion and 
migration of normal epithelial and malignant cells (Timpl et 
al 1979, Abrahamson 1986, Herbst et al 1988, Zabrenetzky et 
al 1990, Timpl et al 1990). Tumour cells attach and grow 
better when cultured on laminin substrates and demonstrate a 
more malignant behaviour. They also display increased 
synthesis of collagenase IV, an enzyme responsible for the 
invasive behaviour of tumour cells (Kleinman et al 1990). In 
a recent in vitro study, Coopman and coworkers (1991) have 
furnished data suggesting that amongst several purified 
basement membrane components only laminin can function as a 
stop signal for cell migration. Within laminin, the activity 
was associated with the PI fragment. The authors concluded 
that laminin is the major determinant of the barrier function 
of the basement membrane to which some cell types (i.e. 
malignant tumour cells) may have become insensitive.
The presence of laminin ensures the formation of functional 
and specialised ECM (Hernandez et al 1986). The past few
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years have seen the publication of numerous reports on the 
presence and function of laminin and a complex picture is 
beginning to emerge concerning the role of this 
macromolecule. However, the majority of these studies have 
been conducted on animal tissue. It may not be appropriate 
to extrapolate from one species to another as diverse 
biological matrices may be employed in different species. 
Moreover, it is now becoming apparent that specialised organs 
such as the eye are characterised by specialised ECM.
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CHAPTER 3 MATERIALS AND METHODS FOR PART I
3.1 Conventional morphological studies
3.1.1 Clinical source of material
Tissue from the iris and trabecular tissue were obtained from 
surgical patients.
Open angle glaucoma group
In a prospective clinico-morphological study 100 consecutive 
patients with open angle glaucoma admitted for filtration 
surgery were examined by the author by comprehensive clinical 
examination for the presence of exfoliation material (section 
9.1). Pathological examination of iris tissue obtained from 
all 100 patients provided a definitive diagnosis (exfoliation 
glaucoma or primary open angle glaucoma (POAG) in every case. 
Subsequently, all the exfoliation glaucoma specimens (26) and 
an equal number of age-matched POAG specimens were used for 
the detailed description of the range and characteristics of 
pathological changes in exfoliation glaucoma.
Closed angle glaucoma group
Iris tissue from 31 consecutive patients who were deemed to 
warrant trabeculectomy for closed angle glaucoma were also 
collected. These patients were clinically examined by the 
author in the same fashion as the open angle glaucoma cases 
for the presence of exfoliation material (section 9.1.1).
Iris tissue from these patients was examined morphologically 
for the presence of exfoliation material. These 31 cases
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were included in this study as controls to determine whether 
the prevalence of exfoliation material varies in the two 
glaucoma groups.
3.1.2 Methods for conventional studies
Clinicopatholoqical examination
The open angle glaucoma group was investigated by 
comprehensive clinical examination (section 9.1.2) and was 
classified into 3 clinical groups: exfoliation glaucoma, 
possible exfoliation glaucoma and POAG. LM and TEM 
examination was performed on iris tissue from all patients 
with exfoliation glaucoma and possible exfoliation. All of 
the 60 iris specimens from those with POAG were examined by 
LM. Sixteen specimens were subsequently examined by TEM 
either because LM indicated the possibility of exfoliation (4 
cases), or gonioscopy had not been performed (12 cases). In 
addition, TEM was also employed upon a random sample of group 
III iris specimens (18 cases).
All 31 specimens from the closed angle glaucoma group had LM 
assessment and 15 specimens, chosen at random, also had TEM 
examination for the presence of exfoliation material.
Conventional processing
Following surgery iridectomy specimens were fixed in buffered 
glutaraldehyde 2.5% (pH 7.6) for several days at 4°C. They 
were then washed in three changes of cacodylate buffer for 20 
minutes; post-fixed in equal parts of 2% osmium tetroxide and 
cacodylate buffer for one hour at room temperature; washed
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several times in cacodylate buffer and dehydrated through the 
following graded series of ethanol:
25% ethanol 10 mins
50% ethanol 10 mins
75% ethanol 10 mins
95% ethanol 10 mins
Absolute alcohol (4 times) 20-30 mins
The tissue was then cleared with two 5 min changes of 
propylene oxide and infiltrated overnight with a 50:50 
mixture of araldite and propylene oxide. Infiltration was 
continued with a 75:25 mixture of fresh araldite and 
propylene oxide for 6hrs on a rotivator at room temperature 
before blocking out into labelled rubber moulds? 
polymerization was carried out for 24-48hrs at 60°C.
Cutting and staining
Iris tissue was cut in a tangential plane so as to section 
the majority of iris vessels in transverse section. Semithin 
sections 1-3 micron thick were cut with a glass knife mounted 
on an LKB Ultrotome nova III stained with 1% toluidine blue 
and examined by LM. Ultrathin sections were cut from the 
selected iris blocks and mounted on 150 mesh, or 200 mesh 
copper grids. Post-staining with freshly made saturated 
aqueous uranyl acetate (15 mins) and Reynolds lead citrate 
(15 mins) was performed at room temperature. To facilitate 
recognition of exfoliation material at deeper tissue planes 
serial ultrathin sections were cut approximately every 20-30 
microns. An attempt was made to cut at least 50% of the
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block to identify and delineate exfoliation material 
deposits. At least five levels from every block were 
submitted for ultrastructural examination in a Philips 301 
or a Jeol 1200 EXII transmission electron microscope.
Coding for masked morphological assessment 
In order to allow unbiased morphological assessment all 
specimens were coded. The specimens were examined with a 
dissecting microscope at a x50 magnification and allocated a 
file number from the Ophthalmic Pathology Laboratory. LM 
evaluation of coded iris sections stained with toluidine blue 
was conducted on all specimens. The histological 
identification of exfoliation material in the iris was 
conducted according to the criteria described by Ringvold 
(1970c). Ultrastructural assessment was conducted on serial 
sections from coded iris specimens from 22 exfoliation 
glaucoma cases, 18 possible exfoliation glaucoma cases and 34 
POAG cases (see section 10.2.1).
3.2 Immunocytochemical studies
3.2.1 Introduction
Definition
Immunocytochemistry provides a means of identification of a 
tissue component in situ by means of a specific antigen- 
antibody reaction in which the antibody is bound to a visible 
label (reviewed by Polak & Varndell 1984, Beesley 1985; 1987) 
For the purposes of this study, the terms immunocytochemistry 
and immunogold localisation refer exclusively to the
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identification of tissue components at the EM level.
Gold coniungates
The interest in the use of gold-tagged antibodies as an 
immunocytochemical marker has greatly increased for a number 
of reasons. First, the visibility and discrete nature of 
gold particles is much higher than that of other labels such 
as ferritin. As gold atoms in the gold particles occur in 
their elemental form, the electron density due to their high 
atomic weight is augmented by the density of atoms within the 
particles. This permits the localization of antigenic sites 
occuring in regions with non-homogenous electron density.
Gold probes, unlike other antibody markers, can therefore be 
used in conjunction with optimally contrasted thin sections 
as they do not obscure the ultrastructural details of the 
labelled structures. This has permitted very fine 
localisation of antigens. Secondly, the particulate nature 
of the gold probe allows the indirect estimation of the 
amount of antigenic sites. Individual gold particles are 
assumed to be in the numbers proportional to the number of 
antigenic sites.
Antigenicity vs ultrastructure
The quality of ultrastructure and the preservation of 
antigenicity is greatly influenced by the type of fixative, 
its concentration, the duration and temperature of fixation 
(Beesley 1987). Unfortunately, ultrastructural preservation 
and the preservation of antigenicity are often in diametric 
opposition. Fixation protocols that preserve fine structure 
may destroy antigenicity and vice versa (Beesley 1987). Only
94
the most robust antigens survive the standard fixation regime 
of 2% glutaraldehyde followed by 1% osmium tetroxide, which 
normally ensures satisfactory ultrastructural preservation. 
More sensitive antigens are preserved with low concentrations 
of paraformaldehyde, but the concomitant loss of 
ultrastructure is a problem. It is thus important to 
experiment with numerous fixation regimes for a particular 
antibody and tissue in order to establish the optimum 
compromise between antigenic and ultrastructural 
preservation. The basic investigations for the development 
of the immunogold technique in this laboratory were conducted 
by Dr G.E. Marshall.
Labelling of resin embedded sections
All the preparatory steps in embedding biological material 
adversely affect antigenicity. Such embedding procedures 
elicit conformational changes of proteins by exposing them to 
denaturing fixatives, organic solvents and high temperatures 
(during resin polymerization). The influence of the 
embedding medium on the protein conformation is not well 
understood, but the environment provided should be as polar 
as possible to minimize disruption of protein conformation. 
The use of London Resin white (LR white) resin for embedding 
partially dehydrated tissue (up to 70% alcohol) is beneficial 
in that a hydration shell is maintained around antigenic 
epitopes. This results in increased antigenic conservation.
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3.2.2 Advantages of immunocytochemistry in the study 
of the ECM components in the eye
Introduction
The precise localisation and role of individual ECM 
components in the eye in health and disease were not explored 
in the past due to limitations of the experimental research 
tools available (reviewed by Marshall 1991). The 
immunocytochemical (immunoelectron) localisation of ECM 
components is a sensitive technique which allows fine 
structural localisation of antigens.
Advantages of immunocvtochemistrv
Immunohistochemistry at the LM level has insufficient 
resolution to unravel the structural components of normal, or 
diseased ophthalmic tissues and to resolve pathological 
substances (e.g. fibrillar and extrafibrillar exfoliation 
material), into its constituent parts. In addition, 
immunohistochemistry may be affected by relocation of the 
antigen (frozen sections) and diffusion of the label into 
surrounding tissues (immunoperoxidase technique). In the 
immunoperoxidase method at the EM level problems encountered 
at the LM are compounded by the difficulty in distinguishing 
between peroxidase labelling and background staining. Thus, 
interpreting the results is difficult.
In contrast to immunohistochemistry, immunogold particles 
employed in immunocytochemistry are localised in very close 
proximity to the antigen (i.e. attach themselves to the 
primary antibody, which in turn interacts with antigenic
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epitopes), allowing precise localisation of individual 
constituents. Other advantages include the potential for 
semi-quantitation (calculation of relative value of 
concentration of antigen), multiple labelling (two or three 
different sizes of particles can be attached to the 
antibodies in the same tissue) and the permanence of the 
results, unlike immunofluorescence which quenches or fades.
Disadvantages of immunocvtochemistrv
Disadvantages of immunocytochemistry when compared to 
immunohistochemistry include 1) the lack of macrodistribution 
of a given antigen, since only a very small tissue area is 
studied, 2) the demand for significantly more technical skill 
and 3) the significant increase in time and work in 
evaluating the immunocytochemical results.
Immunogold studies in the eve
The immunogold ultrastructural technique has been employed 
over the last decade for the identification of specific ECM 
components (collagens, laminin, fibronectin) mainly in animal 
tissues (Burgeson 1987;1988, Charonis & Chilibary 1990, 
Yurchenco 1990). It is only recently that some investigators 
have utilised the immunogold technique at the EM level in the 
study of the ECM in the human eye (Morrison et al 1989, Das 
et al 1990a; 1990b, Marshall et al 1990a; 1991a; 1991b;
1992a; 1992b). Most immunogold studies have investigated 
normal tissues; the potential for addressing biological 
problems is easily apparent.
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Antibodies
The immunocytochemical studies conducted in this work have 
been based on commercial antibodies. This is because it 
proved difficult to secure consistently reliable private 
sources. Attempts in this laboratory to employ antibodies 
from private sources (for example collagen type VII) proved 
disappointing. It was thought that the use of commercial 
antibodies would aid future comparisons and independent 
confirmation of results obtained herein by other studies. 
However, constant use of control material was essential.
3.2.3 Pathological material
Normal tissue
For the purposes of the immunocytochemical studies 16 
surgically enucleated eyes with ostensibly normal anterior 
segments of patients aged 52-81 years were obtained, 
principally from the eye theatre of the Tennent Institute of 
Ophthalmology, Western Infirmary, Glasgow. Normal iris 
tissue and control tissue (cornea and trabecular meshwork) 
was taken from these 16 eyes at the time of the first gross 
examination. The details for the eyes selected for this 
study are indicated in Appendix I. The anterior segment was 
ostensibly normal as determined by routine paraffin histology 
and LM examination of London Resin (LR) white semithin 
sections (courtesy of Professor W.R. Lee).
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Exfoliative cases
Exfoliative tissue (iridectomies and trabeculectomies) were 
obtained from 20 patients aged 65-85 years. The exfoliative 
iris tissue for the immunocytochemical studies comprised 
peripheral iridectomies from 12 patients who underwent 
trabeculectomy for exfoliation glaucoma and 3 patients with 
exfoliation syndrome who underwent intracapsular cataract 
extraction. In addition, trabecular meshwork tissue from 6 
patients with exfoliation glaucoma was employed in the study 
of laminin and collagen type I (chapters 5 & 6). The details 
of the 20 exfoliative cases used in this study are provided 
in Appendix II. All but 3 patients were examined 
preoperatively by the author (slit-lamp microscopy and 
gonioscopy) and the diagnosis was made on the basis of 
exfoliation material deposits on the lens capsule and pupil. 
The diagnosis for the other 3 patients was made by the 
referring clinician.
3.2.4 Methods for immunocytochemical studies
Fixation
The concentration of fixative and type of buffer used for 
each individual eye is listed in Appendices I and II. One of 
two buffers was employed in the fixation regime: 0.15M sodium 
cacodylate pH 7.2, or 0.1M sodium phosphate pH 7.2. The 
fixative used for each eye was freshly prepared by adding 4g 
of paraformaldehyde (PFA) to 100ml of preheated buffer. A 
few drops of 4M NaOH was added to the phosphate/cacodylate 
buffer solution to complete dissolution of the PFA. The 
solution was cooled with cold running tap water after
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complete dissolution and the pH readjusted with 0.1M HC1.
The relevant volume of 25% glutaraldehyde was then added to 
the solution.
Dissection of specimens 
Normal specimens
Enucleated eyes were immersed in fixative within a matter of 
minutes after enucleation and left for 10-15 mins for the 
sclera to harden: this facilitates the orientation of the 
calottes. On removal of the portion relevant for 
pathological investigation the remainder of the globe was 
dissected and the normal tissue fixed for a total of 2hrs 
before washing three times in buffer. The anterior segment 
was then divided in a radial manner with a razor blade. 
Corneal blocks were dissected out approximately 3mm anterior 
to the chamber angle and iris tissue blocks at about 1.5mm 
adjacent to the angle thus leaving blocks containing 
trabecular meshwork and part of the ciliary body. Thus 
anterior segment control blocks routinely contained 
trabecular meshwork, peripheral iris and anterior pars 
plicata (ciliary body).
Exfoliative specimens
The iris specimens were embedded without dissection as 
described in the next paragraph. The trabeculectomy 
specimens generally measured 2 by 2 mm and were cut in a 
meridian plane. The trabecular meshwork was easy to 
recognise due to the heavy pigmentation.
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LR White plastic embedding
Blocks allocated for LR white embedding were dehydrated in 
two 1 hour changes of 70% alcohol and infiltrated with LR 
white hard grade resin (two 1 hour changes). In a number of 
cases, for convenience, tissue blocks were left overnight in 
the second LR white change. Dehydration and infiltration 
were conducted on a modified TAAB type N rotator at 4°C in a
domestic fridge. The blocks were then deposited in 00 size
gelatin capsules filled with LR white resin and the capsules 
sealed (gelatin capsules are mandatory because plastic 
capsules are permeable to air and LR white resin will not
polymerize in the presence of oxygen). Attempts made to
maintain the orientation of the blocks in the capsules by 
inserting the capsules into a home made capsule holder either 
in the vertical or horizontal position were unsuccessful. 
Polymerization was conducted at 48°to 49°C for 48 hours in a 
Mark II TAAB embedding oven.
LR white sectioning
Semithin sections (1 and 2 microns) were cut on a LKB 
Ultratome nova (Cambridge Instruments), mounted on glass 
slides and stained with toluidine blue. A trapezoid was then 
cut round the desired area of tissue. Ultrathin sectioning 
was more satisfactory at higher cutting speeds than the 
normal (5mm/sec as compared to 2mm/sec). It was essential 
that the block face should be kept dry as wetting greatly 
impaired the sectioning process. Acetone was never added to 
the distilled water in the trough as it had a deleterious 
effect on antigenicity. The refractive index of LR white 
ultrathin sections appeared to be different from that of
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Araldite or Epon: interference patterns were higher up the 
scale in sections of comparable thickness. Ultrathin 
sections were mounted on the matt side of 200 mesh nickel 
grids. In order to ensure adhesion of the sections to the 
grids, the grids were left to dry for 15 mins in the grid box 
before rehydration on distilled water. Rehydration was 
conducted on microtitre plates with one grid per well in the 
pattern in which they came out of the grid box.
Immunocvtochemistrv
Antibodies
The anti-collagen antibodies (types I-V) were raised in goats 
against human and bovine collagens and were supplied by 
Southern Biotechnologies (UK distributors, Bionuclear 
Services Ltd, 24 Westleigh Drive, Sonning Common, Reading RG4 
9BL). All were affinity-purified and cross-absorbed against 
the remaining four purified human collagens. The specificity 
of these antibodies to human antigens was confirmed by the 
supplier using indirect enzyme-linked immunosorbent assay. 
Polyvalent rabbit antibodies against laminin were supplied by 
Heyl (Berlin, Germany) and had been raised in rabbits by 
multiple injections of human laminin. The serum was tested 
by the supplier with the following immunological assays: 
ELISA, immunoblot and immunohistology (fluorescence, APAAP).
Antibody dilutions
The antibody dilutions in TRIS buffer plus 1% BSA, was 
determined by a number of preliminary experiments and were 
between 1:30 and 1:60 for collagen types I,II,III and V and 
between 1:30 and 1:120 for collagen type IV. Laminin
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antibodies were used at dilutions between 1:20 and 1:60. It 
was found that staining intensity increased with antibody 
concentrations below 1:20, but the non-specific labelling was 
unacceptably high. Types I-V collagen goat antibodies were 
visualized with lOnm rabbit anti-goat immunogold conjugate. 
Laminin rabbit antibodies were visualized with lOnm goat 
anti-rabbit immunogold (Biocell Laboratories, Cardiff 
Business Technology Centre, Senghenydd Rd, Cardiff CF2 4AY).
With the delivery of a new batch of primary antibody a range 
of dilutions was tested in the immunocytochemical procedure 
against tissue known to contain the antigen under 
investigation to determine the dilution of the primary 
antibody which produced optimal labelling. This dilution 
was, as a rule, the minimum dilution of the normal serum 
control at which there an acceptably low level of nonspecific 
labelling. The dilution range was effectively covered by 
having a factor of two to three between subsequent dilutions 
with the minimum dilution at 1:20. Dilutions were adjusted 
for the season as it was found that, particularly in the 
summer, the room temperature could exceed 25°C. High 
temperatures appeared to increase specific and non-specific 
labelling. The possibility of standardization by conducting 
incubation of the primary antibody at 37°C was considered but 
was not pursued for practical reasons. A typical dilution 
range experiment would be 1:20, 1:60, 1:90, 1:120, 1:160. In 
exceptional circumstances, lower and higher dilutions would 
be used. Having determined the preferred dilution it was 
found that use of that dilution level generally produced 
satisfactory labelling in all subsequent immunocytochemical
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runs within the lifetime of an antibody batch. A dilution 
test was also performed with the immunogold label without the 
primary antibody. Very little nonspecific labelling was 
found within the range 1:20 to 1:100. The dilution range was 
also confirmed by inserting the normal serum before 
immunogold labelling.
Normal serum in primary antibody
Inclusion in the primary antibody solution of 1% bovine serum 
albumin (BSA), which was essentially immunoglobulin free, 
helped to prevent non-specific staining by competing with the 
primary antiserum for non-specific binding sites in the 
tissue.
Immunocytochemical buffer
The buffer used throughout the immunocytochemical procedure 
was 50mM TRIS pH 7.2 with the addition of 0.5M NaCl and 0.05% 
Tween 20 to reduce nonspecific antibody labelling (Marshall
1991). The addition of 0.5M NaCl and Tween 20 to the 
immunocytochemical buffer produced a harsh environment for 
antibody binding. Carbon Formvar coated grids were used to 
promote section retention by increasing the area for 
adhesion. However, with these grids, section retention was 
promoted at the expense of specific immunogold labelling and 
with an increase in the amount of unwanted deposit.
Transfer of grids
Transfer of grids from one solution to another was done using 
gold loops, whose diameter was slightly smaller than the 
outside diameter of the grid. Designated loops were used for
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each particular antibody. Transfer of fluid via the loop was 
largely eliminated by making a small break in the loop. The 
use of forceps to transfer grids was avoided: not only this 
proved technically difficult, but also there was greatly 
increased contamination from one puddle to another due to 
capillarity between the tips of the forceps. Buffer and 
distilled water washes were performed by transferring the 
grids on loops through a series of 1.5 ml puddles on 
parafilm, depositing the grid onto each puddle for the time 
indicated. Each antibody had its own separate series of 
puddle washes.
Immunogold labelling
On completion of ultrathin sectioning, free aldehyde groups 
were quenched by incubation on 0.5M NH4 in 50mM TRIS buffer 
pH 7.4 for 20-30 mins, again using a microtitre plate. The 
grids were then washed four times in distilled water (2 mins 
each) and pre-incubated overnight on 1% bovine serum albumin 
(essentially immunoglobulin free) in the buffer at 4°C. 
Primary antibody labelling was conducted at room temperature 
for 2 hours on 20 1 drops of antibody diluted in the immuno- 
buffer with the addition of 1% BSA. Antibody labelling was
performed on 2Old drops on parafilm. Evaporation of the
/
drops was prevented by covering the group of drops with a 
glass trough which also enclosed a wad of cotton wool 
saturated with distilled water. The grids were then passed 
through a series of six buffer puddles (approximately 4 mins 
each) to remove unbound antibody and deposited on 1% BSA 
dissolved in the buffer for 5 mins. Immunogold labelling was 
conducted for 1 hour at room temperature on 2Onl drops of the
i
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Figure 3.1: Summary of immunogold labelling post-embedding 
procedure for transmission electron microscopy.
gold conjugate diluted in the immuno-buffer with the addition 
of 1% BSA. Unbound gold conjugate was removed with three 
washes (4 mins each) of immuno-buffer plus 0.2% BSA followed 
by three washes (4 mins each) with immuno-buffer. The 
sections were then fixed in 2.5% glutaraldehyde in 0.15M 
sodium cacodylate buffer pH 7.2 for 5 mins in a modified grid 
box used for staining and washed three times (1 min each) in 
distilled water.
Staining was performed with freshly made saturated uranyl 
acetate in distilled water for 15 mins using the grid box 
stainer in a light tight container. This was followed by 
three quick distilled water washes. Figure 3.1 summarises 
the immunogold labelling procedure and Figure 3.2 illustrates 
the criteria for positive labelling.
3.2.5 Immunocytochemical controls
It is well recognised that with immunocytochemistry it is 
technically difficult to obtain reproducible and reliable 
results. Hence, it is essential to have control systems to 
consolidate information. With post-embedding immunolabelling 
controls may be employed on sections from the same tissue 
block and on different tissue blocks.
Negative controls
Two types of negative controls were incorporated into the 
immunocytochemical procedure, (1) omission of the primary 
antibody, (2) substitution of the primary antibody with non- 
immune serum from the same species in which the primary was
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raised. The first negative control was found of little 
significance in that non-specific labelling was always found 
to be minimal. The normal goat (Sigma-S 2007) and rabbit 
sera (Sigma-S 2632) controls were conducted at dilutions 
identical to those used for the corresponding antibodies. 
Figure 3.3. shows the criteria for negative serum controls in 
the iris. In this laboratory, the reliability of the 
immunocytochemical results was repeatedly tested by comparing 
labelling obtained with ultrathin frozen sections and LR 
white embedded tissue sections from adjacent tissue blocks.
Positive controls
The use of positive controls strengthens the validity of the 
results. Therefore, for each ECM component studied,
(collagen types I-V and laminin), an appropriate control age- 
matched tissue was selected as a positive control (Fig 3.4).
A number of control tissues were identified as potentially 
suitable positive controls. These included aged cornea, 
trabecular meshwork and lens capsule. The selected tissues 
have been previously studied and the antigen in question had 
a well documented distribution (Marshall et al 1990a? 1990b; 
1991a? 1991c). One or more positive controls were used in 
parallel with the study of the normal and exfoliative iris.
Evaluation of immunogold labelling 
Positive immunogold labelling
Electron microscopy was performed on a Philips 301 
transmission electron microscope at 80kV. An antigen was 
considered to be positively localized if the immunogold 
particles were restricted to discrete structures. Such
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labelling, particularly if it was weak, was not considered a 
positive result if a significant number of immunogold 
particles were present on what was termed internal negative 
controls which were the first structures to exhibit 
nonspecific labelling. These internal negative controls were 
cell nuclei, mitochondria, pigment granules and red blood 
cells. Little attention was paid to accumulations of 
immunogold particles associated either with folds and holes 
in the sections or with contaminating deposits that were 
usually homogenous and of low electron density. Such 
labelling was regarded as spurious.
With regard to the interpretation of the results, it must be 
emphasised that with indirect immunolabelling the gold 
particle may be up to 20 nm away from the labelled antigenic 
epitope. Postembedding immunolabelling only labels 
antigenic epitopes on the surface of a thin tissue section. 
Therefore, the density of immunolabelling depends upon the 
number of epitopes exposed on the surface of the section.
Negative immunogold labelling
In order to ensure that the absence of labelling was due to 
the absence of the antigen and not to failure of the 
immunocytochemical technique, a tissue in which the antigen 
was known to be present was included in the immunorun which 
is refered to as the positive control (Fig 3.4). With most 
of the antigens another positive control was normally present 
within the same tissue section (internal positive control).
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CHAPTER 4 CONVENTIONAL MORPHOLOGICAL STUDIES ON THE 
EXFOLIATIVE IRIS
4.1 The choice of iris for this investigation
This section provides background information for chapters 
4, 5, 6 and 7. Iris tissue was used to provide a) an 
accurate description of conventional morphology in 
exfoliation glaucoma (chapter 4) and b) information on the 
precise distribution of collagens I-V and laminin in the 
normal and exfoliative iris (chapters 5, 6, 7).
The choice of iris for the present investigation was the 
result of preliminary studies and practical limitations in 
the study of other tissues. Extensive review of the 
pertinent literature (see sections 1.2.3, 1.4 & 6.2.3) has 
highlighted the superiority of iris to other affected 
tissues.
Preliminary studies
To evaluate the suitability of exfoliative iris as a tissue 
for immunocytochemical studies and to accustom the author to 
the morphological appearance of exfoliation aggregates in the 
iris, preliminary conventional LM and TEM studies were 
conducted upon a number of peripheral iridectomy specimens 
from Greece. Fifteen iris specimens were randomly selected 
from a group of Greek surgical iridectomies with exfoliation 
syndrome and exfoliation glaucoma. All the 15 specimens 
contained exfoliation material, principally in association 
with iris vessels. On the basis of these preliminary
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observations, it was considered that a fruitful line of 
research could be undertaken by studying exfoliative iris.
In both conventional morphological and immunocytochemical 
studies it was considered necessary to include an appropriate 
number of aged-matched control irides. An important 
distinction however, should be drawn on the control tissue 
employed. In the conventional morphological studies the 
control tissue comprised surgical iridectomies from patients 
with POAG, whereas, in the immunogold studies control tissue 
from enucleated eyes was used (see Appendix I).
4.2 The normal iris
Structure
The iris forms the most anterior portion of the uveal tract. 
Anatomically, it forms a delicate and mobile diaphragm 
between the posterior and anterior chamber. Functionally, it 
corresponds to the aperture in optical systems (Hogan et al 
1971). Amongst the ocular structures, the iris is unique in 
possessing atypical blood vessels, an ability for contractile 
movement and a stroma which is freely permeable to aqueous 
humour via openings (Fuch's crypts) along the anterior 
surface of the iris. The iris can be divided into 3 regions: 
(1) anterior border layer, (2) stroma and sphincter muscle 
and (3) iris pigment epithelium. The gross anatomy of the 
iris is illustrated in Fig 4.1.
The anterior border layer consists of a single layer of 
fibroblasts whose long branching processes interconnect with 
each other and beneath which there are several layers of
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POSTERIOR SURFACE
Fig 4.1: Diagram of iris gross anatomy. The collarette(Co) divides the iris into 
pupillary(P) and ciliary zone(C). The pigmentary ruff is arrowed.
Radial branches of the major arterial circle(M) form minor arterial 
circle(m) from which capillaries radiate to the pupillary margin.
D:dilator muscle; S:sphincter muscle. Radial contraction furrows on 
posterior surface of the iris are arrowheaded.
Fig 4.2: Histological section of the pupillary zone in normal human 
iris. ABL:anterior border layer; Co:collarette; IS:iris stroma; 
S:sphincter muscle; IPE:iris pigment epithelium. LM.
melanocytes. This layer forms the anterior surface of the 
iris and is frequently interrupted with gaps (Fuch's crypts). 
The thickest part of the iris is in the region of the 
collarette which is located about 1.5 mm from the pupillary 
margin (Fig 4.1). The collarette divides the iris into two 
zones: a narrow pupillary zone and a wider ciliary zone, the 
latter is marked by circular contraction furrows. The 
rounded irregular openings (Fuch's crypts) which are located 
on the anterior surface of the iris are continuous with 
spaces in the iris stroma. A pigmentary ruff is present at 
the pupillary edge and is a continuation of the posterior 
iris pigment epithelium (Figs 4.1 & 4.2).
The iris stroma is derived from mesenchyme and consists of 
highly vascularised connective tissue (Fig 4.3). Striated 
collagen fibrils are the major component of the stroma and 
provide mechanical support for this tissue which undergoes 
constant movement. The collagen fibrils have a diameter of 
about 60 nm, a periodicity of 65 nm and are aggregated into 
small and large bundles, which cross at wide angles to form 
spaces of various sizes. The collagen fibrils are more 
abundant in heavier sheaths around blood vessels and nerves. 
The cells most commonly found in the stroma are fibroblasts 
and melanocytes, but clump cells, mast cells, macrophages and 
lymphocytes are also present.
The iris pigment epithelium, is derived from the neural 
ectoderm and is composed of two layers of pigmented cells, 
the anterior and the posterior pigmented epithelia. These 
layers meet at their apices. Cells of the anterior pigmented
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epithelium possess an apical epithelial portion and a basal 
muscular portion (Fig 4.3). They are therefore classified as 
myoepithelial cells. The muscular extensions of the basal 
portion are embedded in a basement membrane and are 
orientated in a radial direction from the iris root towards 
the pupil and collectively form the dilator muscle (Hogan et 
al 1971). The cells of the posterior pigmented epithelium 
are rectangular, varying in shape only in the folds and 
contraction furrows of the posterior surface (Fig 4.1).
Their cytoplasm contains a large number of melanin granules.
A thin basement membrane is found adjacent to the basal cell 
membrane (Fig 4.3).
Blood supply
The iris receives its arterial blood supply from the major 
arterial circle of the iris, which lies in the stroma of the 
ciliary body near the iris root (Fig 4.1). Branches from the 
major circle (arterioles) enter the periphery of the iris 
through its root. These branches occupy the anterior iris 
stroma as they extend towards the collarette. Arterioles 
rapidly diminish in size as they enter the stroma and travel 
in a radial manner toward the pupil eventually forming an 
incomplete minor arterial circle in the region of the iris 
collarette (Fig 4.1). Iris blood vessels are believed to 
have a slight 'corkscrew' shape: this allows them to 
accommodate rapid changes in the radius of the iris during 
dilation and constriction. Iris vessels possess a thick 
collagenous adventitia with the striated collagen fibrils 
arranged in a helical manner around the vessel. Blood 
vessels are surrounded invariably by a basement membrane,
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Fig 4.3: Transmission electron micrograph illustrating the 3 regions of normal human 
iris (ciliary portion). (1) anterior border layer (2) iris stroma (3) iris pigment 
epithelium. The basal muscular portion, (dilator muscle:dm) and the apical 
epithelial portion (ep) of the anterior pigmented epithelium are clearly 
discernable. PPE:posterior pigmented epithelium.
which is up to 3 microns in thickness; muscular tissue is 
sparse and elastic fibres are absent (Ringvold 1970a).
The iris venous drainage follows the route of the arterial 
supply, the larger venules lie in the anterior stroma and the 
smaller ones near the dilator muscle. The collector trunks 
from these venules enter the ciliary body, where the blood 
then drains into the vortex system and the ciliary plexus 
(Hogan et al 1971). There is a close anatomic relationship 
between the iris and the lens which has important functional 
repercussions. The central third of the iris is in loose 
contact with the anterior lens capsule. Only the flow of 
aqueous prevents constant contact and this area of iris-lens 
contact may be more extensive in an eye with a shallow 
chamber and in partial mydriasis. In the exfoliation 
syndrome, adhesions may form between the pigmented epithelium 
and the lens capsule hindering pupillary dilatation.
Terminology
Iris vessels possess a unique architecture which differs from 
systemic vessels. For example differentiation between 
arterioles and venules and pericytes and myocytes is 
difficult due to the prominent vascular coat. In the present 
investigation, as in chapters 5, 6 & 7, no distinction was 
drawn between pericytes and myocytes: they were collectively 
termed supporting, or cohort cells. In the study of the 
exfoliation iris vasculopathy the prevailing term 'vascular 
basement membrane' employed by some authors (Ringvold 1969; 
1970a; 1970b, Ghosh & Speakman 1974) to describe the matrix 
surrounding the endothelial and contractile cells has been 
avoided. The term 'vascular matrix' has been chosen because
113
of the difficulty encountered in applying the conventional 
nomenclature to diseased vessels.
4.3 Introduction: exfoliative iris
Numerous morphological studies have highlighted the extensive 
involvement of iris in the exfoliation syndrome (sections 
1.2.2, 1.4 & 4.1). Most investigators tacitly accept that 
the iris may be one of the sources of exfoliation material 
synthesis (section 1.4). However it remains uncertain which 
precise subcompartment(s) of the iris is responsible for the 
synthesis of exfoliation material. Furthermore, little 
attention has been paid to the morphological sequence by 
which a healthy iris vessel is converted into a non­
functioning 'ghost vessel'. This chapter provides 
information on these topics.
4.4 Results
The clinical significance and the diagnostic value of iris 
biopsy are discussed in chapter 10.
Light microscopic features
The typical LM appearance of a surgical iris specimen is 
shown in Figure 4.4. Artefactual problems encountered in 
many iris specimens included fragmentation of the posterior 
pigmented epithelium (Figs 4.4 to 4.6). This was more common 
in the exfoliation glaucoma specimens. In some cases a 
portion of well preserved pigmented epithelium was enclosed 
in the centre of the specimen. In contrast, the anterior
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Fig 4.4: A typical iridectomy specimen from a patient with exfoliation glaucoma.
Although dilator muscle is present (D), the bulk of the associated posterior 
pigmented epithelium is absent. Exfoliative vessels are distinguished by increased 
density of their perivascular matrix (arrows). Araldite, LM.
Fig 4.5: Higher magnification of Fig 4.4 illustrating three stages of exfoliation
vasculopathy; 1:arteriole with dense perivascular matrix but healthy wall, 
2:dense perivascular matrix associated with degenerate vascular elements, 
3:ghost vessel where vascular elements are absent. ABL:anterior border layer;
D:dilator muscle. Araldite, LM.
Fig 4.6: Exfoliative iris. The increased density of the iris stroma and collapse 
of vessels may be due to preparation. A small portion of the posterior 
pigmented epithelium is preserved (arrow). Araldite, LM.
Fig 4.7: Higher magnification of Fig 4.6. an ‘abnormal deposit’ (arrowhead) in
the upper part of the perivascular matrix was subsequently shown by TEM to 
be exfoliation material. Note ghost vessel (GV), (arrow) with prominent lumen. 
ABL:anterior border layer. Araldite, LM.
Fig 4.8: LR white semi-thin section of POAG control iris tissue has a less compact 
appearance with reduced staining contrast. The large iris vessel (V) is of 
normal appearance and is surrounded by a lightly stained zone. 
ABL:anterior border layer. LM.
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Fig 4.9: LR white section of exfoliative iris specimen in which exfoliation
material is seen as increased staining of the perivascular matrix (arrows). 
S:iris stroma. LM.
Fig 4.10: Control iris tissue which exhibits a vessel suspected of being 
associated with exfoliation material (arrow).
LR white, LM.
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Fig 4.11: Higher magnification of suspected vessel in Fig 4.10, reveals 
a regular circular orientation of the perivascular matrix (vm). 
Absence of exfoliation material was subsequently 
confirmed by TEM. LR white, LM.
border layer, the iris stroma and the anterior pigmented 
epithelium were generally well preserved (Figs 4.5 & 4.7). 
Thus, in this investigation no systematic study could be 
carried out on the morphological changes of the posterior 
pigment epithelium. Since all specimens reported herein were 
taken from the periphery of the iris the sphincter muscle was 
absent.
All 52 surgical specimens contained iris vessels and in some 
specimens there were more than 20 vessels. The iris vessels 
were easy to identify due to their circular perivascular 
collagenous zone (Fig 4.5). In the iris vessels of the POAG 
controls an unstained, or lightly stained, region separated 
the supporting cells from the identifiable fibres of the 
inner collagenous zone (Figs 4.8 & 4.9). In exfoliative iris 
tissue there were ostensibly normal vessels and vessels which 
contained blue fibrillo-granular clumps, 'abnormal deposits' 
(Figs 4.4, 4.5 & 4.7). These 'deposits' were found to lie 
adjacent to the cellular layer of the wall of some iris 
vessels. The frequency and density of these 'deposits' 
varied considerably between specimens and within individual 
specimens. In some cases the whole circumference of the 
blood vessel had been replaced by this fibrillo-granular 
'abnormal material' (Fig 4.5). Approximately one third of 
the iris vessels in the 26 exfoliation glaucoma cases 
were affected. It is noteworthy that it was not possible to 
identify 'abnormal deposits' in the extravascular stroma with 
any degree of confidence.
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Ultrastructural features
The 'abnormal deposits' observed by LM were confirmed by TEM 
to be exfoliation material in every case. In the exfoliation 
glaucoma specimens a few ostensibly normal vessels by LM, 
contained small nodular aggregates of exfoliation material by 
TEM. In 3 POAG specimens the presence of exfoliation 
material was suspected but this was not subsequently 
confirmed by TEM (Figs 4.10 & 4.11). However, in no case 
where the suspicion for the presence of exfoliation material 
was not raised by LM, was exfoliation material detected by 
TEM. Conversely, when the POAG specimens were examined in no 
case was exfoliation material identified.
The typical TEM appearance of an exfoliative iris specimen is 
shown in Figure 4.12. The specific ultrastructural features 
are described in anatomical regions:
Anterior border layer
In both POAG and exfoliative specimens a fine fibrillo- 
granular matrix, different in appearance from exfoliation 
material, was observed between adjacent fibrocytes in the 
anterior border layer. In the diseased tissue exfoliation 
material was not a common occurence, but when present in the 
anterior border layer two types of exfoliation material 
aggregates were noted. The first pattern observed in 3 
cases, comprised loosely arranged exfoliation fibres 
dispersed in the intercellular spaces in the anterior border 
layer of the iris (Fig 4.13). The second pattern noted in 2 
cases, consisted of densely packed exfoliation material, 
clearly separated from the surrounding tissue. In one case a
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Fig 4.12: Exfoliative iris, an arteriole (A) has a small exfoliation material 
aggregate (ex). Venule (V) possesses few supporting cells and 
lamina densa is reduplicated (arrow). Note ghost 
vessel (GV). TEM.
Fig 4.13: Loose exfoliation material (ex) in the anterior border layer of an 
exfoliative iris specimen. Note absence of cell membranes 
(arrowheads) and tertiary lysosome (TL). TEM.
Fig 4.14: Large aggregate of exfoliation material (EX) outwith 
the anterior border layer (ABL). TEM.
nodular aggregate of exfoliation material was present outwith 
the anterior border layer, (Fig 4.14). Exfoliation material 
in the anterior border layer was always associated with 
advanced exfoliation vasculopathy.
Iris stroma
In the iris stroma of the control and exfoliative cases 
collagen fibrils were distributed in a random pattern. Some 
exfoliation material aggregates initially thought to 
represent stromal deposits, were identified as 'ghost 
vessels' when the original contour, remnants of the vascular 
matrix, and fragments of supporting cells were noted within 
these aggregates (see section on iris vessels). Exfoliation 
material in the majority of cases was identified in the iris 
stroma in association with iris vessels.
Iris pigment epithelium
In all control and exfoliative samples a thin basement 
membrane surrounded the muscular processes of the anterior 
myoepithelium. A fibrillo-granular matrix, (basement 
membrane material), often fused with this basement membrane 
and filled the extracellular spaces. In only a few 
exfoliative samples exfoliation material was seen to 
infiltrate this matrix, or the blood vessels close to the 
muscular processes (Fig 4.15).
In a few exfoliation glaucoma cases where the posterior 
pigmented epithelium was well preserved exfoliation material 
aggregates were observed in association with the basement 
membrane of neighbouring pigmented cells (Figs 4.16 to 4.18).
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Fig 4.15: Apical pigmented epithelial portion (AP) and basal myo portion (MP) of anterior 
pigmented epithelium in an exfoliative iris specimen. Reduplication of lamina 
densa (arrow) is present in an iris vessel. An adjacent vessel exhibits a grossly 
thickened basement membrane (bm) in association with a large aggregate of 
exfoliation material (ex). The lumen is obliterated. TEM.
wmm
Fig 4.16: Massive deposition of exfoliation material over basal cell membrane 
of posterior pigmented epithelium. Note cytoplasmic 
rarefaction (R). TEM.
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Fig 4.17: Exfoliation material aggregate (EX) bounded by basement membrane 
in the region of the posterior pigmented epithelium. Note free melinin 
granules (m) and basement membrane bounding 
exfoliation deposits (arrows). TEM.
Fig 4.18: A more homogeneous aggregate of exfoliation material (ex) in the 
region of the posterior pigmented epithelium. Note rarefaction of 
cytoplasm (R) and concomitant compromise of 
cell integrity (arrow). TEM.
Reduplication and disruption of the basement membrane of the 
posterior layer of the pigmented epithelium was sometimes 
noted (Fig 4.15) in these cases. In one case exfoliation 
material aggregates were bounded by 'new' basement membrane 
(Fig 4.17).
Iris vessels
The normal ultrastructure of iris vessels is considered in 
section 4.2 and illustrated in Figs 4.19 & 4.20. The 
vascular endothelium of both control and exfoliative iris 
samples was thicker in some vessels with tall endothelial 
cells protruding into the lumen. These were thought to 
represent arterioles (Fig 4.19). On the other hand, some 
vessels showed a thin endothelium with a higher ratio of wall 
thickness to lumen diameter and fewer supporting cells.
These vessels were considered to be venules (Fig 4.20). In 
some sections zonulae occludentes were prominent (Fig 4.19). 
The perivascular collagenous zone surrounding the vessel wall 
consisted of two layers: an inner layer of fine collagen 
fibrils and an outer layer of thicker fibrils (Fig 4.21).
The most interesting ultrastructural features were observed 
in the iris vessels of exfoliative specimens. All 26 
exfoliative specimens demonstrated vascular involvement but 
this was patchy and diseased tissue often contained 
ostensibly normal vessels. In exfoliative specimens 
arterioles appeared to be affected more frequently and more 
severely than venules, but this was not uniform in all 
specimens.
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Fig 4.19: Normal arteriole with lamina lucida (arrow), lamina densa
(arrowhead) and lamina fibroreticularis (If). Collagen fibrils are 
inserted into the basement membrane. Note zonulae 
occludentes (zo). L:lumen. TEM.
Fig 4.20: Normal venule. The wall thickness ratio to lumen diameter is
considerably greater than that arterioles. Supporting cells arrowheaded. 
CC:perivascular collagenous coat.
TEM.
Exfoliation vasculopathy (Figs 4.21-4.33)
All 26 exfoliation glaucoma specimens demonstrated vascular 
involvement with exfoliation aggregates accumulating around 
and within the vascular wall of iris vessels. Exfoliation 
fibres showed a variable degree of staining: some exfoliation 
fibres displayed a distinct outline and some a more 
indistinct contour. The spectrum of vascular pathology 
observed in these exfoliation glaucoma cases was divided in 
early and advanced vasculopathy on the basis of analysis of 
the specific ultrastructural changes occuring in all cases. 
Early vasculopathy corresponded to exfoliation material 
accumulation, with, or without evidence of degeneration of 
supporting and endothelial cells. Advanced vasculopathy 
corresponded to the presence of non-functioning 'ghost 
vessels'.
In exfoliative specimens a zone of finer collagen fibrils was 
often seen close to the supporting cells (Fig 4.25). It was 
noteworthy that even in advanced exfoliation vasculopathy the 
outer perivascular collagenous zone appeared 'free' from 
exfoliation aggregates (Fig 4.30). In most specimens 
exfoliation aggregates were localised in the space between 
the endothelial lining of vessels and the inner collagenous 
zone (Fig 4.24). Rarely, small aggregates of exfoliation 
material infiltrated the inner collagenous zone.
The thickness of the vascular matrix in exfoliative vessels 
was more diverse than in POAG vessels. It varied from 0.2-
0.5 microns in small capillaries to 6 microns in larger 
vessels depending on the degree of exfoliation vasculopathy
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Fig 4.21: Degenerate supporting cell (SC) associated with band of exfoliation material (ex). 
Vascular matrix between the lamina densa of the endothelial cells 
(single arrow) and the boundary of the perivascular collagenous coat 
(double arrows) is thickened. L:lumen; E:endothelium. C:collagenous coat. TEM.
Fig 4.22: Transmission electron micrograph to demonstrate the close relationship 
between exfoliation material (ex) aggregation and supporting cell (SC) in 
an exfoliative iris vessel. L:lumen.
Fig 4.23: Exfoliative iris vessel (arteriole). Degeneration of endothelial cell (arrow) is 
accompanied by disruption of its basement membrane. The perivascular 
collagenous coat (CC) is free of exfoliation material (ex).
Fig 4.24: Exfoliation material (ex) intermingled with
filaments (arrow), which are more apparent outwith 
an abnormal granular vascular matrix (VM). TEM.
Fig 4.25: Exfoliative iris vessel showing extensive perivascular aggregation of exfoliation 
material (ex) with concomitant thickening of the vascular matrix.
The remainder of the vessel is mormal. Note absence of supporting 
cells and fine collagen fibrils (arrows).L:lumen. TEM.
Fig 4.26: Exfoliation material (ex) aggregation within
granular matrix completely surrounds an arteriole. 
The lumen is completely filled with a white blood 
cell (wbc). Supporting cells are absent. TEM.
Fig 4.27: Higher magnification of the vascular wall in Fig 4.26. Endothelial cell (E) is 
rich in organelles and appears to be normal. Note distinctive 
lamina lucida (arrowhead) and lamina densa (arrows); 
ex:exfoliation material. TEM.
Fig 4.28: Absence of lamina densa (arrows) associated with 
infiltration of exfoliation material (ex) 
surrounding an arteriole. Cell junction:j; 
pinocytotic vesicles-.arrowheads. TEM.
Fig 4.29: Arteriole with grossly thickened vascular matrix (vm) exhibits moderate to 
advanced degeneration of its endothelial lining (rarefication of cytoplasm:R; 
degeneration of organelles:arrows). Lumen is filled by a 
polymorphonuclear leucocyte (PL) and a red blood cell (RBC). TEM.
Fig 4.30: Advanced exfoliation vasculopathy. Exfoliation material (ex) aggregation 
throughout the circumference of the vessel is associated with 
degeneration of supporting cells (SC) and is absent from the 
collagenous zone (CZ). Vascular integrity is maintained. L:lumen. TEM.
■^9 4.31: End stage exfoliation vasculopathy; ghost vessel (GV). 
Vascular matrix has been replaced by 
exfoliation material (ex). Identity of cell within 
lumen unknown. TEM.
Fig 4.32: Degenerate exfoliative vessel (ghost vessel, GV). Exfoliation 
material (ex) is intermingled with remnants of lamina densa 
(single arrow), basement membrane material (double arrow), 
cell debris (arrowheads) and collagen fibrils (cf). TEM.
Fig 4.33: Ghost vessel (GV). Exfoliation material (ex),
intermingled with basement membrane (arrow) has 
replaced endothelial lining. Note degenerate 
endothelial cell (E). TEM.
cells was typically associated with a halo of exfoliation 
material, whilst supporting cells within the same vessel free 
of exfoliation material were relatively healthier. Globules 
of lipid and myeloid bodies were sometimes present within the 
diseased vascular matrix. As a rule advanced degeneration of 
supporting cells was associated with large amounts of 
exfoliation material surrounding most of the circumference of 
the vessel. The more prominent features of cell distress 
were swelling of organelles, rarefaction of cytoplasm and the 
appearance of vacuoles on the luminal side of the affected 
vessels. Despite these changes convincing evidence of 
breakdown of the endothelial barrier (separation of cell 
junctions) was seldom encountered.
Nearly all specimens contained one or more 'ghost vessels'
i.e. vessels with advanced vasculopathy. The entire 
circumference of such ghost vessels contained exfoliation 
material. In only two cases exfoliation material did not 
surround a ghost vessel entirely and where the material was 
absent, a portion of a basement membrane remained. In 
advanced vasculopathy the endothelial lining was severely 
disrupted and discontinuous, with remnants of the lamina 
densa intermingled with cell debris and exfoliation material 
(Figs 4.31-4.33). In these specimens exfoliation material 
aggregation appeared to 'replace' the original outline of the 
vessel. Only in ghost vessels was exfoliation material 
observed inside the lumen of the vessel. Membranous debris 
were often observed within the wall of ghost vessels.
Electron dense granules possibly tertiary lysosomes were also 
seen. In some ghost vessels, several layers of basement
121
membrane material surrounded a portion of the vascular 
circumference. In a more 'advanced stage' no fragments of 
basement membrane, membranous debris, or cellular fragments 
were observed.
It was of interest to note that in the exfoliation glaucoma 
cases exfoliation material aggregates initially thought to 
represent stromal deposits, were subsequently identified as 
'ghost vessels' i.e. end stage exfoliation vasculopathy.
This observation was made when the original contour, remnants 
of the vascular matrix, and fragments of supporting cells 
were noted within these aggregates. Indeed, exfoliation 
material was rarely identified in the iris stroma when it was 
not in association with iris vessels.
4.5 Discussion
Serial sectioning of iris tissue from each of the exfoliation 
glaucoma specimens revealed the presence of exfoliation 
material around some vessels in every case. This supports 
the concept that exfoliation material aggregates, are 
morphologically similar to those seen in other ocular 
tissues and occur in the affected iris vasculature.
Therefore this represent a pathognomonic feature of the 
disorder. The present study is in agreement with Ghosh & 
Speakman (1974) who studied 4 iris specimens with exfoliation 
glaucoma and found some 'abnormal iris vessels' in every 
case. It was of interest to compare the proportion of 
affected vessels in the present study with that recorded by 
Ringvold (1970). In that study which included 12 iris
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specimens from patients with exfoliation syndrome 
approximately 20% of iris vessels showed exfoliation 
material. In the present study with 26 specimens exclusively 
from exfoliation glaucoma patients the rate of involvement of 
the iris vasculature was considerably higher.
The relative paucity of exfoliation material on the anterior 
border layer observed in the present study has been noted 
by Ghosh & Speakman (1974). However, Ringvold (1970) stated 
that he found 'abundant exfoliation material in the area 
measuring 20-30 microns from the iris surface'. Other 
authors, for example Layden & Shaffer (1973), only comment 
that 'exfoliation material was present in the anterior border 
layer'. On the basis of the evidence of the present study it 
is suggested that exfoliation material aggregates are not 
synthesised in that subcompartment and most likely originate 
from the aqueous. This study is therefore in agreement with 
Ghosh & Speakman (1974) who considered that the anterior 
border layer is not a likely source of exfoliation material.
By LM it was difficult to identify isolated aggregates of 
exfoliation material within the iris stroma, but foci of 
exfoliation material were identified with certainty by TEM.
In many cases serial sections showed that these isolated foci 
were continous with the walls of diseased vessels. This is 
in agreement with the elegant LM reconstructions of diseased 
vessels by Shimizu (1985). This author has also found 
that deposits of exfoliation material could frequently be 
traced back to the vascular supporting cells of exfoliative 
vessels.
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From the present investigation no conclusion can be drawn on 
the role of the iris pigmented epithelium in the synthesis of 
exfoliation material in the diseased iris. This is because 
the posterior layer of the pigmented epithelium was severely 
traumatised in many cases. However, the close association 
between exfoliation material aggregates and the basement 
membrane of the posterior layer of the pigmented epithelium 
in the few cases, where the pigmented epithelium was 
preserved, suggests a synthetic role for this anatomic 
structure. Ghosh & Speakman (1974) have found fragmentation, 
redublication and 'shedding' of the basement membrane of the 
posterior layer of the pigmented epithelium in areas where 
there was accumulation of exfoliation material. These 
investigators have interpreted these findings as evidence 
that the pigmented epithelium is a source of exfoliation 
material. In a recent communication Ritch and coworkers 
(1992) on the basis of cell culture studies have suggested 
that posterior pigmented epithelial cells can synthesise 
exfoliation material in vitro. The deposition of exfoliation 
material within the anterior layer of the pigmented 
epithelium was better studied in the material processed for 
immunocytochemistry and is more appropriately discussed in 
in chapter 6.
Significantly, aggregation of exfoliation material was found 
around some, but not all, iris vessels. Ringvold (1969) was 
the first to document the presence of normal iris vessels 
close to vessels with exfoliation aggregates. This study 
therefore confirms previous suggestions (Ghosh & Speakman 
1974, Shimizu 1985) that passive deposition of exfoliation
124
material via the aqueous circulation is not the mechanism for 
the presence of exfoliation material within the iris stroma. 
The present study could not confirm the observation by 
Anastasi and coworkers (1974) that in exfoliative iris, blood 
vessels are very rare. In all specimens there were at least 
4-5 vessels and some specimens exhibited up to 20 iris 
vessels. Similarly, it was not possible to corroborate the 
observation of Ringvold & Davanger (1981) that in some 
diseased vessels there is extreme reduction of the vascular 
lumen due to increased volume of the endothelial cells. This 
may be due to the fact that 2 out of the 3 eyes investigated 
by these authors were examples of painful end stage 
exfoliation glaucoma.
The consistent ultrastructural involvement of the iris 
vasculature in all 26 specimens studied suggests that in the 
iris this anatomical subcompartment is involved in the 
synthesis of exfoliation material. In accordance with 
Shimizu (1985) and Ringvold (1969) it was found in the 
present study that exfoliation material aggregates frequently 
do not surround the entire circumference of diseased vessels. 
The observed pattern of involvement suggests that vascular 
supporting cells and endothelial cells have a role in the 
synthesis of exfoliation material. Thus the present study 
contradicts the view expressed by Sugar and coworkers (1976) 
that in the iris only the pigment epithelium is a likely 
source of exfoliation material.
Vascular supporting cells appear to be the first cells 
involved in the synthesis of exfoliation material since
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changes in these cells were often not accompanied by changes 
in neighbouring endothelial cells. The present study does 
not agree with the general observation made by Shimizu (1985) 
that exfoliation aggregates are 'attached to vessels with 
degenerated walls'. The role of endothelial cells requires 
further elucidation because exfoliation material was rarely 
adherent to the basement membrane of endothelial cells and 
was only convincingly seen attached to endothelial cells in 
advanced vasculopathy.
In agreement with Layden & Shaffer (1973) there was generally 
no evidence of exfoliation material in the lumen of diseased 
vessels. Exfoliation material however, did appeared in the 
lumen of a few ghost vessels exhibiting advanced vasculopathy 
and disorganisation of the vascular wall. One of the most 
interesting observations in this study has been the presence 
of one or more 'ghost vessels' in each of the 26 specimens 
studied. These vessels which presumably indicate advanced 
vasculopathy have rarely been noted in the literature (Ghosh 
& Speakman 1974, Sugar et al 1976). Previous studies have 
often included iris tissue from exfoliation syndrome patients 
(Ringvold 1969; 1970) but even Shimizu (1985) who studied 8 
specimens from patients with exfoliation glaucoma did not 
mention the presence of ghost vessels. It is likely that 
ghost vessels are more common in exfoliation glaucoma than in 
exfoliation syndrome. The functional significance of the 
presence of these ghost vessels has not been dealt with 
before in the literature. It is conceivable that their 
presence could lead to localised hypoxia which subsequently 
leads to new vessel formation. The latter feature has been
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consistently documented in anterior segment fluorescein 
angiographic studies (Brooks et al 1987). It is also 
relevant to note that Ghosh & Speakman (1974) have documented 
marked atrophy of iridic cellular elements in a case with end 
stage exfoliation glaucoma and speculated that these may be 
associated with the obliteration of the lumen of these ghost 
vessels.
The problem of iris vasculopathy has not been properly 
addressed by previous morphological studies. For example, 
Shakib and coworkers (1965) did not find 'changes in the iris 
vasculature'. Spinelli and coworkers (1985) have only stated 
that all their iris specimens showed 'some vessels in 
different stages of pathological alteration'. From the 
present study it is possible to reconstruct the evolution of 
exfoliation vasculopathy. I would like to suggest the 
following morphological sequence. Initially, subtle changes 
develop in the vascular matrix and the supporting cells. 
Subsequently, exfoliation material synthesis by the 
vascular supporting cells is accompanied by more extensive 
accumulation of exfoliation material and attenuation, or 
degeneration of the synthesising cells. Endothelial cells 
begin to degenerate at a later stage. Finally, as an extreme 
manifestation of advanced disease, the iris vessel disappears 
and is replaced by a circular aggregate of exfoliation 
material (formation of a ghost vessel). The latter may 
account for the strong resemblance between stromal deposits 
of exfoliation material and ghost vessels.
The present study is in agreement with previous suggestions
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that the histological manifestation of the disorder in the 
eye may exist in the absence of clinically obvious 
exfoliation material deposition (Prince et al 1987, 
Schlotzer-Screhardt et al 1991a). In those studies however, 
the definition of an exfoliation suspect patient relied upon 
a number of pigmentary signs which arise as a consequence of 
pigment liberation from the posterior layer of the iris.
This suggests that in all these cases the iris was involved 
early in the disease process. The precise timing of 
appearance of exfoliation material in the iris in comparison 
with other ocular, orbital or systemic tissues is as yet 
unknown. It is likely that iris is only one of many tissues 
involved in the synthesis of exfoliation material (Morrison & 
Green 1988). Indeed recent investigations (Streeten et al 
1990, Sugino 1990, Schlotzer-Screhardt et al 1991a) have 
focused on other ocular, orbital and systemic tissues for 
possible sources of exfoliation material.
It is well documented that in exfoliation syndrome it is 
sometimes difficult to establish a definitive diagnosis 
(sections 1.7 & 1.8). As discussed in section 10.2 the 
pathological examination of iris biopsies from open angle 
glaucoma patients can provide a definitive diagnosis. 
Furthermore, it was confirmed in the present study that 
that TEM examination of tissue biopsies can identify 
exfoliation material in cases where it is not detected by 
clinical examination. This suggests that exfoliation 
syndrome may be responsible for a greater proportion of 
glaucomas than previously thought.
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The reliability of the electron microscopic localisation of 
exfoliation material in the iris was convincingly 
demonstrated in this study by finding exfoliation material in 
all 22 specimens with the clinical diagnosis of exfoliation 
glaucoma (chapter 10). Thus, iris biopsies appear more 
reliable with regard to the ultrastructural presence of 
exfoliation material than conjunctival biopsies (see section 
1.2.3). Of course, unlike conjunctival biopsy, iris tissue 
can only be studied in surgical patients.
4•6 Summary
Iris tissue obtained from 26 consecutive patients operated 
upon for exfoliation glaucoma and control iris tissue from 26 
age matched patients with POAG was used to investigate the 
involvement of the iris subcompartments and the vasculopathy 
associated with exfoliation glaucoma. By LM exfoliation 
material was discerned by the increased density of the 
perivascular matrix of affected vessels. By TEM exfoliation 
vasculopathy was divided into early and advanced. Early 
vasculopathy was associated with focal accumulation of 
exfoliation material with or without degeneration of 
intrinsic vascular cells. Degeneration of vascular 
supporting cells was sometimes accompanied by preservation of 
endothelial cells. In advanced exfoliation vasculopathy 
exfoliation material occupied an acellular vascular wall 
(ghost vessel). It is suggested that in iris vessels the 
synthesis of exfoliation material can be attributed primarily 
to the supporting cells.
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CHAPTER 5 IMMUNOGOLD ULTRASTRUCTURAL LOCALISATION OF
COLLAGENS IN THE NORMAL AND EXFOLIATIVE IRIS
5.1 Preface
This chapter deals with the distribution of collagens in the 
normal and exfoliative iris. An ambiguity was observed in 
the distribution of collagen type I in exfoliation material. 
To solve this problem a supplementary study was carried out 
on exfoliative trabecular meshwork and for convenience the 
results are included in this chapter (section 5.2.4).
5.1.1 Introduction: collagens in the normal iris
The eye is composed of highly specialised tissues possessing 
distinct collagenous structures that exhibit a great degree 
of biological diversity. Amongst the ocular structures, the 
iris is unique in possessing a barrier-free stroma, atypical 
blood vessels and an ability for contractile movement. 
Collagens are the major constituents of the extracellular 
matrix (ECM) and thus provide biomechanical support for this 
tissue, which undergoes constant movement. In addition, the 
ECM of the iris influences the exchange of macromolecules 
between the plasma of the iris vessels and the aqueous humour 
which bathes the anterior segment structures. This constant 
exchange is primarily dependent upon the presence and complex 
interaction of the ECM components present in the iris 
vascular basement membranes (vascular matrices). This is 
suggested by immunocytochemical studies in other tissues of 
both man and animals (Abrahamson 1986, Grant & Leblond 1988,
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Morrison et al 1989, Das et al 1990b), which indicate that 
the fluid movement is dependent on the barrier and 
hydrophilic properties of laminin, heparan sulphate 
proteoglycan and the intrinsic basement membrane collagens.
To my knowledge, the precise distribution of the various 
collagen types has not been documented previously in either 
human or animal iris tissue. It is important to document the 
presence and distribution of the iris collagens in order to 
study potential collagen alterations in the exfoliation 
syndrome and other disorders. The fine structural 
localisation of collagen types I-V was investigated in the 
normal human aged iris.
5.1.2 Results
All 6 iris specimens studied (cases 1-6 in Appendix I) were 
ostensibly normal on LM examination of toluidine blue stained 
LR white semithin sections. An intense specific signal for 
collagen types I, III and IV was demonstrated in the aged 
human iris of all cases. Collagen types II and V did not 
demonstrate a signal fulfilling the criteria for positive 
localisation as described in section 3.3.6 and were therefore 
considered to be negative.
Collagen type I
Collagen type I was present in the vascular matrices of iris 
vessels (Figs 5.1, 5.2 & 5.3), the iris pigment epithelium, 
and within striated collagen fibrils of the iris stroma (Fig 
5.4). Labelling intensity increased proportionally with the
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rFigure 5.1: Distribution of collagen type I in the wall of an iris vessel. Intense 
labelling is observed in wall’s vascular matrix (vm),which has a 
distinct fibrillar nature. Arrowheaded gold particles are considered 
non-specific. L:lumen; Eiendothelium; sc:supporting cells; N:nucleus.
Figure 5.2: Collagen type I in an iris vessel and surrounding collagenous
zone(cz). The fibrillar vascular matrix(vm) and striated collagen 
fibrils(cf) of the collagenous zone exhibit strong labelling. 
L:lumen E:endothelium; sc:supporting cells.
Figure 5.3: Collagen type I labelling over the fibrillar
vascular matrix(vm) of a supporting cell(sc) and 
collagen fibrils(cf). Note absence of labelling 
over nucleus(N) and cytoplasm(c).
Figure 5.4: Collagen type I is present within the core of 
striated collagen fibrils(cf) in the iris stroma.
WMBSmw
Figure 5.5: Example of tissue preservation obtained with 
LR white resin embedding. Ultrathin section of 
the iris pigment epithelium(IPE) shows cytoplasmic 
rarefaction(arrows).
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Figure 5.6: Type I collagen in the posterior pigmented 
epithelium(PPE). Immunogold labelling of the 
basement membrane follows the posterior infoldings 
(arrows).
Figure 5.7: Type III collagen in the iris stroma is restricted 
to striated collagen fibrils(cf). Peripheral 
labelling is apparent in transverse sections of 
fibrils. TEM.
Figure 5.8: Higher magnification of type III labelling in 
striated collagen fibrils of the iris stroma.
size of the vessel, i.e. larger vessels exhibited more 
intense immunolabelling. Collagen type I was present within 
the basement membrane of the myoepithelial cells (dilator 
muscle) and the basement membrane of the posterior pigmented 
epithelium (Figs 5.5 & 5.6).
Collagen type III
In the case of collagen type III, immunolabelling was absent 
from epithelial, or vascular basement membrane in the iris. 
Intense labelling however, was noted on the striated collagen 
fibrils comprising the circular collagenous zone and present 
throughout the iris stroma (Figs 5.7 & 5.8). An interesting, 
but not uniform, finding was the more intense immunogold 
labelling present on large collagen fibrils.
Collagen type IV
Collagen type IV was strongly positive for all iridic 
basement membranes (Fig 5.9). The most intense signal was 
observed on the lamina densa and lamina fibroreticularis of 
the iris vessels (Fig 5.9). The lamina lucida appeared not 
to contain collagen type IV. It is of interest to note that 
labelling within the basement membrane (vascular matrix) of 
the iris vessels did not depend on the size of the vessel, 
but labelling intensity appeared to increase with increasing 
endothelial cell thickness. Positive immunolabelling was 
also observed in the loose ECM (basement membrane material) 
forming a supporting sheath around the processes of the 
myoepithelial cells and the basement membrane of the 
posterior pigmented epithelium.
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Figure 5.9: Type IV collagen distribution in an iris vessel.
Labelling intensity between endothelium(E) and the 
first layer of supporting cells(sc) is more 
intense than that of subsequent layers. Lilumen.
Figure 5.10: Collagen type II in an iris vessel. Labelling is 
sparse and non-specific. L:lumen.
Figure 5.11: Absence of collagen type V in an iris capillary. Although some 
labelling is present in the vascular matrix and striated collagen 
fibrils it is also present over the red blood cell anti was 
therefore regarded as non-specific.
5.1.3 Discussion
To my knowledge, there have been no immunohistochemical 
reports published on the presence, or distribution of 
collagen types in the human or animal iris, at either the 
EM, or the LM level. In all cases the iris stroma and the 
pigment epithelium was normal and qualitatively there was no 
apparent age-related change. The results of the present 
study have indicated that type I is the most prevalent 
collagen in iris tissue. This is in agreement with 
biochemical reports (Bailey 1987) and immunocytochemical 
studies (Das et al 1990a, Marshall et al 1991a) in other 
ocular tissues. A similar distribution for collagen type I 
has been reported in other body tissues (Burgeson 1988, 
Fleischmajer et al 1990).
However, type I collagen, an interstitial collagen, has not 
been shown previously to be present in the vascular matrix of 
ocular blood vessels. Therefore, the identification of type 
I collagen at this site was unexpected. Nevertheless, two 
recent immunogold studies on human retinal vessels revealed 
the presence of type I in the outer basement membrane of 
retinal arterioles (Das et al 1990) and in the whole extent 
of the retinal vascular basement membrane (Marshall et al 
1990a). When the basement membrane of the iris vessels was 
examined carefully at high magnification, it became evident 
that the immunogold delineated fine strands within the lamina 
densa and the signal was stronger in the lamina densa of 
supporting cells. The fact that small vessels in the iris 
exhibited weaker signal may have been due to the smaller
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concentration of accompanying supporting cells (pericytes and 
myocytes). Das et al (1990a) could not demonstrate type I 
collagen in retinal capillaries, but this may have been due 
to autolysis and diminished antigenicity as their work was 
performed on autopsy material.
The basement membrane material around the myoepithelial cells 
in the iris showed immunolabelling, which suggests that these 
contractile cells synthesise type I collagen. The basement 
membrane of the posterior pigmented epithelium of the aged 
iris also exhibited immunogold labelling within the basal 
infoldings of the posterior pigmented epithelial cells. This 
also implies a synthetic capability of this monolayer. In 
the iris stroma, the signal intensity for type I collagen did 
not increase with the diameter of the collagen fibrils, which 
is in contrast to the results obtained with type III 
collagen. This would indicate that in the iris an increase 
in fibril diameter is due to the deposition of type III 
rather than type I collagen.
Collagen type II was not detected in the iris and the 
controls (cornea, vitreous and trabeculum) with the technique 
employed in this study. To date collagen type II has not 
been demonstrated in any of the ocular tissues studied by the 
immunogold technique (LR white plastic embedding technique, 
or cryoultramicrotomy), (reviewed by Marshall 1991). Thus it 
was not possible to confirm biochemical findings in the 
vitreous concerning type II collagen (Bailey 1987). This 
might be explained in terms of antigenic sensitivity of type 
II collagen to fixation. The question whether type II
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collagen is present in the iris must therefore remain open.
Collagen type III was localised within the striated collagen 
fibrils throughout the iris, but was lacking from the 
basement membranes of the cellular constituents (supporting 
cells). It is likely that type III collagen co-exists with 
type I (Keene et al 1987). This would be in agreement with 
previous evidence that uniform banded collagen fibres often 
contain more than one collagen type. (Kuhn 1987, Birk et al 
1988, Burgeson 1988, Linsenmayer et al 1990). Considerable 
effort is currently being directed towards the elucidation of 
the role of the different fibrous collagens in the process of 
fibrillogenesis (Birk et al 1990, Fleischmajer et al 1990, 
Linsenmayer et al 1990). It is suggested that the particular 
codistribution of specific collagens within a 'heterotypic' 
collagen fibril determines the biomechanical properties of 
the ensuing tissue matrix.
The main difference in distribution between type I and type 
III in the aged iris was the absence of type III collagen 
from the iridic basement membranes. It is of interest to 
note that two immunogold studies employing LR white embedding 
have localised type I collagen in the basement membrane of 
normal and hyalinised retinal vessels (Das et al 1990a, 
Marshall et al 1990a). This implies a certain degree of 
biological diversity in the ECM composition of ocular 
vascular basement membranes.
Although the function of type III collagen is as yet ill 
defined, it has been suggested that it may increase the
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plasticity of tissues; whenever the collagen ratio shifts in 
favour of type III, the tissue becomes more pliable (Lindberg 
& Pinnell 1982, Birk et al 1986, Bailey 1987, Deluca et al 
1990, Fleischmajer et al 1990). It is possible that the 
proportion of type III collagen changes throughout life as 
maturation of the collagen ensues and this change may occur 
more rapidly, or markedly in ageing and disease. There are 
many ocular disorders in which a specific defect of collagen 
metabolism is either known or suspected. These include the 
Ehlers-Danlos syndrome, keratoconus, osteogenesis imperfecta, 
Marfan's syndrome and pseudoxanthoma elasticum (reviewed by 
Lindberg & Pinnell 1982). Abnormal regulation of type- 
specific collagen has been indicated with biochemical studies 
in patients with osteogenesis imperfecta and Marfan's 
syndrome; type III collagen was found to be increased 
relative to type I collagen (Lindberg & Pinnell 1982).
Collagen type IV has been identified in a series of basement 
membranes of various animal tissues (Laurie et al 1982, 
Kennedy et al 1986, Abrahamson 1986, Grant & Leblond 1988, 
Charonis & Tsilibary 1990) and has been shown to be a major 
component in the basement membrane of retinal vessels in cats 
(Essner & Lin 1988) and human aged retinal vessels (Marshall 
et al 1990a, Das et al 1990a). In this study, an intense 
signal was obtained in the lamina densa of the iris vessels. 
Labelling was also observed in the loose non-fibrous matrix 
around the myoepithelium and the basement membrane of the 
posterior pigmented epithelium. As expected, type IV was 
absent from the stroma of the iris. There was increased 
labelling in association with the perinuclear zone of the
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endothelial cells. This indicates that type IV, like other 
ECM components present in basement membranes, may be secreted 
by endothelial cells (Mecham 1986, Glaser 1988).
The absence of type V collagen from the iris could not be 
definitively established because a low intensity label was 
observed on striated fibrils. It was thought unlikely that 
the epitopes of this fibrous collagen were not available 
since in postembedding immunolabelling the fibrils are opened 
by ultrathin sectioning, thereby potentially exposing the 
type V collagen epitopes. Moreover, a positive signal was 
obtained in the corneal controls. It would therefore appear 
that type V collagen does not play a significant role in the 
normal aged human iris.
A high content of type V collagen within a collagen fibril 
has been reported to result in a fibril of small diameter 
(Linsenmayer et al 1990) . This explains the presence of type 
V collagen in the corneal controls. Corneal transparency 
requires that the collagen fibrils within the corneal stroma 
are thin and of uniform diameter. Nevertheless, future 
technical refinements are required to produce a definitive 
answer to the question of presence or absence of this fibrous 
collagen in the iris.
5.1.4 Summary
Immunogold labelling has been applied at the fine structural 
level for the identification and precise distribution of 
collagen types I, II, III, IV, and V in the normal human aged
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iris. Tissue was obtained from 6 surgically enucleated 
globes. LR white plastic embedding was employed. Collagen 
types II and V were not identified. Types I and III collagen 
were localized to the striated collagen fibrils of the iris 
stroma. Collagen types I and IV were present in all iridic 
basement membranes.
5.2 Collagen types I-V in the exfoliative iris
5.2.1 Introduction
Current knowledge concerning the distribution and role of 
collagens in the exfoliation syndrome is limited. Initially, 
exfoliation material was considered to be similar to collagen 
(Ringvold 1970a; 1970b), but histochemical (Dvorak-Theobald 
1954, Arnesen et al 1963, Bertelsen & Ehlers 1969), 
immunohistochemical (Harnisch et al 1981) and biochemical 
(Ringvold 1973b) studies have indicated that collagens 
contribute little to the composition of exfoliation material. 
However, Harnisch and coworkers (1981) have suggested that 
type IV collagen may be an integral component of the 
exfoliation material. Besides, preliminary biochemical, or 
immunohistochemical data on the collagen profile of tissues 
has often conflicted with subsequent electron microscopic 
immunocytochemical data. This conflict was best illustrated 
in the attempts to document the distribution of collagen 
types I-IV in the animal and human cornea. For example 
collagen type I has been reported as both present in (Ben-Zvi 
et al 1986) and absent from (Bailey 1987), Bowman's layer of 
the human cornea. In addition, biochemical analysis yields
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little information as to the precise localization of 
collagens. As far as I am aware, no other 
immunohistochemical (LM), or immunocytochemical (EM) study 
has been performed on the presence and precise distribution 
of the various collagen types in exfoliative tissues. It was 
thus decided to apply the immunogold technique to elucidate 
the fine structural distribution of five collagen types (I-V) 
in the exfoliative iris. When specific and unexpected 
features of interest in the pattern of immunolabelling of 
types I and IV collagen in exfoliative iris vessels were 
found, these were further investigated (chapter 7). 
Furthermore, in the course of this study it became evident 
that in order to provide a definitive answer as to the 
presence of type I collagen in the exfoliation material it 
was deemed necessary to also study exfoliative meshwork (see 
section 5.2.4). The results of the latter investigation are 
reported in the second part of this section.
5.2.2 Results
Material for this study was provided from 2 patients with 
exfoliation syndrome and cataract and 4 patients with 
exfoliation glaucoma. In all 6 patients the diagnosis was 
confirmed by clinical examination. The exfoliative 
iridectomy specimens used in this study exhibited exfoliation 
material on LM examination of toluidine blue stained LR white 
semithin sections. These findings were confirmed by TEM 
assessment of ultrathin LR white embedded tissue sections.
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Type I collagen
Type I collagen was identified in the vascular matrix of 
exfoliative vessels. Immunolabelling was detected within 
the thickened vascular matrix, whether or not the vessel 
contained clumps of exfoliation material (Fig 5.12).
Labelling for type I was associated with the exfoliation 
material present within the thickened vascular matrix. 
Immunogold particles were also present in exfoliation 
deposits in the iris stroma but the labelling density there 
was significantly lower (Fig 5.13). Sparse labelling was 
observed in ghost vessels where exfoliation material had 
replaced the normal vascular wall and in exfoliation deposits 
in the anterior border layer. It was not possible to draw 
definitive conclusions as to the presence or absence of type 
I in the exfoliation material in the iris because of the 
affinity of the label for the underlying collagenous matrix.
Type II collagen
Type II collagen was not detected in the exfoliation material 
present within the exfoliative iris. A weak immunolabelling 
for type II observed in all regions of the exfoliative iris 
was considered non-specific (for specificity criteria see 
section 3.3.6). As in the studies of the normal iris, no 
labelling was demonstrated on the corneal controls.
Type III collagen
Collagen type III localised, almost exclusively, to striated 
collagen fibrils in the iris stroma. Exfoliation deposits 
within the iris stroma were labelled with collagen type III 
antibodies. However, the labelling pattern indicated that
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Figure 5.12: Collagen type I in exfoliative iris vessel, o 
Immunolabelling is largely restricted to the 
vascular matrix(vm) which is infiltrated with 
exfoliation material(ex). L:lumen.
Figure 5.13: Collagen type I in exfoliation material within iris
stroma. Immunogold particles are largely localised 
to ‘fibres’.
type III was not a component of exfoliative fibres, because 
immunogold particles were mainly associated with the 
interfibrillar matrix of both exfoliation material and normal 
collagen. Significantly, collagen type III labelling was 
absent from exfoliation aggregates present within the 
vascular matrix and the anterior border layer (Fig 5.14).
Type IV collagen
Collagen type IV was detected in the exfoliative specimens 
exclusively in association with the vascular matrix. The 
distribution of type IV collagen in the vascular matrix of 
healthy iris vessels of exfoliative iris specimens without 
evidence of exfoliation material was similar to that observed 
in the control normal iris vessels. Labelling for type IV 
collagen in the diseased iris vessels exhibiting exfoliation 
material deposits was diverse. Collagen type IV was found in 
abundance in the thickened multilayered vascular matrix of 
those exfoliative vessels, which were infiltrated by 
exfoliation material. In contrast, the density of labelling 
was considerably reduced in thin degenerate vascular 
matrices (see chapter 7). The majority of immunogold 
particles were not located on the coarser individual 
exfoliative fibres, but on the finer filamentous material of 
the vascular matrix. Immunolabelling for type IV collagen 
was not detected in exfoliation material deposits outside the 
vascular matrix: in the iris stroma and in exfoliation 
material aggregates in the anterior border layer (Fig 5.15).
141
'M
’ / J t
n.
4» *
*' 'C:1*pm
• / "  > 1 -<*r +
Figure 5.14: Absence of collagen type III from a loose aggregate 
of exfoliation fibres(ex) in the anterior border 
layer (ABL)of the exfoliative iris. f:fibrocyte.
y r
\
f
o'lk
Figure 5.15: Type IV collagen is absent from an exfoliation 
material(ex) vegetation projecting from the 
anterior border layer to the anterior chamber(AC).
5.2.3 Discussion
It should be noted that the morphological appearance of 
exfoliation aggregates in LR white sections differs somewhat 
from that of the conventionally fixed and processed iris 
tissue; firstly, because of different fixation (see section 
3.3.5) and more importantly because this method leads to 
retention of larger amounts of ECM (Marshall et al 1990b; 
1991c; 1992a). This is due to the hydrophilic nature of this 
resin. This feature is advantageous in the study of the 
interfibrillar matrix of the exfoliation material. Still, 
the qualitative ultrastructural features observed in this 
study were comparable to those reported in the conventional 
morphological studies of chapter 4.
In this investigation it was not possible to detect collagen 
types II, III and V in exfoliation material aggregates in the 
iris. With regard to type II collagen this negative finding 
is in agreement with the only immunohistochemical study 
conducted on collagens in the exfoliation syndrome (Harnisch 
et al 1981). This study reported the absence of collagen 
types I and II from the exfoliation material. However, this 
study employed the LM immunoperoxidase technique, which is 
limited in resolution and specificity due to the diffusion of 
the stain (see chapter 3). The absence of type III collagen 
from exfoliation material was as expected. The potential 
effects of exfoliation material synthesis and deposition on 
the normal synthetic functions of the native cells are 
discussed in chapters 6 and 7.
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Collagen types V was absent throughout the exfoliative iris. 
Collagen type V is known, from animal studies, to occur in 
association with basement membranes (Mayne & Burgeson 1987) 
and, separately, in fibrous stroma such as cornea (Marshall 
et al 1991b). As in the normal aged iris, it is most likely 
that this collagen is absent from the stroma of the
exfoliative iris. Experiments in the chick cornea, at low
temperature employing double immunogold labelling, have 
indicated that collagen type V co-assembles in the same 
collagen fibril with type I collagen in order to control the
diameter of the fibril (Linsenmayer et al 1990). This
controlling infuence however, may not be required in the
iris. The detection of collagen type V may also be
facilitated by the use of cryoultramicrotomy (Marshall et al 
1991b? 1991c), which was not employed in this study. 
Therefore, a possibility exists that a small amount of this 
collagen may be present in the exfoliative iris.
Collagen type IV was not found to be an integral component of
exfoliation material. This conclusion was reached on the 
absence of labelling in exfoliation aggregates outside the 
iris vascular matrix. The subject of the quantitative 
alterations of collagen type IV in the exfoliative vascular 
matrix will be dealt with in a separate investigation 
(chapter 7). The present study has indicated that the 
biosynthesis of the exfoliation material is associated with 
alterations of intrinsic vascular matrix components, such as 
collagen type IV. This lends weight to the hypothesis 
advanced by some investigators (Ringvold 1969; 1988, Eagle et 
al 1979, Sugar 1984, Seland 1985, Streeten et al 1986,
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Yannoff & Fine 1989) that local basement membrane-producing 
cells, are involved in the synthesis of exfoliation material.
The significance of the positive identification of type I 
collagen in exfoliation material aggregates was uncertain.
It was impossible to decide with conviction whether or not 
this collagen comprises a true component of exfoliation 
material, or simply results from labelling of collagen of the 
indigenous iris tissue. As type I collagen was found to be 
the main collagen of the normal iris vascular matrix and 
stroma (section 5.1.2), the label between exfoliative fibrils 
could easily be attributed to a residue of intrinsic basement 
membrane, or stromal collagen. Alternatively, exfoliation 
material may have entrapped collagen type I within its 
structural framework. To address the contribution of type I 
collagen to the formation of exfoliation material, it was 
considered appropriate to study the ocular tissue spaces from 
which intrinsic collagens are absent.
5.2.4 Further studies. Collagen type I in the exfoliative 
meshwork
Introduction
Having established the fine structural localisation of 
collagens types II-V in the exfoliative material by studying 
exfoliative iris the question as to the role of type I 
collagen remained unresolved. Ocular tissue spaces where 
intrinsic collagens are absent can be found in the aged 
outflow system (Marshall et al 1991c). Exfoliative 
trabecular tissue from patients with exfoliation glaucoma
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undergoing filtration surgery have been collected, fixed 
suitably and processed routinely by the author (see section 
3.3.3). It was decided to study further the distribution of 
collagen type I in the exfoliation material employing 
exfoliative meshwork.
Results
Most exfoliative specimens exhibited a significant degree of 
surgical trauma. The ultrastructural distortion prevented 
investigation of morphologically distinct zones. One out of 
8 specimens exhibited considerable surgical trauma and was 
not considered appropriate for detailed study. In 5 out of 7 
specimens exfoliation material deposition was noted in the 
inter-trabecular spaces (3 cases), within the cribriform 
layer (1 case) and in both (1 case). Exfoliation material 
was not found in 2 specimens. In the intertrabecular spaces 
exfoliation material was arranged in the form of isolated 
deposits often intermingled with pigment. The endothelial 
cell covering of the trabecular beams was sometimes 
disorganised and not infrequently endothelial cells contained 
pigment granules. Exfoliation material within the cribriform 
layer had a much more confluent appearance: masses of 
randomly distributed exfoliation fibres were located 
underneath the endothelial lining of Sclemm's canal. Pigment 
granules were not present there.
Collagen type I
Collagen type I was absent from exfoliation material deposiits 
within the cribriform layer (Fig 5.16) and lying in the 
intertrabecular spaces (Fig 5.17). Weak immunolabelling wras
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Figure 5.16: Collagen type I in the exfoliative outflow system.
Exfoliation material(ex) in the cribriform layer 
is devoid of gold labelling. SC: Schlemm’s canal.
Figure 5.17: Collagen type I in the exfoliative trabecular meshwork. Labelling is 
present over the collagenous core(cc) of the trabecular beam(TB), 
but is absent from exfoliation material(ex) in the intertrabecular 
space. The endothelial cover of the trabecular beam is missing(arrow).
noted in one case where a clump of exfoliation material was 
attached to a trabecular beam denuded of endothelial cover. 
Sparse labelling was present in exfoliation material lying 
underneath the endothelial lining of Sclemm's canal in two 
specimens. The label however, was not located specifically 
on the exfoliative fibres but was randomly distributed and 
was thought to be associated with striated collagen fibrils. 
Collagen type I was convincingly demonstrated in the 
collagenous core of the trabecular beams (Fig 5.17). More 
specifically, the immunogold particles were restricted to 
collagen fibrils comprising the collagenous cores. Labelling 
of moderate intensity was also observed in the periphery of 
the trabecular beams. Collagen type I was present in the 
iris controls; the distribution of collagen type I there was 
identical to that described in section 5.1.2.
Discussion
Collagen type I was shown not to be an intrinsic constituent 
of the exfoliation material in the outflow system. By 
contrast, exfoliation aggregates observed within basement 
membranes and other iris tissue subcompartments label with 
antibodies against collagen type I. The question arises 
whether this phenomenon is due to the presence of collagen 
type I within the exfoliation compound, or is simply due to 
the presence of intrinsic collagen intermingled with 
collagen. The lack of immunolabelling for type I collagen 
from exfoliation deposits located in the empty spaces between 
trabecular beams provides evidence that the latter hypothesis 
is correct. The combined results of the present study and 
section 5.2.2 suggest that exfoliation syndrome may affect
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the biosynthesis of collagen type I, but that this collagen 
is not an integral component of exfoliation material.
The qualitative distribution of collagen type I in the 
exfoliative meshwork was similar to that reported by Marshall 
et al (1991c) in the normal meshwork. No attempt in was made 
in the present study to analyse quantitative changes specific 
to the exfoliation outflow system for collagen type I. This 
because the normal aged outflow system does not provide 
suitable control data for the exfoliation glaucoma cases.
Only the outflow system of primary open angle glaucoma 
patients can provide suitable control data for exfoliation 
glaucoma.
5.2.5 Summary
The immunogold technique combined with LR white embedding was 
employed for the study of the fine structural distribution of 
types I-V collagen in exfoliative iris tissue. Collagen 
types II, III and V were not identified as constituents of 
the exfoliation material in any region of the iris. Type I 
collagen was present within the exfoliation material 
aggregates in the vascular matrix (basement membrane) of 
exfoliative vessels and in stromal deposits. Subsequent 
studies on exfoliative meshwork confirmed that collagen type 
I is not an intrinsic constituent of the exfoliation 
material. Collagen type IV was present in the interfibrillar 
matrix of exfoliation material in the vascular matrix of 
exfoliative vessels, but was absent from stromal deposits of 
exfoliation material.
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CHAPTER 6 IMMUNOGOLD ULTRASTRUCTURAL LOCALISATION OF 
LAMININ IN NORMAL AND EXFOLIATIVE IRIS
6.1 Laminin in the normal iris
6.1.1 Introduction
Little is known about the fine structural distribution and 
the functional role of laminin in the normal human ocular 
tissues (see section 2.5). To date, there have been three 
published studies on the subject (Das et al 1990a, Marshall 
et al 1990b? 1991a). The electron microscopic (EM) 
localisation of this macromolecule in the various ophthalmic 
tissues is important for understanding their normal function, 
as well as their alteration in disease (Morrison et al 1989, 
Das et al 1990a, Marshall 1991).
Laminin has not been previously studied in the normal iris. 
The investigation of the fine structural distribution of 
laminin in the normal aged iris serves two purposes. To 
evaluate the effect of the exfoliation syndrome on normal 
tissues it is necessary to know the normal distribution of 
laminin. Added to this, as iris is commonly involved in many 
ophthalmic and systemic disorders, this study would provide 
baseline information for future investigations.
6.1.2 Results
Seven normal iris specimens were studied (cases 6-12 in 
Appendix I). For details of the source of material uskd for
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this study see section 3.3.3? the techniques applied and the 
control tissues are described in section 3.3.4.
Laminin was specifically localized to the basement membranes 
(vascular matrices) within the walls of blood vessels and to 
the extracellular matrix (ECM) in the dilator muscle region. 
No difference in the qualitative pattern of laminin 
distribution was noted between specimens. A summary of the 
positive immunogold localisation of laminin and the iris 
collagens (chapter 5) is shown diagrammatically in Fig 6.1. 
The specific features were as follows:
Vasculature
The label was most intense on the lamina densa of the 
vascular matrix surrounding the supporting cells of the 
larger iris vessels (Figs 6.2 & 6.3). Labelling for laminin 
was prominent in large and medium sized vessels (Fig 6.3), 
and greatly reduced, or absent in small vessels. When 
present in small vessels the label was more intense over the 
vascular matrix of the outer side of supporting cells. Of 
the 7 cases studied the highest intensity of labelling around 
small vessels was observed in the youngest individual (52 
years old). In this particular specimen laminin was 
demonstrated throughout the whole of the iris vasculature.
In contrast, laminin was markedly reduced in iris vessels 
from the oldest patient (81 years old).
Iris pigment epithelium
Laminin was localised to the ECM (basement membrane material) 
in which the basal muscular portion of the anterior iris
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Figure 6.1: Summary diagram of positive localisation of 
laminin and collagens types I, III and IV in the 
normal aged iris. PE:pigmented epithelium.
Figure 6.2: Labelling for laminin in the vascular matrix (vm) of the normal aged iris 
Immunogold particles are confined to the vascular matrix of 
supporting cells (SC). Labelling is absent from the basement 
membrane (bm)of the endothelium (E). L:lumen.
Figure 6.3: Laminin distribution in a large iris vessel. Labelling is most intense 
over the vascular matrix (vm) surrounding supporting cells (SC) 
and reduced the endothelial basement membrane (bm).
L:lumen; E:endothelium.
Figure 6.4: Laminin in anterior pigmented epithelium of the iris (APE). Gold 
particles are localised to clumps of filamentous electron dense 
basement membrane material (bm). Note basal myo process of 
anterior pigmented epithelium (M).
Figure 6.5: Laminin labelling of the electron dense core of the
basement membrane (bm) surrounding macular portion 
(M) of anterior pigmented epithelium (APE).
Figure 6.6: Intense labelling for laminin over bundles of
parallel filaments adjacent to fibrocyte process 
(f). D:dilator muscle region.
pigmented epithelium was embedded, (Figs 6.4 & 6.5). 
Immunolabelling was mainly concentrated on dense bands of 
filaments within an amorphous granular substance filling the 
intercellular spaces of the muscular portion of the anterior 
pigmented epithelium. Labelling intensity increased in 
proportion to the quantity and density of the filamentous 
bands and was largely restricted to these electron dense 
areas in all of the normal iris specimens studied. Laminin 
was also demonstrated on the basement membrane of the 
anterior iris pigmented epithelium. The thin basement 
membrane of the posterior pigmented epithelium of the iris 
exhibited weak, but specific labelling. Intense labelling 
was noted in association with iris fibrocytes which form the 
boundary between the dilator muscle region and the iris 
stroma. Labelling was concentrated over filamentous bodies 
adjacent to these fibrocytes (Fig 6.6).
Stroma and anterior border laver
Gold particles were absent from the iris stroma and 
associated cells (fibrocytes, melanocytes, and mast cells). 
However, a discrete localized signal was present on small 
clusters of filaments associated with fibrocytes of the 
anterior border layer. Such labelling was generally absent 
from the outermost layer of fibrocytes.
6.1.3 Discussion
The biological functions of laminin have been reviewed in 
section 2.5. The following brief description serves as a 
basis for this discussion. Laminin is a large multidomain
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glycoprotein which together with collagen type IV and heparan 
sulphate proteoglycan comprises most of the protein found in 
basement membranes (Timpl et al 1979, Abrahamson 1986, Martin 
& Timpl 1987, Charonis & Tsilibary 1990). Basement membranes 
are specialized sheets of extracellular matrix directly 
involved in a number of important biological processes 
(Vracko 1974, Timpl & Dziadek 1986, Martin & Timpl 1987). It 
is thought that individual components within basement 
membranes are responsible for particular functions.
It was of interest to note the distribution of laminin in the 
aged normal iris vasculature. Labelling for laminin was 
restricted principally to the ECM enclosing the supporting 
cells within the walls of the larger iris vessels. A similar 
pattern was also observed in smaller vessels where labelling 
was observed around supporting cells, but not over the lamina 
densa of the vascular endothelium. Essner & Lin (1988) also 
noted stronger labelling for laminin around the pericytes 
of cat retinal vessels. This pattern of laminin distribution 
may indicate that within the iris vasculature the synthesis 
of laminin is a responsibility of the supporting cells 
(myocytes and pericytes) rather than the endothelial cells. 
This conclusion is based on the general assumption that cells 
attached to basement membranes secrete most, if not all, of 
the ECM components present within that basement membrane 
(Ruggeri & Motta 1984, Martin & Timpl 1987, Trinkaus-Randall 
et al 1988, Tawara et al 1989).
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By contrast, collagen type IV, (see section 5.1.2), exhibited 
more intense labelling in the subendothelial basement 
membrane of aged iris vessels than in the matrix around 
supporting cells. Consequently, it appears that in iris 
vessels endothelial cells secrete primarily collagen type IV, 
whilst laminin is produced mainly by supporting cells 
(myoepithelial cells and pericytes). This is important as 
differences in the production and utilization of laminin may 
contribute to variations in cell behaviour (Pratt et al 1985, 
Abrahamson 1986, Trinkaus-Randall et al 1988). It is 
relevant that a recent in vitro study demonstrated that 
aortic endothelial cell adhesion is preferentially promoted 
by collagen type IV when compared to laminin (Herbst et al 
1988).
The observation that in the aged iris, laminin seems to be 
mainly present in the walls of thicker vessels indicates 
heterogeneity in the components of thick and thin vascular 
matrices within the iris. These findings are in accord with 
an immunogold quantitative study performed on a variety of 
animal basement membranes (Grant & Leblond 1988), and with 
results obtained in other ocular tissues (Das et al 1990a, 
Marshall et al 1990a; 1991e? 1992b). Abrahamson (1986) has 
emphasized that the chemical composition of basement 
membranes may vary according to the demands of particular 
tissues.
The significance of the presence of laminin in the matrix 
(basement membrane material) in which the dilator muscle is 
embedded is not completely understood. It is possible that
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in this region laminin is acting as an adhesive factor 
between individual myocytes and between myocytes and the 
laminin rich posterior stroma region (Fig 6.6). The adhesive 
properties of laminin have been well documented (Abrahamson 
1986, Martin & Timpl 1987, Adair & Mecham 1990). Its 
presence in the matrix may be instrumental for the orderly 
contraction of the dilator muscle. Therefore, changes in its 
distribution within this matrix may well interfere with the 
dilatation of the normal iris. Likewise, the significance of 
the label associated with the filamentous bundles bordering 
iris stromal fibrocytes is also difficult to assess, as the 
functional role of these cells in the iris remains unclear. 
These iris fibrocytes may separate the dilator muscle from 
the iris stroma and synthesise the matrix in which the 
dilator muscle is embedded. An intriguing possibility is 
that this layer anchors the stroma to the muscle.
The ECM possesses important regulatory properties governing 
cell behaviour (Abbot 1988, Getzenberg et al 1990, Streuli & 
Bissell 1990, Adair & Mecham 1990). Alterations in the 
interaction between cells and their matrices can precede and 
may eventually result in ocular tissue malfunction (Ben-Zvi 
et al 1986, Glaser 1988, Caldwell 1989, Das et al 1990b, 
Marshall 1991). It is conceivable that during the ageing 
process quantitative alterations of specific ECM components 
occur within ocular tissues and may result in functional 
impairment. Such a process could account for the reduction 
of laminin associated with ageing in the material of this 
study. Nevertheless, the effect of ageing upon the quantity 
of laminin can only be confirmed with the use of an
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immunogold quantitation technique similar to that employed by 
Grant & Leblond (1988), or Das et al (1990b). However, 
quantitation of immunogold particles has many serious 
drawbacks.
The results of the present study could not be correlated with 
any previous human or animal iris study, as a literature
search failed to retrieve published reports on the subject at
the EM, or LM level. It is surprising that so little
attention has been paid to the distribution of laminin in the
normal iris considering that iris has many unique structural 
and functional properties. This work provides information 
in order to better comprehend the functional role of laminin 
in the normal aged iris.
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6.2 Laminin in the exfoliative iris
6.2.1 Introduction
As stated before (section 1.5.1), it has long been speculated 
that exfoliation material may be abnormal basement membrane 
material synthesized at multiple sites by defective ageing 
cells. Since basement membranes contain collagenous and 
non-collagenous components, disordered synthesis, or 
degradation of collagenous and/or non-collagenous components 
may be a significant feature of the disorder. In normal 
tissue one non-collagenous component of basement membranes, 
namely the glycoprotein laminin, has been identified by 
established immunocytochemical techniques (Schittny et al 
1988, Das et al 1990a, Marshall et al 1990a; 1990b).
Therefore an attempt was made to identify laminin in the 
exfoliation material.
6.2.2 Results
Material for this study was provided by iridectomies 
performed in 13 patients with the clinical diagnosis of 
exfoliation syndrome (2 cases) and exfoliation glaucoma (11 
cases), (see Appendix II). The specimens were fixed and 
processed according to the methods given in section 3.3. In 
all of the exfoliative iris specimens studied, exfoliation 
material was identified in the iris by LM examination of LR 
white semithin sections and subsequent TEM examination of 
ultrathin sections. Exfoliation aggregates were observed 
mainly around and within the vascular matrices of iris
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vessels. The ultrastructural distribution of exfoliation 
material was similar to that seen in section 4.3. The 
specific immunocytochemical results are as follows:
£
Exfoliation material
Recognition of the exfoliation material was relatively easy 
in LR White processed tissue (Figs 6.7, 6.8 & 6.9). This was 
due to a difference in tissue contrast in comparison with 
conventionally processed tissue and it resulted in greater 
detail in the ECM components. In addition, larger amounts of 
ECM material were retained with the LR white embedding 
procedure. This often resulted in more prominent 
interfibrillar spaces (Fig 6.7). These spaces which contain 
the interfibrillar matrix of exfoliation material, did not 
appear to contain other ECM components, with the exception of 
iris granules (alternatively referred to as dense bodies).
In only a few cases were collagen fibrils intermingled with 
exfoliation fibres in the boundary of exfoliation aggregates.
Intense labelling for laminin was observed over areas where 
exfoliation material was present within the iris (Figs 6.7 to 
6.12). This finding was consistent in all exfoliative iris 
cases. The signal obtained was regarded as extremely 
specific on the basis of the absence of gold particles from 
the nuclei, cell cytoplasm and lumina of vessels (the 
criteria of specificity are explained in section 3.4.7). 
Better antigenic preservation was achieved in iris tissue 
fixed with paraformaldehyde 4% only, but this was at some 
expense of ultrastructural preservation (Fig 6.12). In 
tissue fixed with paraformaldehyde and glutaraldehyde (0.1-
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Figure 6.7: Exfoliative iris. Intense labelling for laminin is restricted to the vascular 
matrix (VM) infiltrated with exfoliation material and to exfoliation 
aggregates (EX) outwith the vascular matrix. The endothelial basement 
membrane exhibits a signal free zone (BM). L:lumen, E:endothelium.
Figure 6.8: Loosely arranged exfoliation material (EX) excrescence on the 
anterior iris surface. Laminin is localised to the fibrillar 
component. Interfibrillar matrix is absent. AC:anterior chamber.
Figure 6.9: Exfoliation material (EX) labelled with laminin in 
the basal region of the posterior pigmented 
epithelium (PE), whose cellular integrity is absent.
Figure 6.10: Laminin located in exfoliation material (EX) within 
the muscular portion of the anterior pigmented 
epithelium. Exfoliation material is packed in the 
vicinity of the dilator muscle processes (DM).
Figure 6.11: Laminin labelled exfoliation material (EX) in 
anterior border layer of exfoliative iris. As in 
the previous figures, glutaraldehyde fixation has 
highlighted the fibrillar nature of exfoliation material.
1 jjm
igure 6.12: Exfoliation material labelled with laminin in wall of degenerate iris vesse 
The endothelium (E) is atrophic. This figure illustrates the poor 
preservation of the fibrillar nature of exfoliation material (EX) with 
the omission of glutaraldehyde from the fixative. L:lumen.
0.75%) labelling was less intense, but still highly specific.
Laminin was present predominantly in the exfoliation fibres 
but weak labelling was also observed on the electron-lucent 
interfibrillar matrix (Figs 6.7 to 6.11). In four of the 
specimens, vegetations consisting of laminin labelled 
exfoliation material were seen to project into the anterior 
chamber from the anterior border layer (Fig 6.8). Within an
individual case the intensity of the signal was proportional
to the density of the exfoliative deposits. Intense 
immunolabelling was observed on closely packed fibres of 
exfoliation material around large iris vessels in all cases 
(Figs 6.7 & 6.12) and in the dilator muscle region in two of
the cases (Fig 6.10).
Iris vasculature
In exfoliation positive vessels laminin was almost 
exclusively associated with the exfoliation material (Fig 6.7 
& 6.12). In vessels where exfoliation material was not 
identified (exfoliation free vessels), vascular matrix 
labelling was reduced or absent in comparison with normal 
iris vessels in control specimens. This phenomenon was 
considered in more depth in chapter 7. In all exfoliation 
positive vessels a thin signal-free zone was observed 
corresponding to the lamina lucida of endothelial basement 
membranes. The label for laminin closely followed the 
configuration of the ribbon-like exfoliative deposits focally 
distributed around some iris vessels. Some of the 
exfoliative vessels exhibited attenuation of the endothelial 
cells and atrophy of the myocytes. This was particularly
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evident in advanced cases of exfoliation glaucoma.
Iris pigment epithelium
The association between exfoliation material and the dilator 
muscle was intriguing. In two of the specimens, exfoliation 
material had infiltrated the basal muscular portion of the 
anterior iris pigment epithelium causing a marked disturbance 
in the architecture of this layer (Fig 6.10). Laminin was 
again mainly localised to the exfoliation fibres (Fig 6.10). 
In these cases exfoliation material surrounded the muscular 
processes of the anterior iris pigmented epithelium. It was 
observed between the intact walls of adjacent epithelial 
cells, but did not penetrate the cell membrane. In every 
specimen exfoliation material was not noted between the two 
layers of the pigment epithelium. In only one case laminin 
labelled exfoliation material was seen on the basal surface 
of the posterior pigmented epithelium of the iris (Fig 6.9).
Controls for normal and diseased iris
Background labelling of negative serum controls was virtually 
absent. In the corneal positive controls employed in this 
study laminin was demonstrated in the basement membrane 
complex of the corneal epithelium (chapter 7, Fig 7.15). The 
fine structural distribution of laminin in the human aged 
cornea were in agreement with previously described 
immunohistochemical results for human cornea at the LM (Ben- 
Zvi et al 1986) and EM level (Marshall et al 1991a). In the 
exfoliative meshwork tissue controls, intense immunolabelling 
for laminin was observed in clumps of exfoliation material 
lying in the intertrabecular spaces and in the cribriform
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Figure 6.13: Exfoliative meshwork. Intense immunolabelling for laminin in an 
aggregate of exfoliation material (EX) lying within the 
intertrabecular space. The trabecular beam (TB), including 
elastic like fibres (F) is devoid of immunogold particles.
layer (Fig 6.13, see also controls in chapter 7).
6.2.3 Discussion
This is the first study that has shown a molecule with the 
antigenic characteristics of laminin to be an integral 
component of exfoliation material. Whether this molecule is 
identical to laminin found in normal ECM, or an aberrant form 
of laminin synthesised only in the exfoliation syndrome 
remains uncertain. However, since a signal for laminin was 
present in exfoliation free vessels within the same specimen 
and in the positive controls it is justified to assume that 
laminin is an important constituent of exfoliation material.
Intense specific immunolabelling associated with exfoliation 
aggregates was obtained in all specimens. Labelling was 
principally present on the exfoliation fibres, with a low 
density of immunogold label associated with the 
interfibrillar matrix. At high magnification immunolabelling 
was shown to be evenly distributed over the exfoliation 
fibres. Moreover, the labelling density increased with 
increasing packing of exfoliation fibres. Therefore, these 
results demonstrate that laminin constitutes an integral 
component of the exfoliation fibres and to a lesser extent to 
that of the interfibrillar matrix.
LR white processing resulted in retention of a larger amount 
of interfibrillar matrix. There is histochemical and 
morphological evidence that this electron lucent matrix 
may contain proteoglycans and it has been suggested that it
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excludes other macromolecules and particles from penetrating 
into the exfoliation aggregates (Davanger & Pedersen 1975, 
Davanger 1977; 1978; 1980). The latter suggestion is 
supported by the present study. The presence of iris 
granules (dense bodies) within the exfoliation material 
aggregates is in agreement with previous investigations 
(Ringvold 1970a; 1988, Dark et al 1977, Dark & Streeten 
1990). The significance of these granules remains unclear.
In diseased iris vessels, laminin was principally localised 
in exfoliation material and considerably reduced in 
exfoliation free vascular matrix (basement membrane). This 
reduction of laminin in exfoliation free vascular matrix may 
reflect an abnormal pattern of laminin utilization (see 
also chapter 7). This suggests that laminin, which normally 
is incorporated into the basement membrane by basement 
membrane-producing cells, is being diverted to the formation 
of exfoliation material. This is not surprising, as the 
cells that produce the matrix components for the ocular 
basement membranes are the same as those proposed for the 
synthesis of exfoliation material (Ringvold 1969; 1988, Ghosh 
& Speakman 1974, Eagle et al 1979, Seland 1985) The 
triggering mechanism behind this functional conversion awaits 
clarification. In the past, a 'metabolic mechanism' has been 
suggested for the pathogenesis of exfoliation syndrome 
(Bertelsen et al 1964, Dickson & Ramsey 1979, Mizuno et al 
1980, Dark & Streeten 1982, Morrison & Green 1988).
The reduction of laminin from the iris vascular matrices 
surrounding supporting cells and the ensuing alterations of
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its binding with the other basement membrane constituents, 
like heparan sulphate proteoglycan and collagen type IV, 
could compromise the structural integrity and the filtration 
properties of iris vascular basement membranes. This 
underlying mechanism may account for the increased 
permeability of exfoliative iris vessels visualized by 
fluorescein angiography (Vannas 1969, Laatikainen 1971, 
Friedburg & Bischof 1982, Brooks & Gillies 1987).
Another point of clinical interest was the relationship 
between exfoliation material and the iris dilator muscle. In 
two exfoliative specimens there was extensive infiltration of 
the dilator muscle ECM with laminin labelled exfoliative 
fibres and this was associated with atrophy of the muscle 
cells. This phenomenon together with a potential alteration 
of the laminin distribution in the embedding matrix of the 
dilator muscle could account for the impaired dilatation 
commonly seen in patients with exfoliation syndrome and 
glaucoma (Kristensen 1965, Bartholomew 1970a, Carpel 1988, 
Hovding 1988, Olivius et al 1989, Metge et al 1989, Pedersen 
1990). The adhesive properties of laminin may be 
instrumental in the adherence of exfoliation aggregates to 
ocular structures, such as the anterior hyaloid face (Mailing 
1938, Sunde 1956, Petersen 1958) and the corneal endothelium 
(Sugar et al 1976, Brooks et al 1988). It is also 
conceivable that laminin 'adheres' to the exfoliation 
aggregates.
Despite the fact that most investigators in the field have 
favoured the involvement of basement membrane-producing cells
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in the production of exfoliation material (Ringvold 1969? 
1988, Layden & Shaffer 1973, Sugar et al 1976, Layden 1982, 
Seland 1985, Yanoff & Fine 1989), there has been less 
conformity on whether or not exfoliation material contains 
basement membrane components (see section 1.5.1). 
Histochemical evidence has already been advanced to indicate 
that exfoliation material may contain glycoproteins (Streeten 
et al 1986a, Morrison & Green 1988) and proteoglycans 
(Davanger 1980, Harnisch et al 1981), which are major 
components of basement membranes. However, a group of 
investigators has repeatedly shown an association between 
exfoliation material in the conjunctiva and skin of patients 
with exfoliation syndrome and components of the elastic 
system-elastin and amyloid P- (section 1.3.4). These 
components, with the possible exception of amyloid P (Li et 
al 1989), are not thought to be intrinsic constituents of 
normal basement membranes. Nevertheless, on the grounds of 
the variations seen in the histochemical staining properties, 
it is clear that exfoliation material is a composite of more 
than one substance (Davanger & Pedersen 1975, Baba 1983, 
Streeten et al 1984, Jerndal 1986, Tarkkanen 1986, Ringvold 
1988, Streeten et al 1990). Furthermore, it has even been 
suggested that the composition of exfoliation material may 
vary in different tissues (Streeten et al 1987? 1990).
Although exfoliation fibres does not appear ultrastructurally 
similar to elastic fibres, it is possible that elastin and 
other constituents of the elastic system are produced as part 
of an aberrant ECM synthesis, a process which is probably 
orchestrated by basement membrane-producing cells.
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The results of the present investigation suggest that within 
the iris vasculature, exfoliation material is synthesized by 
the vascular supporting cells. The presence of laminin in 
the basement membrane of the iris pigment epithelium suggests 
that these epithelial cells may also be involved in the 
synthesis of exfoliation material. The inconsistent presence 
of exfoliation material in this anatomical region however is 
difficult to explain. This can only be confirmed by the 
immunocytochemical investigation of whole eyes, as surgical 
iridectomy specimens represent only a small fraction of the 
whole iris tissue. Moreover, such specimens are unsuitable 
for the detailed study of the posterior pigmented epithelium 
of the exfoliative iris.
In conclusion, it is postulated that in the exfoliative iris 
the synthesis of exfoliation material is initiated at the 
molecular level by aberrant basement membrane biosynthesis, 
which also results in laminin being incorporated in the 
exfoliation material. In that context, it is reasonable to 
assume that the triggering factor underlying exfoliation 
syndrome is a disturbance of a specific factor which controls 
the orderly synthesis and remodelling of ECM. The main 
challenge however, remains the identification of this 
aberration as a first step towards prevention of this common 
blinding disorder.
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6.2.4 Summary
Immunogold labelling was applied at the ultrastructural level 
to the identification of the glycoprotein laminin in the 
normal and exfoliative iris. In the normal iris, laminin was 
localised in iris basement membranes and in the extracellular 
matrix (basement membrane material) in which the dilator 
muscle is embedded. In the normal vascular basement 
membranes (vascular matrices) laminin was identified in the 
matrix surrounding vascular supporting cells, but not beneath 
the endothelium.
Immunoelectron microscopic studies of exfoliative iris tissue 
revealed the presence of laminin in the fibrillar component 
of exfoliation material. The immunogold label was uniformly 
distributed on the exfoliation fibres and increased with 
increased density of exfoliation aggregates. Deposition of 
laminin labelled exfoliation material in the dilator muscle 
in two cases was a noteworthy feature, as was an apparent 
depletion of laminin in the vascular matrix of ostensibly 
unaffected vessels.
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CHAPTER 7 IRIS VASCULOPATHY IN THE EXFOLIATION 
SYNDROME: AN IMMUNOCYTOCHEMICAL STUDY
7•1 Introduction
Iris vasculopathy is a well recognized but poorly understood 
pathological feature of the exfoliation syndrome (Ringvold 
1969? 1970a? 1970c, Vannas 1969, Anastasi et al 1974, Brooks 
& Gillies 1987). Conventional LM and TEM investigations 
have revealed abnormal accumulations of, as yet, unknown 
extracellular matrix (ECM) components within the iridic 
vascular wall, often in conjunction with deposition of 
exfoliation aggregates (Ringvold 1969, Ghosh & Speakman 1974, 
Harnisch 1977, Shimizu 1985 and section 4.4). In advanced 
disease the deposition, or infiltration of exfoliation 
material in the iridic vascular matrix is frequently 
accompanied with a varied degree of endothelial degeneration 
and, ultimately, the obliteration of the lumen in some 
vessels (Ringvold 1970a, Ghosh & Speakman 1974, Ringvold & 
Davanger 1981, Spinelli et al 1985).
The conventional morphological study of the exfoliative iris 
(chapter 4) and the immunogold studies of collagen types I 
and IV (chapter 5) and laminin (chapter 6) in the normal 
and exfoliative iris provided the background to the present 
chapter. The specific vascular matrix alterations that 
account for the ultrastructural features seen in exfoliative 
vasculopathy have not been investigated previously. Laminin, 
a major basement membrane constituent, has been shown to be 
an integral component of the exfoliation material (section
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6.2.2) and collagen types I and IV have been identified in 
the normal iris vascular matrix (section 5.1.2). In this 
chapter the changes of these three ECM components in the 
various stages of exfoliation vasculopathy will be 
considered. Collagen type III was absent from the vascular 
matrix of normal and exfoliative vessels (section 5.1.2) and 
therefore was not considered here. The study of the vascular 
matrix of the affected and unaffected iris vessels merits 
further investigation. It was hoped that the immunogold 
study of vascular matrix changes could furnish important 
clues as to the aetiology and pathogenesis of the disorder.
7.2 Results
Fifteen exfoliative iris specimens (cases 1-15 in Appendix 
II) and 12 age matched control iris specimens from 
enucleations (cases 1-12 in Appendix I) were used. Details 
of the source of material used for this study and the 
techniques applied are described in sections 3.3.3 & 3.3.4. 
All the control specimens were examined by LM to exclude the 
possibility of unsuspected secondary pathological changes. 
Exfoliative specimens had the diagnosis confirmed clinically 
and morphologically. The morphological findings (LM and TEM) 
were similar to those described in sections 4.3 & 5.2.2. The 
immunocytochemical findings of this study are as follows:
Laminin
In all normal control iris specimens immunolabelling was 
localised predominantly in the ECM of vascular supporting 
cells (cf Figs 6.1 & 6.2). In all of the 15 exfoliative
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specimens studied, every exfoliation aggregate was uniformly 
labelled with anti-laminin antibodies. Immunolabelling was 
almost exclusively located to the exfoliation fibrils (cf Fig 
6.7 & Fig 7.1). Within the iris vasculature of each 
individual specimen a wide spectrum of additional 
pathological alterations was noted. Discrete clumps of 
exfoliation material, labelled with laminin, often appeared 
to form a bridge between the bulk of the exfoliative deposits 
and the outer surface of supporting cells (Fig 7.1). Iris 
granules, presumably originating from degenerate melanin 
containing cells, were occasionally present within the 
exfoliative deposits. In all of the specimens, the intensity 
of immunolabelling was directly proportional to the quantity 
and density of the exfoliation deposits around the vessel 
wall. Immunogold labelling assisted in the detection and 
recognition of discrete exfoliative deposits in other iris 
sites. In a few specimens such isolated aggregates of 
exfoliation material were only detected as a consequence of 
their gold labelling.
By comparison with the normal iris controls, the label for 
laminin was markedly reduced, or completely absent in that 
part of the vascular wall that did not contain clumps of 
exfoliation material (see also section 6.2.2), (Figs 7.2 & 
7.3). A similar depletion occured in ostensibly 'normal' 
vessels in exfoliative iris specimens, (exfoliation free 
vessels).
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Figure 7.1: Laminin immunolabelling over a large aggregate of exfoliation materi 
(EX) in the vascular matrix(VM) of an exfoliative vessel. Exfoliation 
material is in contact(arrows) with the outer surface (arrowheads)ol 
an endothelial cell(E); L:lumen; Iklamina lucida; DB:dense bodies.
Figure 7.2: Laminin is greatly reduced in the vascular
matrix(vm) of an unaffected vessel within an 
exfoliative iris specimen. L:lumen; 
E:endothelium; SC:supporting cell.
igure 7.3: Absence of laminin from the vascular matrix(vm) of a supporting cell(SC) 
in an exfoliation free vessel. Failure of structural preservation highlights 
the drawback of PFA fixation. All other figures in this chapter are of 
tissue fixed with glutaraldehyde. L:lumen; E:endothelium; CZ:collagenous zone.
Type I collagen
Specific immunolabelling for type I collagen was present in 
the vascular matrix of normal (cf Fig 5.1) and exfoliative 
vessels (Fig 7.4) with the label evenly distributed 
throughout. In exfoliative vessels increased labelling for 
type I collagen was detected in the vascular matrix in the 
presence of exfoliation aggregates (Fig 7.5). In such 
vessels immunogold particles were present in exfoliation 
aggregates and 'appeared' to label them (Fig 7.5). Collagen 
type I was significantly reduced in the vascular matrices of 
exfoliation free vessels.
Type IV collagen
In the normal iris controls type IV collagen labelling was 
located in the basement membranes of endothelial cells and 
vascular supporting cells of all vessels (see section 5.1.2). 
In contrast to type I collagen and laminin, the label was 
most intense near the endothelium (cf Fig 5.9).
In all exfoliative specimens labelling for type IV collagen 
in iris vessels could be divided into four patterns, which 
related to the severity of the iris vasculopathy: (1) iris 
vessels with no evidence of exfoliation material and with a 
relatively healthy endothelium/supporting cells, (2) 
relatively healthy iris vessels with visible aggregates of 
exfoliation material, (3) those without evidence of 
exfoliation material deposition, but with a degenerate 
endothelium and atrophic, or fragmented supporting cells and 
(4) ghost vessels where exfoliation material had replaced the 
vascular wall and advanced degeneration or absence of
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Figure 7.4: Collagen type I labelling in exfoliative iris. The
vascular matrix (VM) of this unaffected vessel is diffusely 
thickened, but free from exfoliation material.
L:lumen; RBC:red blood cell; E:endothelium.
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Figure 7.5: Vascular matrix of an exfoliative vessel infiltrated with exfoliation 
material(EX). Immunogold particles labelling for type I collagen 
are located over fibrils throughout the vascular matrix, which is of 
increased thickness.
Figure 7.6 Collagen type IV localisation in the vascular 
matrix(vm) of a vessel devoid of exfoliation 
material. The vascular matrix(vm) is normal in 
appearance. L:lumen; E:endothelium.
Figure 7.7: Immunolabelling for collagen type IV in early exfoliation vasculopathy. 
Exfoliation material is present in the thickened vascular matrix(VM). The 
distribution of collagen type IV is over a larger area than that of exfoliation 
free vessels, (cf 7.6);but is absent from exfoliation material (ex) outwith 
the abnormal vascular matrix. Lrlumen; E:endothelium; SC:supporting cell.
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Figure 7.8: Collagen type IV in the thickened vascular matrix (vm) of an exfoliativi 
vessel. Labelling is increased in comparison with exfoliation free vascular 
matrix. Note reduction of label in exfoliation material (ex) outwith the 
vascular matrix. L.’lumen; E:endothelium; SC:supporting cell.
Figure 7.9: Absence of labelling for collagen type IV over exfoliation 
fibres(ex) outwith the thickened vascular matrix(vm).
In this micrograph some exfoliation fibres intermingle with thicker 
collagen fibrils (arrowheads).
Figure 7.10: Collagen type IV localisation in vessel exhibiting advanced
exfoliation vasculopathy. Labelling is restricted to a markedly 
thinned vascular matrix(vm); exfoliation material is absent. 
L:lumen; E:endothelium; CZ:collagenous zone.
endothelial and supporting cells was evident (for description 
of vascular changes see section 4.4).
In the first category (Fig 7.6) immunolabelling was similar 
to that seen in age matched normal iris controls. In the 
second category an increase of type IV collagen was noted in 
the thickened vascular matrix infiltrated by exfoliation 
material (Figs 7.7 & 7.8). Type IV collagen accumulation in 
the vascular matrix was uneven, and was more prominent in 
areas with densely packed exfoliation material. However, the 
immunogold label was not associated with the coarser 
individual exfoliative fibres, but was located on the finer 
filamentous material of the vascular matrix. Furthermore, 
exfoliation material outwith the vascular matrix (Figs 7.7 & 
7.8) and in the iris stroma did not contain type IV collagen.
Few specimens contained vessels which belonged in the third 
category. In these vessels immunogold labelling for type IV 
collagen (Fig 7.10) was reduced in comparison with the normal 
age matched controls and exfoliative vessels of the first two 
categories. This reduction in collagen type IV was even more 
prominent with ghost vessels.
Exfoliation vasculopathy
At am early stage of exfoliation vasculopathy some of the 
vessels exhibited a varied degree of thickening of the 
vascular matrix. However, thickening of the vascular matrix 
was mot accompanied by an anticipated increase in labelling 
for laminin. On the contrary, laminin labelling was sharply 
reduced (Fig 7.11). At an advanced stage of exfoliation
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Figure 7.11: An exfoliation free vessel with thickening of the
vascular matrix (VM), but sparse labelling for laminin. 
SC:supporting cell.
Figure 7.12: Ghost vessel(GV) in end stage exfoliation vasculopathy.
Type I collagen is localised to the striated collagen fibrils of the 
perivascular collagenous zone (CZ), but is largely absent from 
exfoliation material(EX), which has replaced the vascular wall.
Figure 7.13a: Diagramatical description of the localisation of laminin (triangles), 
collagen type I (crosses) and collagen type IV (squares) in the 
vascular matrix-basement membrane complex(BM) of the normal 
aged iris. N:nucleus; P:pericyte (supporting cell).
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re 7.13b: Diagramatical representation of exfoliation vasculopathy in a relatively 
healthy vessel with visable exfoliation material(ex). Intense laminin labelling 
in exfoliation material aggregate is accompanied by a decrease in the label 
for laminin in the vascular matrix (BM), which is free from exfoliation material.
j^eased labelling for collagen types I and IV occurs in the affected matrix,
in the unaffected matrix labelling is comparable to that of normal vessels.
Figure 7.13c: Vascular matrix components in advanced exfoliation vasculopathy. 
Degenerate exfoliative vessel is ostensibly free from exfoliation material. 
Note reduction of laminin (triangles), collagen type I (crosses) and collagen 
type IV (squares) in association with visable thinning of the vascular matrix.
v  . - 4 S P * ^ f T 7 ' «
■ to  S H
' AJlW:<Mi
K a  g r '
T"— — T
Figure 7.14: Exfoliative meshwork control. Laminin is present in an aggregate 
of exfoliation material(ex) within the intertrabecular space. 
Elastic-like fibres(arrows) and long spacing collagen(arrowheads) 
are devoid of label.
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Figure 7.15: Exfoliative meshwork control. Collagen type IV is present in the
basement membrane of trabecular beams (TB), but is absent from  
exfoliation material(ex). Endothelial cell covering is missing
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Figure 7.16: Positive corneal control for type I collagen with immunogold 
labelling of collagen fibrils in Bowmans layer (BL).
The corneal epithelium (Ep) is devoid of immunogold particles.
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Figure 7.17: Positive corneal control for laminin. Laminin is localised 
to anchoring plaques (ap) of the epithelial basement 
membrane complex. Ep:epithelium; BL:bowmans layer.
vasculopathy laminin was absent from the residual vascular 
matrix (Fig 7.3).
Immunolabelling for type I collagen was significantly reduced 
in vessels which were at an advanced stage of exfoliation 
vasculopathy. These vessels exhibited thinning of their 
vascular matrices, atrophy and ultimately loss of all 
cellular elements. Sparse labelling for type I collagen was 
observed in ghost vessels in which exfoliation material had 
replaced the normal vascular wall (Fig 7.12). Overall, the 
pattern of type IV collagen labelling in vessels free of 
exfoliation material in exfoliative iris specimens, was 
dependent upon the degree of degenerative vasculopathy 
observed. Whenever the vessels exhibited significant 
degenerative changes i.e. atrophic supporting cells and 
marked degeneration, or absence of endothelial cells, type IV 
collagen was considerably reduced (Fig 7.10). This reduction 
was closely associated with thinning of the vascular matrix. 
The immunocytochemical findings of the present investigation 
are summarised diagramatically in Figures 7.13a,b,c.
Positive controls
In exfoliative meshwork control tissue, specific labelling 
for laminin was observed in exfoliation material aggregates 
within the intertrabecular spaces (Fig 7.14). Collagen types 
I and IV were not present in the exfoliation material (Fig 
7.15). The qualitative distribution of collagen types I and 
IV in the exfoliative meshwork was similar to that reported 
by Marshall and coworkers (1991c). Corneal positive controls 
showed collagen type I in striated collagen fibrils in
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Bowman's layer (Fig 7.16) and the corneal stroma. Laminin 
was localised to anchoring plaques in the corneal epithelial 
basement membrane complex (Fig 7.17).
7.3 Discussion
The range and characteristics of the exfoliation vasculopathy 
observed in the exfoliative iris vessels of the specimens was 
diverse, but similar to that reported previously using 
conventional TEM (chapter 4 and Ringvold 1969; 1970b,
Anastasi et al 1974, Ghosh & Speakman 1974, Shimizu et al 
1980, Spinelli et al 1985, Shimizu 1985). As previously 
stated, the morphological appearance of exfoliation deposits 
in LR white sections differs from osmicated/glutaraldehyde 
fixed tissue embedded in araldite. The main difference 
comprises the less 'dense' appearance of exfoliation 
aggregates. It is conceivable that conventional fixation 
removes a proportion of ECM present within the electron 
lucent amorphous structural framework of the exfoliation 
material (interfibrillar matrix).
With TEM the detection of the larger, electron-dense 
aggregates of exfoliation material was easy, but the 
identification of discrete clumps of exfoliation material, or 
isolated exfoliative fibres was more difficult. This 
difficulty was exacerbated by the morphological resemblance 
between isolated exfoliative fibres and collagen fibres. 
Immunogold labelling of exfoliative fibres with anti-laminin 
antibodies was thus, advantageous in the identification of 
exfoliation material. In agreement with a previous
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conventional TEM study of exfoliative iris vessels by Shimizu 
(1985) the present study confirmed the intimate relationship 
between exfoliation aggregates and iris vessels. Exfoliation 
aggregates in the iris frequently extended to form a bridge 
which linked with vascular supporting cells.
The intimate relationship between exfoliation aggregates and 
the vessel wall observed in this study is important as it 
could mean that vascular cells, which normally remodel the 
vascular matrix, are the 'synthesisers' of exfoliation 
material. The cells in the iris vessels can be divided into 
supporting (smooth muscle cells and pericytes) and 
endothelial cells. The vascular extracellular matrix is 
thought to be synthesised by the cellular components of the 
vessel wall, but there may be a contribution to the overall 
structure from the plasma components (Garner 1982). The 
results of this study together with evidence cited in 
chapters 4 & 6 suggest that in the iris the vascular 
supporting cells are the principal source of exfoliation 
material. It is generally thought that these cells provide 
structural support to the underlying vasculature and possess 
contractile, phagocytic and synthetic properties (reviewed by 
Garner 1982). It is highly likely that these cells control 
aspects of vascular matrix metabolism and become the 'target 
cells' in the development of the exfoliation syndrome. If 
such a hypothesis is right, this disturbed synthetic activity 
leads to the deposition of exfoliation material.
The localisation of laminin in the normal vascular matrix 
surrounding supporting cells suggests that these cells
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produce laminin, a principal basement membrane component 
(section 2.5). Chapter 6 has shown laminin to be an 
important constituent of exfoliation material. Moreover, 
laminin labelled exfoliation material frequently appeared to 
be preferentially located in proximity to supporting cells. 
Thus, it is possible that the same cells that under normal 
conditions incorporate this macromolecule into the ageing 
iris vascular matrix, may at some stage deviate and begin to 
incorporate laminin into the exfoliation material. The 
present study lends weight to the hypothesis that exfoliation 
material is abnormal basement membrane material produced at 
multiple sites by abnormal ageing cells (Eagle et al 1979).
One finding which was not anticipated was the reduction in 
the laminin content of the vessel wall in exfoliation free 
vessels, i.e. when there was no evidence of exfoliation 
material deposition in that particular level of section.
This enigmatic depletion of laminin could reflect a 
widespread disturbance in matrix remodelling in exfoliation 
vasculopathy. This reduction could be attributable to an 
aberrant diversion of laminin macromolecules into exfoliation 
material synthesis. A physico-chemical attraction between 
laminin and exfoliation material is also possible.
If there is a sequence of abnormal utilisation of normal 
matrix components, the aberrant vascular cohort cells may be 
stimulated to synthesise other ECM molecules (which under 
normal conditions are not produced by vascular basement 
membrane cells). This abnormal ECM synthesis could explain 
the reported presence of components of the elastic system
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within the exfoliation material structural framework 
(Streeten et al 1986? 1990, Li et al 1988).
In chapter 5 evidence was provided to show that collagen 
types I & IV are not constituents of the exfoliation material 
structure. Though the amount of type IV collagen increased 
in the vascular matrix in association with exfoliative 
aggregates, exfoliation deposits outside the vascular matrix 
in the iris stroma were completely negative for type IV 
collagen. The results of the present study are in accordance 
with preliminary biochemical data furnished by Ringvold 
(1973) which indicated that collagens do not comprise a 
significant proportion of the exfoliation material. The 
present investigation however, has indicated for the first 
time that the biosynthesis of the exfoliation material is 
combined with alterations of collagenous vascular matrix 
components, such as collagen types I and IV.
Increased accumulation of collagen types I and IV in the 
vascular matrices of exfoliative iris vessels probably 
accounts for the thickening of vascular matrices described in 
chapter 4. The lamination of vascular basement membranes in 
exfoliation syndrome is most likely due to the deposition of 
collagen type IV. Increased synthesis of collagen types I 
and IV appears to be an early feature of the disease.
Enhanced collagen synthesis may either reflect a generalised 
disturbance of vascular matrix synthesis by distressed 
vascular supporting cells, or may represent a secondary 
attempt at repair in response to subtle ECM alterations, such 
as the reduction of laminin. Alternatively, it could
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represent a 'failure' in the cycle of collagen turnover in 
which deficient enzymatic degradation results in accumulation 
of these two collagen types.
In advanced exfoliation vasculopathy in the material studied 
the loss of endothelial cells and the fragmentation of cohort 
cell was accompanied by a reduction of collagen types I and 
IV. This implies that while at an early stage of exfoliation 
vasculopathy the vascular cells are stimulated to synthesise 
increased amounts of collagen types I and IV, at a late stage 
of the disease the ailing cells lose the ability to maintain 
a healthy matrix. The reduction of collagen types I and IV 
and the corresponding reduction of the thickness of the 
vascular matrix do not support the theory of aberrant 
resorption of the vascular matrix, at least at the stage of 
advanced vasculopathy.
Alternatively, the findings in exfoliation vasculopathy may 
reflect secondary ECM alterations which occur as a result of 
the exfoliation material being transferred into the iris from 
the aqueous. Exfoliation material may circulate with the 
aqueous humour and enters the iris subcompartments and vessel 
wall by osmotic attraction. However, such a concept of 
passive exfoliation material deposition cannot account for 
all the morphological features and the preferential 
distribution of exfoliation material in the iris vessels (see 
section 4.5). Nevertheless, more studies are required to 
explore the possibility of passive exfoliation material 
deposition.
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Degenerative changes of the vascular matrix seen by 
conventional morphology (chapter 4) have been confirmed in 
this study. It is interesting to relate the ECM changes 
observed in the iris vessels with two clinical features with, 
as yet, an obscure aetiology: 1)increased permeability of the 
affected iris vasculature and 2)iris neovascularisation. 
Fluorescein studies performed on patients with the condition 
have found profuse leakage of fluorescein from the iris 
vasculature (Vannas 1969, Brooks & Gillies 1987). Similarly, 
clinical and ultrastructural observations concerning the 
formation of new vessels in the disorder have puzzled 
investigators (Ringvold & Davanger 1977, Shimizu 1985). It 
is reasonable to assume that these findings result from 
remodelling of the vascular matrix in the course of 
exfoliation vasculopathy. A reduction of the laminin and 
collagen content in the vascular wall of the affected vessels 
would compromise the structural integrity and adhesion of 
endothelial cells (see section 4.4). The breakdown of 
healthy vascular matrices to ultimately form degenerative 
'ghost vessels' would bring about iris tissue underperfusion, 
anoxia and atrophy which would stimulate neovascularisation.
It is relevant to note that in the walls of hyalinised 
retinal vessels the fibrous tissue which gradually replaces 
the cellular constituents was found to comprise an 
accumulation of collagen types I, III, IV and VI (Marshall et 
al 1990a) and this precedes neovascularisation. Information 
on the ECM content of the walls of ocular vessels in disease 
is of importance, because the location of the biochemical 
products help to identify the cells producing the protein.
176
Moreover, the ECM components produced during the various 
vasculopathies modify the behaviour of the vascular cells in 
the matrix.
The results of the present study support the hypothesis that 
in the exfoliative iris the pathogenesis of exfoliation 
syndrome is associated with disordered synthesis and/or 
assembly and turnover of the vascular ECM. It is tempting to 
speculate whether exfoliation material synthesis is 
associated with similar ECM changes in other ocular and 
extraocular tissues. Given that there is, as yet, no 
consensus on the primary site(s) of exfoliation material 
synthesis, immunocytochemical studies on other ocular tissues 
bathed by the aqueous humour and other ocular tissues not in 
contact with the aqueous humour may assist in the elucidation 
of exfoliation material synthesis.
In conclusion, the investigation of iris vasculopathy in 
exfoliation glaucoma and its precursor the exfoliation 
syndrome, is complicated by the extensive range of vascular 
abnormalities witnessed within single specimens. The results 
of the present study indicate that specific ECM alterations 
may occur in the iris vasculature during the evolution of the 
disease. These findings highlight the enigmatic nature and 
pathogenesis of the disorder.
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7.4 Summary
Samples of control iris tissue obtained from 12 enucleated 
eyes and 15 exfoliative iridectomy specimens were prepared 
for an immunocytochemical study of the matrix of the walls of 
iris vessels. The distribution of collagen types I, IV and 
laminin was studied in normal and exfoliative vessels.
Laminin was an integral component of exfoliation material and 
was present mainly in the matrix of the outer surface of 
normal vascular supporting cells. The laminin content in the 
latter location was reduced in vessels in which exfoliation 
aggregates were not visible. The iris vascular supporting 
cells, which produce laminin are implicated in the synthesis 
of exfoliation material. Exfoliation deposits appeared to 
stimulate the synthesis, or impair the resorption of collagen 
types I and IV at an early stage of the disease. In an 
advanced stage of exfoliation vasculopathy (thinning of 
vascular matrix, degeneration of cellular elements) a 
significant reduction of collagen types I and IV was noted.
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PART II CLINICAL STUDIES ON THE EXFOLIATION SYNDROME AND 
OPEN ANGLE GLAUCOMA
CHAPTER 8 PLAN OF PROPOSED CLINICAL INVESTIGATION
8.1 Exfoliation glaucoma in a group of Scottish surgical 
patients
The first clinical study of part II is an attempt to 
determine the prevalence, diagnostic features and response to 
trabeculectomy in exfoliation glaucoma. The rationale for 
this investigation is highlighted in sections 1.12 & 10.1.
One hundred consecutive Scottish patients requiring 
trabeculectomy for open angle glaucoma (exfoliation glaucoma 
and POAG) were prospectively investigated (selection of 
patients and methods are discussed in section 9.1). Thirty- 
one consecutive patients with closed angle glaucoma were used 
as controls to determine whether the presence of exfoliation 
material is linked to the development of open angle glaucoma 
or represents a coincidental feature (discussed in section 
10.3). All patients were comprehensively examined (section 
9.1.2) by the author for the presence of the well known 
exfoliation and pigmentary signs (described in sections 1.7, 
1.8 & 1.9) .
Following surgery all peripheral iridectomy specimens were 
collected, fixed in buffered glutaraldehyde and processed 
through araldite for light and electron microscopy (see 
sections 3.2.2 and 9.1.2). Examination of the iris biopsies 
were carried out to provide the most accurate prevalence
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figure before delineating the clinical features of 
exfoliation glaucoma and POAG in the studied group (reasons 
outlined in section 10.3). In addition, iris biopsy allowed 
determination of the accuracy of clinical observations 
(section 10.2.5). The aims of the first clinical study are:
(1) To determine the prevalence of exfoliation glaucoma in a 
Scottish surgical population and assess the optimal 
diagnostic features in such patients.
(2) To highlight important clinical differences between 
exfoliation glaucoma and POAG.
(3) To compare and contrast the surgical complications and 
IOP response after trabeculectomy in patients with 
exfoliation glaucoma and POAG.
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8.2 Modification of trabeculectomy to avoid postoperative 
hyphaema
The second clinical study of part II aims at determining the 
influence of the position of a trabeculectomy fistula on the 
rate of postoperative hyphaema in a group of open angle 
glaucoma (exfoliation glaucoma and POAG) patients undergoing 
trabeculectomy. The rationale for this investigation is 
discussed in sections 11.1 & 11.3. Seventy-eight patients 
with either exfoliation glaucoma or POAG were randomised into 
two groups and examined by the author in a manner outlined in 
section 9.2. The principal aims of this study are given 
below:
(1) To investigate whether varying the size and site of the 
fistula in a trabeculectomy affects the postoperative 
rate of hyphaema and the subsequent duration of 
hospitalisation.
(2) To establish whether exfoliation glaucoma patients 
exhibit a higher incidence of postoperative hyphaema in 
comparison with POAG patients.
(3) To determine whether the type of surgery performed 
influences the final surgical outcome.
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CHAPTER 9 PATIENTS AND METHODS FOR PART II
9.1 Exfoliation glaucoma in a group of Scottish surgical 
patients
9.1.1 Patients and control subjects
Selection criteria
Consecutive phakic patients deemed to warrant trabeculectomy 
for open angle glaucoma and admitted to the Tennent Institute 
between September 1989 and February 1991 were recruited to 
this study, which investigated the prevalence and clinical 
attributes of exfoliation glaucoma. Patients were enrolled 
if they were white Caucasian and born and residing in the 
Greater Glasgow area. Data concerning one eye of each of 100 
patients operated on for POAG, or exfoliation glaucoma were 
entered in this study. Patients undergoing bilateral 
trabeculectomy had their first eye to be operated upon 
selected (23 cases). All degrees of severity of glaucoma 
were included in the present study.
Patients with closed angle glaucoma, secondary glaucoma, 
previous ocular surgery, concurrent ocular inflammation, 
diabetes mellitus and eyes with previous trabeculectomy 
procedure were excluded. Three patients who underwent 
trabeculectomy for open angle glaucoma during the course of 
this study were also excluded for other reasons, such as loss 
of the peripheral iridectomy specimen (2 cases) and poor 
state of general health hindering proper assessment (1 case).
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A second clinical study, which investigated the prevalence of 
postoperative hyphaema in patients with POAG and exfoliation 
glaucoma, following two methods of surgical dissection 
(section 9.2) was carried out. Seventy-two out of the 100 
patients enrolled in the first study were also included in 
this investigation.
Clinical and morphological classification
Following detailed clinical examination, seeking the signs 
listed in section 1.7, patients were allocated to one of 
three groups:
Group I (definite exfoliation glaucoma)
A diagnosis of exfoliation glaucoma was made if exfoliation 
material was present upon the pupillary margin, or on the 
lens surface.
Group II (possible exfoliation glaucoma)
Patients were categorised into this group if they exhibited 
pigment related signs and/or exfoliation syndrome/glaucoma in 
the other eye, (in the absence of biomicroscopical evidence 
of exfoliation material). The inclusion criteria for this 
group are shown in Table 9.1.
Group III (POAG, no evidence for exfoliation)
This group of patients consisted of all open angle glaucoma 
patients clinically assessed as having POAG and no signs 
commensurate with possible exfoliation glaucoma.
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TABLE 9.1 INCLUSION CRITERIA FOR GROUP II
Loss of the pupillary ruff (>90‘)
Pigment deposits upon the iris and/or the corneal endothelium 
Moderate to dense pigmentation in the angle (2+ plus)
Presence of Sampaolesi's line in the angle 
Exfoliation syndrome/glaucoma in the other eye
Light microscopy (LM) and transmission electron microscopy 
(TEM) provided a definitive diagnosis of the presence or 
absence of exfoliation material in all cases (see also 
section 3.2.2). Patients from groups I, II and III were 
classified morphologically into two final groups. They 
comprised exfoliation glaucoma patients (group A) and POAG 
patients (group B).
The determination of the definitive diagnosis allowed: 1) 
calculation of the diagnostic sensitivity, specificity and 
predictive value of the classic clinical features. 2) 
accurate delineation of the overall clinical characteristics 
of exfoliation glaucoma patients, in order to compare them 
with those of POAG patients in whom the diagnosis has been 
established without doubt (group B).
Closed angle glaucoma controls
Controls for the presence and role of exfoliation in the open 
angle glaucoma population comprised 31 consecutive patients 
who underwent trabeculectomy for acute, or chronic primary 
closed angle glaucoma. These patients had been admitted to 
the Tennent Institute during the course of this study. Only 
patients with primary closed angle glaucoma secondary to 
pupillary block were enrolled in the control group. These 
patients underwent a detailed clinical examination for the 
presence of exfoliation material, in a comparable way with 
that for the open angle glaucoma group, but only underwent 
pupillary dilatation postoperatively in order to complete the 
clinical examination to exclude concomitant exfoliation.
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Open angle
glaucoma
group
Closed angle
control
group
CONTROLS
N-31
Exfoliation No Exfoliation 
N-1 N-30
Exfoliation No Exfoliation 
N-1 N-30
Group A 
exfoliation 
glaucoma N-26
Group B 
POAG N-74
OAG GROUP 
N-100
Figure 9.1: Flow chart indicating the research methodology 
followed in the exfoliation glaucoma study.
9.1.2 Methods
Preliminary data collection
Patient details were recorded on a study card, which was used 
to store and analyse the information obtained. All patients 
were given a serial code number preoperatively. The 
following information was recorded on the study card: sex, 
age, systemic disorders, other ophthalmic conditions, 
presenting clinical feature (screening, visual symptoms- 
vision/field loss- and pain) and details of glaucoma at time 
of diagnosis (IOP without treatment, cup to disc ratio and 
visual field). The same glaucoma details at the time of 
listing for surgery (including the IOP on medical therapy) 
were recorded together with the time from diagnosis to 
operation (in months). A detailed search of the case notes 
was conducted to identify whether the diagnosis 'exfoliation 
glaucoma' had been made prior to the admission of the patient 
to the hospital.
Indication for surgery
Patients were classified as follows: those who underwent 
primary trabeculectomy and individuals who were operated upon 
following failed medical therapy. For the purposes of the 
present study the term primary trabeculectomy refers to a 
decision for surgical intervention at the time of diagnosis 
of glaucoma. Any attempts to control the glaucoma medically, 
with one, or multiple medications, prior to filtration 
surgery were classified into the failed medical therapy 
group. The specific indication(s) for surgery in the group 
of patients who were operated upon because of failed medical
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treatment were: 1) uncontrolled IOP, 2) progression of visual 
field loss, 3) uncontrolled IOP and progression of visual 
field loss, 4) intolerance/side effects to medications and 5) 
poor compliance. The failed medical regime at the time of 
listing for surgery was recorded for every patient.
Visual field grading
The visual field loss in this study was graded according to 
the classification by Jay and Murray (1988). Briefly, visual 
field changes were classified in 5 stages: early relative 
defects (stage 1)? absolute defects outside 10 degrees of 
fixation in all quadrants (stage 2); encroaching between 10° 
and 5° from fixation in one to four quadrants (stage 3)? 
within 5° of fixation 1-3 quadrants (stage 4); and within 5° 
of fixation in all quadrants (stage 5).
Ethnic origin
An attempt was made to identify the geographic region of 
the parents and grandparents of each patient. Particular 
attention was paid to recent Irish and English ancestry.
Examination for exfoliation
All patients with open angle glaucoma were examined by the 
author on a Haag-Streit 900 Slit Lamp in a dark room for the 
presence of exfoliation, before and after pupillary 
dilatation with two drops of tropicamide 1%. Control 
subjects with primary closed angle glaucoma were examined as 
above but in these patients pupillary dilatation was only 
employed after filtration surgery.
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The biomicroscopic examination was conducted according to a 
standard protocol: first, the corneal endothelium was 
examined for the presence of pigment, exfoliation material 
and Sampaolesi's line. The anterior surface of the iris was 
inspected for the presence of pigmentary dust, the 6 o' clock 
pigmentary sign, new vessels and exfoliation material. The 
degree and localisation of pupillary and peripupillary iris 
atrophy was recorded in all cases. The presence, or absence 
of a relative afferent pupillary defect was noted together 
with the presence of iridodonesis, phakodonesis, or lens 
subluxation. All but twelve patients were gonioscopically 
examined (Goldmann gonioscope) for the presence of pigmentary 
signs consistent with exfoliation glaucoma. In these 12 
unselected patients gonioscopy was not possible. Iris tissue 
from these 12 patients was submitted for LM and TEM 
assessment. Gonioscopic findings recorded in 88 patients 
included the presence of Sampaolesi's line, degree of 
pigmentation of the angle (1+ to 4+ according to Konstas & 
Dutton 1991), visible exfoliation material and angle depth.
Morphological examination
The protocol of morphological examination and the range of 
pathological changes is described in detail in sections 3.2 & 
4.3. Following morphological assessment, exfoliation 
positive patients were categorised in Group A and 
exfoliation negative patients were included in group B.
Group I patients
Patients for whom the diagnosis of exfoliation glaucoma had 
been established underwent a detailed biomicroscopical
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examination of the anterior segment to delineate the 
appearance and the distribution of exfoliation material and 
pigmentary signs in the anterior segment. Transillumination 
defects were drawn on their clinical cards. A drawing of the 
distribution of pigmentation and exfoliation material was 
made in every case. Particular attention was paid to the 
configuration of the exfoliation material deposited upon the 
lens (appearance of the central disc, intermediate zone, 
granular zone? peeling off? rolled off edge? bridges between 
the central disc and the granular zone) when pupillary 
dilatation was sufficient. The fellow eye in exfoliation 
glaucoma patients, was also examined. Any other ocular 
abnormalities were also recorded. Anterior segment 
photography was carried out when possible preoperatively.
The majority of eyes were photographed postoperatively.
Group II
Possible exfoliation glaucoma patients were clinically 
identified according to the criteria described in Table 9.1. 
Suspicion of exfoliation was often raised because of the 
presence of pupillary ruff loss, subtle pigment deposits, or 
radial striations upon the lens surface. These features are 
consistent with the appearance of 'early disease' and have 
been described in sections 1.7 & 1.8. All iris specimens 
from these eyes were examined by LM and TEM to confirm, or 
disprove the presumed clinical diagnosis. To allow unbiased 
assessment all iridectomy specimens were coded.
Group III
Open angle glaucoma cases without evidence for exfoliation
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glaucoma were categorised in group III. A flow chart of the 
classification and examination process is shown in Figure 9.1
Closed angle glaucoma controls
Following the clinical examination, morphology was used to 
confirm the absence of exfoliation material from the 31 
control subjects with closed angle glaucoma (Fig 9.1).
Surgical technique
In the present study, each participating surgeon followed his 
own approach for the preparation of the conjunctival and 
scleral flap. The dissection of the inner block was 
randomised in 72 patients for the benefit of the second 
protocol (section 9.2). The first group of patients 
underwent a modification of the trabeculectomy method 
described by Cairns (1968) with the inner block located 
entirely in corneal tissue. The second group had a 
conventional inner block fashioned according to the method 
described by Watson (1970).
The operations were performed under local, or general 
anaesthesia depending on the choice of the surgeon and the 
patient. Approximately three quarters of the operations were 
performed under local anaesthesia. A facial nerve block with 
a mixture of Lignocaine 1% and bupivacaine 0.5% was used for 
lid akinesia during surgery. Subconjunctival injection of 
0.5 cm3 of Lignocaine 1% was employed in a number of cases to 
aid the dissection of the conjunctival flap. Retrobulbar or 
peribulbar anaesthesia was not used in most cases.
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Following the insertion of a superior rectus suture, a 
fornix-based flap of conjunctiva and Tenon's capsule was 
reflected. A rectangular, or triangular outer scleral flap 
(half to two-thirds of the scleral thickness) was outlined 
measuring between 2.5x3 mm and 4x4 mm (depending on the 
surgeon). This flap was incised initially along the 
posterior incision which lies 2.5-4 mm posterior to the 
limbus. The edges of this flap were not extended into the 
cornea beyond the limbus. A small square measuring between 
0.5x0.5 mm to 2.5x2 mm, (depending on the surgeon), was 
fashioned in the bed of the outer scleral flap. Anterior 
incision of the deep block was accomplished by two radial 
incisions at full thickness and the excision of the inner 
block was completed with straight Vannas scissors.
A peripheral iridectomy was performed in all cases by 
grasping the iris in its centre with a pair of Hoskin forceps 
and cutting it with DeWecker's scissors. The peripheral 
iridectomy specimen thus obtained was fixed immediately in 
buffered glutaraldehyde 2.5%. The superficial flap was 
sutured with one to three 10-0 nylon, or 8-0 vicryl sutures. 
The conjunctiva was closed with continuous, or interrupted 
sutures.
Postoperative assessment
Peroperative details and complications were recorded from the 
patients notes. During the immediate postoperative period, 
patients were treated with topical steroids and antibiotics 
4-6 times a day and examined every day on the ward.
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Postoperative complications sought during the hospitalisation 
period included: hyphaema, uveitis, fibrinous reaction in the 
anterior chamber, flat/shallow anterior chamber and raised 
IOP. Following the discharge of the patient the final follow 
up data were obtained from the patients notes approximately 6 
months after surgery. Possible elevation of the IOP due to 
steroid reaction was recorded. All postoperative IOP values 
were recorded but only the untreated IOP, (a minimum of two 
weeks after cessation of drops), at approximately 6 months 
after surgery was used to determine the final outcome of 
surgery. Other complications including visual symptoms and 
surgical development of lens opacities were documented as 
were the indication for and nature of supplementary medical 
therapy.
Analysis of data
The prevalence of exfoliation in the open angle glaucoma 
group was compared with that of the closed angle glaucoma 
controls. All main features of groups A and B (exfoliation 
glaucoma and POAG group as determined by clinical and 
morphological assessment) were compared at diagnosis, time of 
listing for surgery, postoperatively and at the final follow 
up time (approximately 6 months after filtration surgery).
Parameters analysed for the two groups included age, sex, 
systemic diseases and cause of diagnosis (screening, visual 
loss). Glaucoma variables that were examined comprised:
1) the IOP at presentation (highest untreated value in mm 
Hg), the cup to disc ratio and visual field loss, 2) the 
duration of treatment before surgery, 3) the treated IOP at
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the time of listing for surgery, 4) the cup to disc ratio and 
visual field loss 5) the indications for surgery, 6) the 
number of topical medications at time of listing and 7) the 
use of acetazolamide. Data for IOP was assigned into 
exposure levels. Three IOP gradings were analysed: 22-26 mm 
Hg, greater than 26 mm Hg and greater than 30 mm Hg.
Age and IOP matched subgroups
Two subgroups of patients were formed by exclusion of the 
higher and lower values for age in groups A and B in order to 
facilitate age-matched comparisons. These subgroups 
comprised 23 patients with exfoliation glaucoma and 57 
patients with POAG matched for age: mean 71.9 and 70.9 years 
respectively (t-test p=0.54). In addition, comparisons were 
made between 20 exfoliation glaucoma patients and 20 POAG 
patients randomly selected and matched for age and untreated 
IOP at diagnosis. Finally, the 14 TEM exfoliation-negative 
patients from group II were compared and contrasted with 
glaucoma groups A and B (minus these 14 cases).
Sensitivity, specificity and predictive value
The accuracy of all clinical observations was estimated by 
calculating the sensitivity, specificity and predictive value 
for each clinical sign. The efficiency of any diagnostic 
sign may be assessed by determining the rates of true/false 
positive and true/negative results, which were defined by 
Chard (1988) as follows:
(1) True positive (TP): the result is positive, (exfoliation 
material was present morphologically), in the presence of the 
clinical sign in question.
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(2) True negative (TN): the result is negative, (i.e. no 
exfoliation material detected on morphological examination) 
in the absence of the clinical sign in question.
(3) False positive (FP): the result is positive, (exfoliation 
material was present morphologically), in the absence of the 
clinical sign.
(4) False negative (FN): the result is negative (no 
exfoliation material detected morphologically), in the 
presence of the clinical abnormality.
For the purposes of this study, the sensitivity of each 
clinical sign was defined as an index of the ratio of all 
cases exhibiting exfoliation material morphologically (group 
A) correctly identified by the clinical sign. Specificity 
was defined as an index of the proportion of all patients in 
whom the absence of the exfoliation was accurately 
identified. Predictive value was defined as an index of the 
proportion of all cases who had exfoliation glaucoma 
identified by each clinical feature and those who actually 
have the condition (as determined by morphology). The 
formulae of calculation of these efficiency indices, as 
defined by Chard (1988), were as follows:
1) Sensitivity= TP/TP+FN?
2) Secificity= TN/TN+FP?
3) Predictive Value= TP/TP+FP
These values have been calculated for all clinical signs 
(exfoliation and pigmentary signs), which are relevant to the 
detection of patients with exfoliation glaucoma. Statistical 
analyses were performed with the Minitab software package. 
Differences between the groups were analysed by the two-
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sample t-test, the chi-squared test, analysis of variance and 
non-parametric tests (Mann-Whitney U test and the Wilcoxon 
matched-pairs test) where appropriate. 'p' values of 0.05 or 
less were considered to be significant.
9.2 Modification of trabeculectomy to avoid postoperative 
hyphaema. The guarded anterior fistula operation
9.2.1 Patients
Selection criteria
A randomised prospective trial was set up to study first 
trabeculectomies for POAG and exfoliation glaucoma. One eye 
of 78 consecutive patients operated on between October 1989 
and November 1990 was randomly allocated to either group A, 
or group B using a table of random numbers. Seventy-two 
patients for this group were also included in the first 
clinical study (exfoliation glaucoma in a Scottish surgical 
cohort). The allocation was identified from the code by the 
senior operating theatre nurse at the start of the operation 
and all 13 surgeons in the Tennent Institute of Ophthalmology 
participated.
Group A had the inner block fashioned and excised entirely 
anterior to the scleral spur so that only corneal tissue was 
excised (Fig 9.2). Group B had a conventional inner block of 
corneoscleral tissue extending posterior to the scleral spur 
with the trabecular meshwork near the centre of the excised 
tissue (Fig 9.2), (Watson 1970). Nine additional patients 
with POAG who underwent a trabeculectomy during the course of
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the trial were excluded. The reasons for this were failure 
to allocate a randomisation in 2 cases, reluctance of the 
surgeon to take part (4 cases), other research requirements 
(3 cases). All degrees of severity of glaucoma were included 
in the present study, irrespective of level of IOP, visual 
field loss, optic disc cupping or duration of medical 
treatment. Patients with closed angle glaucoma, secondary 
glaucomas, previous ocular surgery and concurrent ocular 
inflammation were excluded. Patients undergoing combined 
extracapsular cataract extraction and trabeculectomy (18 
cases) were also excluded from this study.
9.2.2 Methods
Data recorded
All patients were examined preoperatively by the author 
according to a predetermined protocol. The following 
information was recorded: sex, age, diabetes mellitus, 
arterial hypertension, haematological disorders, reason for 
diagnosis and details of glaucoma at time of diagnosis (IOP 
without treatment, cup to disc ratio and visual field). The 
same glaucoma details as described in section 9.1.2 were 
recorded together with the time from diagnosis to operation. 
The indication for surgery (uncontrolled IOP, progression of 
visual field loss, both, intolerance to medications and poor 
compliance) was also noted. The visual field loss was graded 
according to the classification by Jay and Murray (1988).
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Surgical technique
The operations were performed under local, or general 
anaesthesia. Following the insertion of a superior rectus 
suture, a flap of conjunctiva and Tenon's capsule was 
reflected as shown in Fig 9.2. A rectangular or triangular 
outer scleral flap was fashioned as described in section 
9.1.2. The edges of this flap were not extended into the 
cornea beyond the limbus. The inner block was dissected as 
described above according to the random allocation. A 
peripheral iridectomy was performed in all cases and the 
superficial flap was sutured with one to three sutures. The 
conjunctiva was closed with continuous or interrupted 
sutures. Viscoelastic substances were not used.
To ascertain the accuracy of dissection with respect to the 
scleral spur each surgical specimen was fixed immediately 
after excision in buffered glutaraldehyde (2.5%). The 
dimensions of the excised tissue were recorded and all 
specimens were examined with a dissecting microscope at a x50 
magnification. Where doubt persisted as to the location of 
the dissected block, paraffin histology was used for 
confirmation (courtesy of Prof W.R. Lee). Similar 
histological confirmation was carried out in a random 25% 
sample of all specimens. If any part of the scleral spur, or 
a portion of trabecular meshwork was found in the specimens 
from group A, the case was reclassified as group B (posterior 
dissection). Similarly, inability to demonstrate anatomical 
structures consistent with the excision of a posterior block 
(scleral spur, part of the outflow system) in a specimen from 
group B led to its transfer to group A. The name of the
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Figure 9.2: Schematic drawing of the area of tissue excised 
with the two methods of surgical dissection in 
the second study. In group A the dissection was 
anterior to the scleral spur and included only 
corneal tissue. Group B had excision of corneal 
and scleral tissue incorporating scleral spur 
and trabecular meshwork.
surgeon was recorded together with his comments as to whether 
there had been bleeding into the anterior chamber.
Postoperative follow-up
The following postoperative information was recorded: depth 
of the anterior chamber? hyphaema (grade 1-diffuse without 
formation of blood level; grade 2.-up to 1 mm? grade 2-more 
than 1 mm), blood clot and other problems. The duration of 
hyphaema and hospitalisation were noted. Patient details 
were recorded three to seven days after discharge and again 
about six to eight weeks later. The final assessment was 
made approximately four months after the operation. The IOP 
was recorded after exclusion of possible steroid response at 
least two weeks after discontinuation of steroid eye drops 
(Thomas & Jay 1988) and without supplementary medical 
treatment. The reason for commencing any supplementary 
medical treatment after the operation was also recorded.
The results for the whole population were analysed first? 
subsequent separate analysis for the results for those 
patients with exfoliation glaucoma was also undertaken. 
Differences between the groups were analysed in a similar 
fashion to the exfoliation glaucoma study (9.1.2).
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CHAPTER 10 EXFOLIATION GLAUCOMA IN A GROUP OF SCOTTISH 
SURGICAL PATIENTS. RESULTS AND DISCUSSION
10.1 Introduction
There are many unresolved questions concerning the clinical 
features of exfoliation glaucoma and its relationship to 
POAG. Most authors, interpreting clinical (Gillies 1972, 
Olivius & Polland 1980, Sugar 1984, Bertelsen 1985) and 
morphological (Rohen & Witmer 1972, Rohen 1983, Lutjen- 
Drecoll et al 1986) evidence believe that exfoliation 
glaucoma is a secondary open angle glaucoma, which differs 
from POAG. Others disagree believing that the entity 
'exfoliation glaucoma' is merely a form of POAG (Tarkkanen 
1984, Wollensak et al 1992).
The reported prevalence of exfoliation glaucoma within an 
open angle glaucoma population has varied from 0% to 79% 
(Leydhecker 1960, Aasved et al 1969, Blika & Ringvold 1987, 
Forsius 1988, Ringvold et al 1988, Konstas 1989) and remains 
a topic of controversy (for example Aasved 1969, Cashwell & 
Shields 1988; see also section 1.6). In addition, some 
authors have indicated that exfoliation glaucoma carries a 
worse prognosis than POAG, irrespective of treatment (Aasved 
1971, Olivius & Thorburn 1978, Pohjanpelto 1985, Gloor & 
Robert 1989). These studies, however, are retrospective in 
nature and often inconclusive. Much of the controversy on 
the prevalence, attributes and prognosis of the disorder 
arises from the difficulty in establishing an unequivocal 
clinical diagnosis (Mizuno & Muroi 1979, Jerndal 1986).
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On cursory examination of the eye the diagnosis may be missed 
(Tarkkanen 1984, Jerndal 1985, Prince & Ritch 1986 and 
section 1.7) and several reports suggest that the prevalence 
of the disorder is underestimated (Layden & Shaffer 1974, 
Layden 1982, Forsius 1988).
Electron microscopic examination of tissue biopsies can 
identify exfoliation material in cases where it is not 
detectable by clinical examination (Speakman & Ghosh 1976, 
Prince et al 1987, Sugino 1990) . It has also been shown that 
a significant number of 'suspect' cases can be confirmed if 
electron microscopic examination of conjunctival biopsies is 
employed (Prince et al 1987). A number of clinical signs of 
disordered pigmentation in the anterior segment of the eye 
(see section 1.7.3) may assist in establishing the diagnosis 
in 'suspect' cases (Layden & Shaffer 1973, Jerndal 1986, 
Konstas & Dutton 1991) but, the specificity and sensitivity 
of these features is unknown.
To date, all comparative information about exfoliation 
glaucoma and POAG in surgical patients is retrospective 
(Jerndal & Kriisa 1974, Jerndal & Lundstrom 1977, Sziklai & 
Suveges 1988, Konstas & Allan 1989). Therefore, a 
prospective comparative study of Scottish patients with 
disease severe enough to require trabeculectomy was designed.
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10.2 Results
10.2.1 Prevalence
Open angle glaucoma
One hundred consecutive patients with open angle glaucoma 
were prospectively examined by the author in this study.
Group I
Prior to this investigation, 19 out of these 100 surgical 
patients (19%) had been diagnosed as suffering from 
exfoliation glaucoma, whereas the remaining 81 patients had 
been considered to suffer from POAG. Clinical examination 
performed by the author upon the total glaucoma population on 
the day of admission confirmed the diagnosis in all 19 
patients previously considered to suffer from exfoliation 
glaucoma. In addition, 3 patients, in whom exfoliation 
glaucoma had previously been undiagnosed, were detected.
In one of these three cases the central disc of exfoliation 
material deposit on the lens was not visible on slit-lamp 
examination, but the granular zone was. Therefore the 
corrected clinical prevalence of exfoliation glaucoma in the 
total open angle glaucoma population under investigation was 
22%. Light and electron microscopic assessment (section 9.1) 
confirmed the clinical diagnosis by identifying exfoliation 
material in the iris of these patients.
Group II
This group (see Table 10.1) consisted of 18 patients who 
demonstrated pigmentary signs on biomicroscopic, or
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gonioscopic examination (16 cases), and/or exfoliation 
glaucoma in the other eye (2 cases). Ultrastructural 
assessment (LM and TEM) of iris tissue from all 18 possible 
exfoliation patients identified exfoliation material in the 
iris of 4 patients (22%).
Group III
Clinical examination identified 60 POAG patients without 
biomicroscopic, or gonioscopic evidence of exfoliation 
glaucoma. In none of these 60 iris biopsies was exfoliation 
material present on pathological examination.
Closed angle glaucoma (control subjects)
There were 31 control patients, 15 with acute closed angle 
glaucoma and 16 with chronic closed angle glaucoma. Only one 
control subject exhibited clinical and morphological evidence 
of exfoliation (3.2%). Exfoliation material was 
significantly more common in the open angle glaucoma group 
than in the closed angle glaucoma group (x2 test,
0.01>p>0.001).
10.2.2 Clinical features
The mean age of the exfoliation glaucoma group, 73.3 years 
(S.D., 7.3), was significantly higher than the mean age of 
the POAG group, mean 66.7 years (S.D., 10.3), (t-test, 
p<0.001). To ensure that the differences reported are not 
due to age, comparisons between exfoliation glaucoma and POAG 
patients were made after age matching (section 9.1.2). Where 
clinically relevant, groups A and B were also compared.
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TABLE 10.1 SPECIFIC DIAGNOSTIC CRITERIA FOR GROUP II
No AGE SEX PRL OTHER CLINICAL SIGNS GONIOSCOPY MORPHOLOGY
1 64 M >180° iris pigm pigm 2+ SPL exf +
2 70 F >180° corneal pigm; exf other eye pigm 3+ SPL exf +
3 71 F 360° iris pigm pigm 3+ exf +
4 69 M 360° exf other eye pigm 3+ SPL exf +
5 83 F >180° - pigm 2+ exf -
6 80 M >180° - pigm 2+ exf -
7 73 F 360° - pigm 1+ exf -
8 81 M 360° corneal pigm; PCL pigm 2 + exf -
9 74 M >180° iris pigm pigm 2 + exf -
10 75 M >180° iris pigm pigm 3 + SPL exf -
11 68 M 360° lens pigm pigm 2 + exf -
12 60 M 120" lens pigm; lens striae pigm 2 + exf -
13 65 M >90° - pigm 1+ exf -
14 68 M 360° - pigm 1+ exf -
15 70 M >180° iris pigm; lens pigm pigm 2 + exf -
16 75 F >180° corneal pigm pigm 1+ exf -
17 77 M >90° - pigm 1+ exf -
18 71 F >180° — pigm 2+ exf “
Keys PRL: pupillary ruff loss in degrees; M: male; F: female; pigm: 
pigmentation; exf: exfoliation; PCL: precapsular layer of the lens; SPL: 
Sampaolesi's line.
Fig 10.1: This table shows the clinical signs of each
patient in group H (possible exfoliation glaucoma).
No difference was observed between groups A and B and age 
matched exfoliation glaucoma and POAG patients for sex and 
systemic diseases: arterial hypertension,(x2 test p>0.80), 
cardiovascular disorders, (test p>0.20), and respiratory 
conditions (p>0.10). With regard to other ophthalmic 
conditions one patient with exfoliation glaucoma had Fuchs' 
heterochromic cyclitis.
A positive family history of glaucoma was established in one 
out of the 26 patients with exfoliation glaucoma and in 14 
out of the 74 patients with POAG (x2 test, 0.10>p>0.05).
With regard to ethnic origin, it is difficult to draw 
conclusions in the West of Scotland since there is a mixture 
of Scottish and Irish ancestry. Nevertheless, in group A 
(exfoliation glaucoma group) 6 patients gave a recent history 
of Irish and one of Greek ancestry (i.e. parents, or grand­
parents born in Ireland, or Greece). In the POAG group six 
patients gave a recent history of Irish and one of English 
ancestry. Recent Irish ancestry was more common in the 
exfoliation glaucoma group (0.05>p>0.02). No apparent 
difference was observed in the incidence of bilateral 
glaucoma in groups A and B. Twenty-one out of the 26 
patients with exfoliation glaucoma and 56 out of 74 patients 
with POAG had bilateral glaucoma (p>0.80).
The presenting clinical features (screening, visual symptoms, 
pain) were analysed prior and subsequent to age-matching. In 
3 out of the 26 patients from group A the cause of diagnosis 
was loss of vision in the other eye caused by exfoliation 
glaucoma in two cases and central retinal vein occlusion in
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the eye of one patient with untreated exfoliation glaucoma. 
Patients with exfoliation glaucoma were diagnosed more 
frequently because of visual symptoms (x2 test, p<0.001 prior 
to age matching? p<0.01 after age matching). In contrast, 
POAG patients were more often detected due to screening 
performed by opticians (p<0.001). However, when exfoliation 
glaucoma and POAG patients were matched for age and IOP 
the difference concerning visual symptoms disappeared.
The untreated IOP at diagnosis in exfoliation glaucoma, 36 mm 
Hg (S.D., 8.5), was significantly higher than that of group 
B, 29.6 mm Hg (S.D., 6.2), (t-test, p=0.0012). The 
difference between the two groups persisted at various levels 
of IOP (higher than 26 mm Hg group, p=0.014? higher than 30 
mm Hg, p=0.038). After age matching, the difference between 
exfoliation glaucoma and POAG patients concerning the IOP at 
presentation remained significant: 36.7 mm Hg (S.D., 8.6) in 
exfoliation glaucoma, compared to 29.0 mm Hg (S.D., 5.7) for 
POAG, (p<0.001). Age-matched exfoliation glaucoma patients 
exhibited a higher untreated IOP at presentation for various 
levels of IOP (higher than 26 mm Hg, p=0.021? higher than 30 
mm Hg, p=0.04). There was no difference between males and 
females in each of the glaucoma groups. When age matched 
male and female patients with exfoliation glaucoma were 
compared separately with their POAG counterparts, a higher 
IOP at diagnosis was found for both male (p=0.028) and female 
(p=0.006) exfoliation glaucoma patients.
At the time of listing for surgery, the mean treated IOP of 
age matched exfoliation glaucoma patients, 34.2 mm Hg (S.D.
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12.5) was significantly higher than the mean treated IOP for 
comparable POAG patients, 24.6 mm Hg (S.D., 6.1), (t-test, p= 
0.002). No difference for sex was observed in each group. 
Following age and IOP matching, the IOP at the time of 
listing for surgery was found to be higher in the exfoliation 
glaucoma group, mean 34.2 mm Hg (S.D., 10.3) compared with 
28.2 mm Hg (S.D., 7.0) in the POAG group.
Age matched exfoliation glaucoma patients were treated 
medically prior to surgery for a significantly shorter 
period, mean 8.4 months (S.D., 8.3), compared with POAG 
patients, mean 39.1 months (S.D., 45.0), (t-test, p<0.001). 
However, when the two glaucoma groups were matched for age 
and IOP at diagnosis the difference in the duration of 
medical therapy was not significant (p=0.08)
The visual field loss at presentation was analysed for the 
whole group and in stages? prior to and following age and IOP 
matching. There was no difference at diagnosis, or at the 
time of listing for surgery in the degree of visual field 
loss between groups A and B and between age matched 
exfoliation glaucoma and POAG patients (p>0.20). Similarly, 
no apparent difference was observed following matching for 
age and IOP at presentation. When the two age matched 
glaucoma groups were compared with regard to progression of 
visual field loss from the time of diagnosis to the time of 
listing for surgery only eyes with POAG exhibited significant 
deterioration (0.02<p<0.05). No difference was observed at 
diagnosis and at the time of listing for surgery in the cup 
to disc ratio for the two glaucomas before and subsequent to
204
age matching and following matching for age and IOP at 
diagnosis (p>0.40).
A comparison of the indications for surgery for groups A and 
B is shown in Table 10.2. Two patients from each group 
refused primary trabeculectomy. A larger proportion of 
patients with exfoliation glaucoma had undergone primary 
trabeculectomy, (0.05>p>0.02). Once suitably matched for age 
the difference concerning primary trabeculectomy was not 
significant (0.10>p>0.05).
In the failed medical therapy group, exfoliation glaucoma 
patients were more often operated upon due to unacceptably 
high IOP (t-test, 0.05>p>0.02 prior to age matching? p<0.01 
after age matching). Subsequent to age and IOP matching 
the rate of primary trabeculectomy and the frequency of 
surgery due to unacceptably high IOP were similar in the two 
glaucomas. Progressive loss of visual field without 
recognised high IOP was more frequent in POAG than in 
exfoliation glaucoma patients (Table 10.2), (p<0.01 before 
and after age matching).
No difference was noted between the two age matched groups in 
the rate of poor compliance (0.10>p>0.05) and intolerance to 
antiglaucoma medications (p>0.30). The medications used by 
the group of patients operated upon following unsuccessful 
medical therapy were further analysed. Exfoliation glaucoma 
patients were using acetazolamide (p<0.001) and a combination 
of three medications (p<0.001) more often than their age 
matched POAG counterparts. One patient with exfoliation
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TABLE 10.2 INDICATIONS FOR FILTRATION SURGERY
INDICATION FOR SURGERY GROUP A (EXG) GROUP B (POAG)
Primary trabeculectomy 9 11
railed medical therapy 17 63
-due to raised IOP 9 17
-due to loss of VF 2 21
-due to raised IOP and VF loss 3 11
-and/or intolerance to medical Rx 5 14
-and/or poor compliance 5 7
Keys VF: visual field; IOP: intraocular pressure; Rx: therapy; EXG: 
exfoliation glaucoma; POAG: primary open angle glaucoma.
The indications for filtration surgery are shown 
for all patients in the exfoliation glaucoma study.
TABLE 10.3 GONIOSCOPIC FINDINGS IN OPEN ANGLE GLAUCOMA POPULATION
GONIOSCOPIC FEATURE GROUP A GROUP B
N=26 N=62
Pigmentation
no pigment 0 13
grade 1+ 0 35
grade 2+ 10 14
grade 3+ 10 3
grade 4+ 6 0
SamDaolesi's line 24 1
Exfoliation material 5 0
glaucoma on medical therapy had lost central fixation because 
of progressive visual field loss. There was no comparable 
event in the POAG group.
10.2.3 Slit lamp findings
The biomicroscopic and gonioscopic features observed were as 
follows:
Exfoliation signs
Whitish flakes of such a size as to suggest exfoliation 
material were found on the central and inferior retrocorneal 
surface in 9 out of the 26 cases of group A (35%)? (Figs 10.1 
& 10.2). Clinical examination revealed exfoliation material 
on the pupillary border of 20 patients from group A (77%); 
Four of the 6 cases that did not show evidence of exfoliation 
material on the pupil were from group II. Slit-lamp 
microscopic examination failed to reveal the presence of a 
central disc (Fig 10.3) in 5 exfoliation glaucoma patients 
(17%). The peripheral granular zone was detected in all 22 
patients from group I (Figs 10.4 & 10.5), but was absent from 
the 4 morphologically determined exfoliation-positive cases 
from group II (possible exfoliation). Solitary flakes of 
exfoliation material, in association with the central disc, 
were observed in 6 out of the 26 patients from group A (23%). 
In one case a bridge of exfoliation material was seen to 
connect the granular zone with the central disc (Fig 10.5). 
The configuration of the central disc and that of the 
granular zone exhibited significant variations (Fig 10.3). A 
pronounced rolled over edge of the granular zone was observed
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Figure 10.1: Slit-lamp photograph of corneal endothelium in 
a patient from group A. Note deposition of 
flecks of exfoliation material (arrows).
Figure 10.2: Slit-lamp photograph of the corneal endothelium
in a patient from group A. In this case exfoliation material 
has formed a large ‘dendritic’ aggregate (arrow).
Figure 10.3A,B: Slit-lamp photographs of the central disc (arrows) in group A
showing central (10.3A) and eccentric (10.3B) location, illustrating 
the variability of this clinical sign.
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Figure 10.3C,D: Fig 10.3C shows exfoliation material (arrow) in the boundry of the 
central disc in the same patient as Fig 10.3A. In Fig 10.3D a more 
conspicuous central disc is demonstrated, 
with a thickened inferior edge (arrow).
Figure 10.4: Slit-lamp photograph of a patient from group A. No exfoliation material 
is evident on the pupillary margin but a serrated granular zone is clearly 
demonstrated (arrows). Note also peeling of exfoliative 
lens capsule (arrowheads).
r
Fiigure 10.5: Biomicroscopical appearance of the granular zone (GZ) in
a patient from group A. In contrast to Fig 10.4 the inner edge 
of the granular zone is smooth and intact (arrows). A bridge 
connects the GZ with the central disc (CD) is arrowheaded
in one case. Two cases demonstrated evidence of peeling of 
the exfoliative lens capsule (Fig 10.4), with a small strip 
of their lens capsule floating in the anterior chamber.
Pigmentary signs
Discrete pigmentation of the corneal endothelium was detected 
by slit-lamp examination in 17 out of 26 exfoliation glaucoma 
patients (65%). A visible pigmented line (extension of 
Sampaolesi's line) was detected upon the inferior posterior 
corneal surface in 9 out of 26 cases with exfoliation 
glaucoma (35%). Twenty-two out of the 26 group A patients 
(85%) demonstrated subtle pigmentary dust scattered upon the 
anterior surface of the iris. This feature was more 
prominent on lightly pigmented irides. A discrete pigmentary 
cluster localised at the 6 o' clock position in the inferior 
iris circumference was noted in 14 out of the 26 patients 
(54%). Biomicroscopically visible fine new vessels were seen 
on the anterior iris of one patient and exfoliation material 
upon the anterior surface of the iris was noted in 3 other 
cases (11.5%).
Well demarcated patches of peripupillary transillumination 
were noted in 16 out of the 26 patients in group A (62%)?
(Fig 10.8B). Five of these patients also exhibited 
transillumination of the iris mid-periphery. All but two 
patients of group A demonstrated advanced to complete atrophy 
of the pupillary ruff (greater than 180°). Two patients 
exhibited moderate atrophy of the pupillary ruff (less than 
180°). Discrete pigment granules at the mid-periphery of the 
lens were seen in 8 cases from group A (31%); (Fig 10.8D).
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The 4 cases diagnosed only by morphological examination 
showed marked atrophy of the pupillary ruff (Fig 10.9). 
Additionally, there was moderate to dense pigmentation of the 
trabecular meshwork in all these patients and Sampaolesi's 
line was present in 3 patients (Fig 10.10). One case 
displayed fine pigment deposits upon the iris surface and a 
pigmented trabecular ring gonioscopically, without 
gonioscopic evidence of Sampaolesi's line.
Other signs
A relative afferent pupillary defect at presentation was 
noted in 8 out of the 26 untreated exfoliation glaucoma 
patients. In contrast, only 4 out of the 74 untreated POAG 
patients demonstrated a relative afferent pupillary defect at 
diagnosis. The difference was significant (t-test, p<0.001). 
Iridodonesis accompanied by phacodonesis and partial lens 
subluxation was observed in one exfoliation glaucoma patient 
(Figs 10.11 & 10.12).
POAG patients
The proportion of POAG patients in this study is shown in 
Figures 10.8 & 10.9. Pigment deposition upon the posterior 
corneal surface was noted in 4 out of the 74 POAG patients 
from group B (5.4%). The difference between groups A and B 
and age matched exfoliation glaucoma and POAG patients was 
statistically significant (p<0.001). POAG patients 
demonstrated a significantly lower incidence of subtle 
pigment deposition on the iris (6.7%), (p<0.001); pigment
deposition upon the anterior lens surface (5.4%), (p<0.001) 
and peripupillary transillumination (3%) (p<0.001). One
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patient from group B with a lenticular precapsular film and 
one with gonioscopic evidence indicating the presence of 
Sampaolesi's line were subsequently shown on ultrastructural 
examination to be exfoliation-negative.
A degree of pupillary ruff loss was relatively common in POAG 
patients. Overall, 38 out of 74 patients from group B (51%) 
exhibited pupillary ruff loss up to 180°. Further analysis 
indicated that POAG patients were more likely to exhibit 
pupillary ruff loss up to 180°, whereas exfoliation glaucoma 
patients were more likely to manifest pupillary ruff loss 
greater than 180°, (x2 test, prior to age matching p<0.001? 
after age matching p<0.01).
10.2.4 Gonioscopic findings
The gonioscopic findings of 26 exfoliation glaucoma patients 
and 62 POAG patients are shown in Table 10.3. The two 
glaucoma groups were similar with regard to angle narrowness. 
Exfoliation glaucoma patients were more likely to show 
moderate to dense pigmentation (grades 3-4+) of the 
trabecular meshwork (t-test, p<0.001) and the presence of 
Sampaolesi's line (p<0.001); (Figs 10.6 & 10.7).
10.2.5 Accuracy of clinical observations
In order to give an indication as to the utility of each 
clinical sign detected during the course of this study the 
sensitivity, specificity and predictive value of each sign 
was calculated. Table 10.4 illustrates the efficiency of
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Figure 10.6: Gonioscopic photograph of the inferior angle in a patient 
from group A. Deposition of pigmentation is greatest 
at the 6 o’clock position (arrow).
Sampaolesi’s line is clearly seen (arrowhead).
Figure 10.7: Gonioscopic photograph of the inferior angle in a 
patient from group A, illustrating irregular punctate 
pigmentation of the trabecular meshwork. Note 
Sampaolesi’s line (arrowhead).
THE GLASGOW STUDY
exfoliation in a surgical population
POAG 60 
60%
clinical diagnosis
Figure 10.8: Pie chart showing the proportion of patients admitted for
trabeculectomy with previously diagnosed exfoliation glaucoma 
(EXG), newly diagnosed exfoliation glaucoma, possible exfoliation 
glaucoma (suspects) and POAG.
THE GLASGOW STUDY
Clinical vs morphological diagnosis
Cl laical E.M diagnosis
Suspects POAG
Figure 10.9: Histogram showing the prevelance of exfoliation glaucoma
in the surgical cohort according to clinical and morphological 
criteria. Patients with possible exfoliation (suspects) are 
subsequently categorised definitively by morphology.
TABLE 10.4 ACCURACY OF CLINICAL OBSERVATIONS
CLINICAL FEATURES SENSITIVITY SPECIFICITY PREDICTIVE VALUE
Exfoliation sians
Presence of granular zone 100% 95% 85%
Presence of central disc 100% 94% 81%
Exf on the pupil 100% 92% 77%
Exf on the corneal endothelium 100% 81% 35%
Exf in the angle 100% 75% 19%
Picrmentarv sians
SPL in the angle 96% 97% 92%
Loss of pupillary ruff >180° 40% 95% 92%
Iris pigmentation 81% 94% 87%
Corneal pigmentation 81% 89% 65%
Angle pigmentation 3-4+ 84% 85% 61%
Tranillumination defects 89% 88% 61%
Iris pigment at 6 o' clock 93% 86% 54%
SPL on inferior cornea 100% 81% 37%
Lens pigmentation 67% 79% 31%
Kay* exf: exfoliation material; SPL: Sampaolesi's line.
Table 10.4: The table shows sensitivity, specificity and 
predictive value for the clinical signs used in 
the diagnosis of exfoliation glaucoma in the 
present study.
each individual clinical sign/observation in predicting the 
'final' diagnosis (exfoliation glaucoma determined by 
morphology, group A). Overall, comprehensive clinical 
examination in this study had a 100% sensitivity, 95% 
specificity and 85% predictive value.
Group II (exfoliation-neaative) patients
Further analysis was undertaken on the subgroup of patients 
from group II (possible exfoliation glaucoma), who were 
exfoliation-negative on ultrastructural examination. These 
14 patients were compared with the remaining POAG patients 
from group B and the total exfoliation glaucoma group. They 
were similar to the remaining POAG patients with regard to 
sex, degree of visual field loss, level of treated IOP at the 
time of listing for surgery, frequency of primary 
trabeculectomy and incidence of surgery due to unacceptably 
high IOP. They were different from the remaining POAG 
patients in that they were older, mean 72.8 years (S.D.,
6*4), (p=0.003)? they exhibited a higher untreated IOP at 
presentation, mean 34.2 mm Hg (S.D., 7.6), (p=0.012) and,
they were treated medically for a shorter period of time, 
mean 16.4 months (S.D., 27.5) versus a mean of 43.8 months 
(S.D., 50.1) for the remaining POAG patients, (p=0.008).
They were different from exfoliation glaucoma patients (group 
A) in that they exhibited a lower treated IOP at the time of 
listing for surgery, mean 25.8 mm Hg (S.D., 6.0) versus 33.0 
mm Hg (S.D., 12.3) for group A.
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10.2.6 Surgical complications
Patients in group A were compared with those in group B with 
regard to immediate postoperative complications.. No patients 
required re-operation to correct surgical complications. One 
patient with clinically significant choroidal detachment was 
re-admitted to hospital. No infections were observed within 
the follow up period of this study (6 months). Patients from 
group A exhibited a significantly higher incidence of 
fibrinous reaction in the immediate postoperative phase (5 
cases versus one for POAG) (p<0.001). No significant 
difference between exfoliation glaucoma and POAG patients was 
observed for the presence of postoperative hyphaema 
(0.10>p>0.05), postoperative uveitis (0.10>p>0.05), temporary 
reduction of visual acuity (p>0.80) and reduction in anterior 
chamber depth (p>0.80). Postoperatively, the ratio of 
steroid responders in group A (2 out of 26) was similar with 
that in the POAG group (10 out of 74).
10.2.7 Final follow up
All patients completed the required follow up (6 months) 
except one patient with exfoliation glaucoma who died one 
month after surgery and one patient with POAG who was lost to 
follow up. Of the 98 patients completing the study follow up 
time, only one patient with POAG (1%) could not be controlled 
with medical therapy and underwent a second trabeculectomy. 
One patient with exfoliation glaucoma (4%) and 9 patients 
with POAG (12%) required supplementary medical therapy (one 
medication each). Examination of cases in which the IOP
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remained controlled after surgery only with the addition of 
supplementary medical therapy showed that in 6 cases (one 
with exfoliation glaucoma and 5 with POAG) one medication was 
added due to an IOP level in excess of 22 mm Hg. In the 
remaining 4 POAG patients medical therapy was added in an 
attempt to reduce the final IOP further (prior to therapy 
postoperative untreated IOP equal or below 22 mm Hg).
The most striking finding at the 6-month follow up, was a 
significant difference in the mean untreated IOP, including 
failures, of the two glaucoma groups. Age matched patients 
with exfoliation glaucoma showed lower untreated mean IOP, 
11.8 mm Hg (S.D., 4.4), when compared with similar POAG 
patients, 15.0 mm Hg (S.D., 4.6), (p=0.008). With regard to 
visual field loss, group A (one case with deterioration, one 
with improvement in visual field) was similar to group B (5 
cases with evidence of deterioration and 9 with improvement 
in visual field). Progression of lens opacities was observed 
in two cases in both groups.
10.3 Discussion
To my knowledge this is the first prospective comparative 
study of exfoliation glaucoma and POAG patients. A 
definitive diagnosis was obtained in every case by iris 
biopsy. It was found that exfoliation glaucoma affects 
almost a quarter of patients requiring surgery. Thus the 
disorder may be relatively common in the glaucoma population 
of Western Scotland. Detailed data on the prevalence of 
exfoliation glaucoma in British surgical cohorts is lacking.
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Only Mills (1981) has estimated a prevalence of 3.2% for 
exfoliation glaucoma in 444 surgical cases in Manchester, but 
this retrospective study may have underestimated the 
prevalence of the disorder. The prevalence of exfoliation 
glaucoma in surgical groups has been reported to vary between 
3% and 88% ( Aasved 1971, Jerndal & Kriisa 1974, Jerndal & 
Lundstrom 1977, Mills 1981, Ruprecht et al 1985, Sziklai & 
Suveges 1988, Konstas & Allan 1989, Psilas et al 1990).
It is likely that sampling errors may result in either 
underestimation, or overestimation of the prevalence of 
exfoliation glaucoma depending on the diagnostic criteria 
employed (see section 1.7).
Some of the data presented herein (e.g. IOP at diagnosis, 
cause of diagnosis, IOP at final follow up) had to rely on 
retrospective retrieval from case notes. It is recognised 
that this may have affected the quality of that data.
The prevalence of exfoliation glaucoma in surgical patients 
does not correspond accurately with the prevalence of the 
condition in a clinical setting or, particularly, in a 
population sample (Aasved 1971a). The policy of all 
clinicians in the Tennent Institute of Ophthalmology during 
the course of this study was to carry out early surgical 
intervention. The surgical glaucoma cohort investigated is 
therefore likely to be more representative of a general 
glaucoma population than cohorts reported in previous 
comparable studies.
Most authors consider that the presence of exfoliation 
material is directly associated with the development of
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a secondary open angle glaucoma, herein referred to as 
exfoliation glaucoma. However, this view is not universally 
shared. Some authors have suggested that the presence of 
exfoliation material is coincidental and that these patients 
suffer from POAG (Trantas 1929, Cebon & Smith 1976, Tarkkanen 
1984, Wollensak et al 1992). Closed angle glaucoma patients 
were included in this study as controls to determine whether 
the presence of exfoliation is linked to the development of 
open angle glaucoma, or represents a coincidental feature.
If the presence of exfoliation material in the aged eye was a 
coincidental finding similar frequencies would have been 
expected in the two comparable glaucoma cohorts: the open 
angle glaucoma (100 cases) and the closed angle glaucoma 
group (31 cases). The eightfold increase in the presence of 
exfoliation material in the open angle glaucoma group 
confirms that exfoliation material is either the cause of 
glaucoma, or alternatively represents an aggravating factor 
in an eye vulnerable to POAG.
In this study 3 previously undiagnosed cases were detected 
clinically by the author and 4 more cases were only diagnosed 
by iris biopsy. The clinical diagnosis of exfoliation 
glaucoma is facilitated when a specific comprehensive 
clinical examination is carried out (section 1.7). The 
present study suggests that specific clinical examination of 
surgical patients to identify exfoliation material should 
detect about 85% of patients with exfoliation glaucoma with 
no false positives. Surgical patients were used so that 
biopsy of the iris could be obtained. Exfoliation material 
was found in all 22 definite exfoliation glaucoma patients,
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in 4 out of 18 (22%) possible exfoliation glaucoma patients 
and in none among the POAG group without clinical suspicion 
for the presence of exfoliation. Thus, the definite clinical 
identification as well as the 'absence' of exfoliation 
material seem reliable. The value and reliability of iris 
biopsy was demonstrated by the detection of exfoliation 
material in all 22 cases with the clinical diagnosis of 
exfoliation glaucoma.
Prince et al (1987) found exfoliation material in 
conjunctival biopsies in 8 of 23 (34.7%) 'suspect' eyes using 
similar criteria to group II in this study. The prevalence 
in group II (22%) was not dissimilar to the prevalence 
reported by Prince et al (.1987) , considering the fact that 
they included both eyes in 7 patients. In agreement with 
that study, this study suggests that in a group of patients 
with pigmentary features but no visible exfoliation material 
the diagnosis of POAG is likely to be inaccurate in some 
cases.
Accuracy of clinical observations
To my knowledge this is the first study that has attempted to 
put a quantitative value to diagnostic features. The iris 
biopsy allowed critical evaluation of the specificity, 
sensitivity and predictive value of the diagnostic signs. 
Signs stated in the literature to indicate the positive 
identification of exfoliation syndrome/glaucoma include the 
detection of exfoliation material upon the cornea, pupillary 
margin, angle and lens capsule. Even though these signs 
exhibit a 100% sensitivity (i.e. all patients exhibiting
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these signs actually have the disorder) their clinical 
usefulness is lessened by their reduced specificity and 
predictive value. For example, the presence of exfoliation 
material upon the pupillary margin showed a predictive value 
of only 77%, that is to say, in 23% of the patients with 
exfoliation glaucoma this sign was not detectable. Even the 
presence of the granular zone, considered a pathognomonic 
feature present in all exfoliation cases (section 1.7.2) 
showed a predictive value of only 85%.
Similar results were obtained with the pigmentary signs. For 
example, Sampaolesi's line in the angle and the loss of the 
pupillary ruff (180° or more) were both found to be of high 
predictive value (92% and 87%). In the case of the latter 
however, a low degree of specificity (40%) was observed.
Angle pigmentation grades 3-4+ were gonioscopic signs of 
reasonably high sensitivity and specificity, but of less 
predictive value (61%). The combination of three of the 
above signs, namely the presence of the granular zone, 
Sampaolesi's line and angle pigmentation 3-4+ will assure a 
100% accurate index of detection.
Patients with possible exfoliation glaucoma 
In the absence of clinically obvious exfoliation material, 
the presence of exfoliation glaucoma in the other eye (2 out 
of 2 cases) and the presence of Sampaolesi's line (3 out of 4 
cases) were reliable indicators of the ultrastructural 
presence of exfoliation material. With the latter, one false 
positive case was found, where the presence of Sampaolesi's 
line was not associated with the presence of exfoliation
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material in the iridectomy specimen. The involvement of the 
clinically 'normal' fellow eye found in each of the two cases 
of unilateral exfoliation glaucoma correlates well with 
previous evidence (Mizuno & Muroi 1979, Konstas 1989, Miyake 
et al 1989, Hattori 1990, Atsumi et al 1991). For 
Sampaolesi's line one false positive case was found.
Four cases from the possible exfoliation glaucoma group 
(group II) were only included in the exfoliation glaucoma 
group following the morphological study of iris tissue from 
these patients. In a clinical study such patients would have 
been accorded the wrong status (POAG). Previous studies 
reliant solely upon clinical examination for disease 
classification have no doubt been similarly afflicted.
Age and exfoliation
In the present study patients coming to surgery with 
exfoliation glaucoma were significantly older than POAG 
patients. This is in agreement with previous studies 
(Aasved 1969, Ruprecht et al 1985, Khanzada 1985, Tarkkanen 
1986, Forsius 1988). The age difference introduces bias, 
which has seldom been taken into account. Aasved (1971) 
established that in both exfoliation glaucoma and POAG that 
optic nerve damage increased with age. In addition, some 
studies have suggested increased susceptibility for males to 
exfoliation glaucoma (Bartholomew 1976, Konstas & Allan 1989, 
Ayed et al 1990) and a significantly higher IOP in male 
patients with exfoliation glaucoma (section 1.12), but the 
present study found no such differences.
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Exfoliation glaucoma and POAG
The impressions of previous workers that exfoliation glaucoma 
is associated with a particularly high level of IOP (section
1.12) have been confirmed in the present study. The 
untreated IOP at presentation was higher in the exfoliation 
glaucoma patients than that seen in comparable POAG patients. 
This difference in presenting symptoms in exfoliation 
glaucoma is related to this higher IOP as the difference in 
symptoms disappeared when the groups were matched for level 
of IOP at diagnosis. This difference was not age, or sex 
related and may be attributed to the different pathogenesis 
of exfoliation glaucoma (section 1.5.2). In addition, the 
mean treated IOP at the time of listing for surgery was 
significantly higher than that seen in a similar POAG group. 
Exfoliation glaucoma patients were prescribed more 
medications, were using acetazolamide more often and were 
treated medically for shorter periods of time (on average 
less than a year). Despite this they more often required 
surgery for unacceptably high IOP. These findings suggest 
that the pharmacological control of the IOP is more difficult 
in exfoliation glaucoma and probably justifies the decision 
to operate earlier.
The similarity between the two glaucomas for visual field 
loss at presentation is in agreement with a retrospective 
study conducted by Lindblom & Thorburn (1984b). This study 
established the same degree of visual field loss at diagnosis 
for exfoliation glaucoma and POAG, despite a higher mean IOP 
in the former (42.9 mm Hg versus 34.8 mm Hg for POAG).
The similarity of the degree of visual loss at the time of
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listing for surgery between exfoliation glaucoma and POAG 
contradicts previous retrospective studies and may be due to 
the short duration of medical therapy before surgery (8 
months).
The long term results of conventional management of 
exfoliation glaucoma have been disappointing. Olivius & 
Thorburn (1978) reported that 5 years after diagnosis, 
treated exfoliation glaucoma patients exhibited severe visual 
field loss in 48% of cases compared with only 19% in the POAG 
group. Furthermore, at the end of their follow up period, 
(mean 10 years), 40% of the eyes with exfoliation glaucoma as 
compared with 26% of the eyes with POAG had become legally 
blind (Olivius & Thorburn 1978). There was a difference in 
the management of exfoliation glaucoma in that study compared 
with the present study: surgery in their cohort was employed 
only as a last resort, whereas in the present study early 
surgery was often undertaken.
Trabeculectomy creates a guarded outflow passage for aqueous 
from the anterior chamber to the subconjunctival space 
(Koryllos 1967, Cairns 1968, Jay 1991). The factors that 
determine the establishment of sufficient filtration are not 
completely understood (Herschler 1985, Lamping et al 1986, 
Stewart 1990). There is evidence that the inflammatory 
reaction and fibrotic response of the involved tissues 
influence the final outcome (reviewed by Herschler 1984). 
Certain preoperative characteristics such as young age, black 
race, aphakia, re-operation and ocular inflammation may 
increase the chance of bleb failure (Jerndal & Lundstrom
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1977, Jay & Murray 1980, Konstas 1989, Dereklis et al 1990, 
Jay 1991). Patients with these risk factors were excluded 
from this study.
The clinical presentation, time course, indications for 
surgery and the therapeutic results of trabeculectomy have 
not previously been documented prospectively in a well 
defined exfoliation glaucoma group. Indeed, in many studies 
the surgical glaucoma groups studied represent an ad hoc 
mixture of different glaucomas. This prospective study 
confirms the hypothesis that exfoliation glaucoma patients 
coming to surgery differ from comparable POAG patients in 
some important respects. The most important difference is 
the higher level of untreated and medically treated IOP and 
the lower level of IOP 6 months after surgery.
Surgical comolications
As with any form of surgery there may be complications 
following trabeculectomy. A comprehensive review of these is 
given by Leblanc & Stewart (1986). However, serious 
complications after trabeculectomy seem very rare (Jerndal & 
Lundstrom 1977, Wilson 1977, Mills 1981, Yamashita et al 
1985, Watson et al 1990, Mylopoulos 1991). In the present 
study the complications of trabeculectomy in exfoliation 
glaucoma and POAG were assessed. There was no significant 
difference in the frequency of postoperative hyphaema in this 
study, but a fibrinous exudate in the aqueous was more common 
in exfoliation glaucoma patients. This finding has not been 
previously reported in association with filtration surgery 
and may be due to the exfoliation vasculopathy (chapter 7).
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Postoperative steroid response
It is well documented in the literature (see section 1.12.1) 
that in exfoliation syndrome/glaucoma there is a lack of IOP 
elevation following steroid administration and this feature 
distinguishes exfoliation glaucoma from POAG. In this study 
no significant difference in steroid response was observed 
between exfoliation glaucoma and POAG following filtration 
surgery. Since the trabecular meshwork is the site of the 
pathology responsible for the IOP elevation (Armaly 1986), it 
is possible to speculate that filtration surgery eliminates 
the difference between the two glaucomas.
Final IOP
This study identified a significantly lower untreated 
postoperative IOP for exfoliation glaucoma than in comparable 
POAG patients, at approximately 6 months after surgery and 
this was not related to the duration of medical therapy 
before surgery. Jerndal & Kriisa (1974) and Jerndal & 
Lundstrom (1977) found a favourable IOP lowering effect but 
did not provide comparison with POAG. Tornqvist and Drolsum 
(1991) did perform a retrospective comparative study and 
found that progression of visual field loss occured less 
often in the exfoliation glaucoma group following surgery 
compared to age matched POAG patients. It is thus possible 
that a genuine difference in IOP response following surgery 
differentiates exfoliation glaucoma from POAG. This concept 
may be supported by the ultrastructural evidence known about 
the morphology of the outflow system and the pathogenesis of 
exfoliation glaucoma (section 1.5.2). A characteristic 
feature distinguishing exfoliation glaucoma from POAG is the
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'mechanical blockade' of the outflow system by pigment and 
exfoliation material (Rohen 1983, Rohen & Jikihara 1988). It 
is thus reasonable to hypothesise that filtration surgery can 
be more effective in exfoliation glaucoma since it relieves 
the mechanical obstruction caused by particle deposition.
Lavin and coworkers (1990) have proposed that earlier 
surgical intervention may provide significantly better IOP 
control. This may be due to a reduction of the duration of 
medical therapy and a decrease in the adverse influence of 
pharmacological agents upon the conjunctiva and Tenon's 
capsule (Lavin et al 1990). Certainly, prolonged medication 
has been associated with the risk of a pemphigoid reaction in 
the conjunctiva (Jay 1992) and increased amounts of 
inflammatory cells have been identified in conjunctival 
biopsies after prolonged medical therapy (Sherwood et al 
1989). In the present study POAG patients had a mean 
duration of medical therapy of 39 months as compared with a 
mean of 8.4 months for exfoliation glaucoma patients. In the 
study by Lavin and coworkers (1990) the medical therapy group 
(mean 77 months) was treated considerably longer than the 
primary trabeculectomy group (medical therapy for a few 
weeks). Therefore, it is considered unlikely that the 
difference in IOP response in the present study was due to 
the more prolonged duration of medical therapy in group B.
Many published reports have failed to make a distinction 
between POAG and exfoliation glaucoma. There are differences 
between these two open angle glaucomas (see section 1.12).
The worse prognosis assumed in exfoliation glaucoma is true
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for medical therapy, but may not apply in the case of timely 
surgical intervention. Early surgery may be an advantage in 
exfoliation glaucoma.
10.4 Summary
The 'true' prevalence and clinical attributes of exfoliation 
glaucoma were investigated prospectively in a Scottish 
surgical cohort. One hundred consecutive patients undergoing 
trabeculectomy for open angle glaucoma were investigated by 
clinical examination (biomicroscopy and gonioscopy and 
classified into 3 categories: exfoliation glaucoma, possible 
exfoliation glaucoma and POAG. A definitive diagnosis of 
exfoliation glaucoma was provided by pathological examination 
of iris tissue. All 22 patients with clinical evidence of 
exfoliation glaucoma and 4 out of 18 patients with possible 
exfoliation glaucoma on clinical examination had 
ultrastructural evidence of exfoliation material. The 
prevalence of exfoliation glaucoma was therefore 26%.
The sensitivity, specificity and predictive value of each 
clinical sign was calculated. In comparison with POAG, 
patients with exfoliation glaucoma had higher untreated IOP, 
higher IOP on medical therapy and shorter duration of medical 
therapy. They were more often operated on for unacceptably 
high IOP. Exfoliation glaucoma patients exhibited 
significantly lower IOP after surgery.
223
CHAPTER 11 MODIFICATION OF TRABECULECTOMY TO AVOID
POSTOPERATIVE HYPHAEMA THE 'GUARDED ANTERIOR 
FISTULA' OPERATION
11.1 Introduction
Trabeculectomy is the standard drainage operation for open 
angle glaucoma (Cairns 1968, Watson 1970, Watson & Barnett 
1975, Watson & Grierson 1981, Jay 1991). Its main advantage 
over full thickness drainage procedures is a reduced 
incidence of complications (Watkins & Brubaker 1978, Mills 
1981, Lamping et al 1986, Konstas 1989, Watson et al 1990). 
The success and safety of the procedure have been established 
(Wilson 1977, Zaidi 1980, Watson & Grierson 1981, Jay &
Murray 1988), so that recently there has been a tendency 
towards earlier surgery (Jay & Murray 1988, Jay & Allan 1989, 
Lavin et al 1990, Jay 1991? 1992).
Nevertheless, filtration surgery may be delayed because of 
fears that there may be surgical complications. The 
frequency of postoperative hyphaema varies from 15 to 53 per 
cent (Ridgway 1974, Watson & Barnett 1975, Wilson 1977, Zaidi 
1980, Mills 1981, Shuster et al 1984, Yamashita et al 1985,
Le Blanc & Stewart 1986), and although it is seldom a serious 
complication, it may prolong the patient's stay in hospital. 
It may also cause temporary reduction in vision which may be 
a serious handicap if vision is poor in the other eye. This 
study was designed to confirm and quantify the hypothesis 
that excising the inner block anterior to the scleral spur 
reduced the frequency of postoperative hyphaema.
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11.2 Results
Patient characteristics
All patients were Caucasians and each group comprised 39 eyes 
of 39 patients. The patient characteristics for the two 
groups are shown in Table 11.1. There was no significant 
difference between the two groups (A and B) for sex, age, 
reason for diagnosis and presence of systemic diseases 
(arterial hypertension, diabetes mellitus, haematological 
disorders). Table 11.2 shows the glaucoma status. At 
diagnosis there was no difference between the groups for IOP 
without medication, cup to disc ratio, prevalence of 
exfoliation glaucoma and duration of medical treatment. 
Similarly, there was no difference at the time of surgery for 
intraocular pressure with medication and cup to disc ratio. 
Neither was there any significant difference for severity of 
visual field loss at diagnosis and at time of surgery, or for 
indication for surgery (early trabeculectomy; failed medical 
treatment).
Twenty-nine patients had their operation performed by three 
consultants, 12 by two senior registrars and 37 by eight 
registrars. There was no bias for any level of seniority in 
the two groups.
Classification
In each group two patients were found to have tissue 
specimens which did not correspond with the intended style of 
dissection and these two patients were reclassified according 
to the histological findings. For the main analysis this
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Table 11.1 A
Mean age Male/female arterial diabetes
n (± SD) ratio hypertension mellitus thrombocytopenia
Group A 39 68.6 (+ 10.4) 20/19 12 1 0
Group B 39 67.7 (± 9.1) 21/18 7 1 1
Table 11.1B
AT DIAGNOSIS Duration AT TIME OF OPERATION
_______________________________  of _____________________________
medical
mean IOP treatment mean IOP
n (untreated, mm Hg) C/D ratio (months) (treated, mm Hg) C/D ratio
'oup A 39 31 (± 9.6) 0.6 (± 0.2) 39.7 (± 59) 25.9 (± 6.9) 0.6 (± 0.1)
'oup B 39 29 (± 9.4) 0.6 (± 0.2) 27.9 (± 32) 24.9 (± 6.3) 0.7 (± 0.1)
histologically confirmed classification was used but no 
significant difference in results was found between the 
histological classification and the classification based on 
the surgeon's intended dissection.
Frequency and severity of hyphaema
The frequency and severity of hyphaema in the two groups is 
shown in Figure 11.1. Thirty-five patients (45%) developed a 
hyphaema: six patients diffuse with no blood level, twenty- 
one with a level of 0.2mm to 1mm and eight with more than 1 
mm blood level. There was no difference in the frequency of 
grade 1 hyphaemas (three patients in both groups). Group B 
exhibited a significantly higher incidence of hyphaemas of 
both grade 2, 0.2mm to 1 mm height, (15 patients versus 6 in 
group A, p<0.05) and grade 3, more than 1 mm height, (7 
patients versus one in group A, x2 test, p<0.01).
Considering only hyphaema severe enough to form a detectable 
blood level, there were 7 out of 39 eyes (18%) in group A, 
compared with 22 out of 39 eyes (56%) in group B. The 
difference was statistically significant (t-test, p<0.001).
Time of occurence of hyphaema
The time of occurence of hyphaema was analysed for the three 
grades of hyphaema (Fig 11.2). The few circulating red blood 
cells which were present in the anterior chamber on the first 
day in every case were disregarded. Most hyphaemas of grade 
1 (5 out of 6) were present on the first postoperative day, 
whereas only 7 of 21 grade 2 and 3 of 8 grade 3 hyphaemas 
were present on day one. Grade 1 was therefore significantly
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Figure 11.1: Frequency and severity of postoperative hyphaema.
Grade 1, diffuse; grade 2, 0.2-1mm; grade 3, >1mm. 
Anterior dissection (groupA) produced significantly fewer 
hyphaemas and those that occurred were less severe.
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Figure 11.2: Time of appearance of postoperative hyphaemas 
of different severity
different from grades 2 and 3 in that respect. In the latter 
grades most hyphaemas appeared on the second (13/29) and 
third (5/29) postoperative day with only one hyphaema (grade 
2) appearing on day four.
Duration of hospitalisation
Patients with hyphaema stayed significantly longer in 
hospital: mean, 4.4 days (S.D., 2.2), than those without: 
mean, 2.5 days (S.D., 0.5). Time in hospital was found to be 
related to the severity of hyphaema. Analysis showed that 
mean hospital stay for grade 1 hyphaema, did not differ from 
grade 2 (3.2 days and 3.6 days respectively), but grade 3 
patients stayed in hospital significantly longer, mean, 7.7 
days (S.D., 2.1). When compared with patients without 
hyphaema, those with both grades 2 and 3 stayed significantly 
longer in hospital, but grade 1 did not. Overall, group A 
patients remained in hospital for an average of 2.9 days 
(S.D., 1.3), compared with an average of 3.8 days (S.D., 1.9) 
for group B. The difference was significant (Mann-Whitney 
test, p=0.004).
Exfoliation glaucoma and other features 
Patients with each of the three grades of hyphaema were 
compared with each other and with those without hyphaema to 
determine possible distinguishing features. Patients with 
hyphaema were similar to those without hyphaema with regard 
to age, sex, systemic diseases, intraocular pressure at 
diagnosis, cup to disc ratio at diagnosis, intraocular 
pressure at the time of surgery and duration of medical 
treatment.
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Out of the 15 patients with exfoliation glaucoma included in 
this study 5 (33%) developed a hyphaema postoperatively.
There was no case of a severe or recurrent hyphaema. There 
were 7 patients in group A and 8 in group B who had 
exfoliation. In group A, one of the 7 patients had a diffuse 
hyphaema (grade 1) compared with one diffuse (grade 1) and 
three grade 2 hyphaemas in the eight exfoliation patients in 
group B. Statistical analysis did not reveal any significant 
association between the presence of exfoliation and 
postoperative hyphaema. Considering only the hyphaemas which 
formed a detectable blood level there was no significant 
difference between the exfoliation group and the POAG group 
(x2 test, 0.05<p<0.1).
With reference to the individual analysis of the three grades 
of hyphaema the only significant difference observed was in 
the sex distribution of grade 1 when compared with grade 2 
(5:1 female to male ratio in grade 1 versus 6:15 for grade 
2). However, there was no difference in the sex distribution 
between grades 1 and 3 and 2 and 3.
Recurrent hyphaemas
Three patients, all of them in grade 3, experienced recurrent 
hyphaemas, two of them on the fifth postoperative day and one 
on the fourth day. These recurrent hyphaemas were of 
moderate degree, up to 2.5 mm in height, occured prior to the 
complete resolution of a pre-existing hyphaema grade 3 and 
there were not detrimental to the final visual acuity of 
these three patients.
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Postoperative complications
The two groups, A and B, i.e. anterior and posterior 
dissection and the patients with and without hyphaema were 
compared with regard to immediate postoperative complications 
(anterior chamber depth, uveal effusion and pain). No eyes 
required re-operation to correct surgical complications.
There was no significant difference between the two 
randomised surgical groups and between the patients with and 
without hyphaema.
Final outcome
At approximately four months after the operation the final 
outcome was analysed with regard to reduction of visual 
acuity, final untreated intraocular pressure, rate of 
postoperative steroid response, and bleb morphology. One 
patient was lost to follow up and one patient did not have 
sufficient follow up. Both patients were in group A. No 
significant difference was noted between groups A and B or 
between those with hyphaema and those without. The untreated 
mean intraocular pressure was similar for group A, 15 mm
(S.D., 4.1); and group B, 14.9 mm (S.D., 5.5). Similarly,
the untreated IOP at four months of patients who had 
hyphaema, 15.7mm (S.D., 5.3), was not significantly higher
than that of the patients who did not experience a hyphaema,
14.2 mm (S.D., 4.1), (t-test, p=0.18).
Examination of individual cases in which the IOP remained 
controlled after the operation only with the aid of medical 
therapy, showed them to be distributed evenly between groups 
A and B and between those with and without hyphaema. Three
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patients in group A (8%) and four patients in group B (10%) 
required supplementary medical therapy (one medication each). 
Similarly, from the hyphaema group three patients (8.5%) 
required supplementary treatment compared with four patients 
(10%) in the no-hyphaema group. One patient from group B 
with a grade 2 hyphaema suffering from thrombocytopenia was 
the only patient with uncontrolled intraocular pressure, 
despite medical therapy, after surgery.
11.3 Discussion
This prospective randomised study confirms the hypothesis 
that excision of the inner block anterior to the scleral spur 
is associated with a significant reduction in the incidence 
and severity of postoperative hyphaema. The two groups of 
patients were comparable, the only difference being the mode 
of dissection of the inner block. Group B, posterior 
dissection, was associated with the majority of the more 
severe hyphaemas (grade 3) and with all the recurrent 
hyphaemas.
The ' guarded anterior fistula/
The anterior dissection method (group A) should not be 
confused with the 'Cairns-type' trabeculectomy (Cairns 1968). 
Cairns (1968) excised trabecular meshwork up to the scleral 
spur and therefore was likely to have disturbed it in at 
least some cases. The anterior dissection in this study, 
termed 'guarded anterior fistula', is further forward and 
excises only cornea, all anterior to the angle structures.
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Incidence of hyphaema
The overall incidence of hyphaema in the present study (45%) 
is amongst the higher values quoted in the literature (Watson 
& Barnett 1975, Mills 1981, Shuster et al 1984, Yamashita et 
al 1985, Watson 1987). This is not surprising as this study 
includes diffuse hyphaemas (six) and small hyphaemas that 
might have been overlooked in retrospective studies. Watkins 
and Brubaker (1978) found a similar incidence of hyphaema 
(43%) in the partial-thickness group of their study which 
compared prospectively partial-thickness and full-thickness 
filtration procedures.
Onset of hyphaema
Most diffuse hyphaemas, grade 1, appeared in the first 
postoperative day. This suggests that in most cases they 
represent resolving peroperative bleeding. This is not the 
case with grades 2 and 3 which appear later and are probably 
new events.
The anterior dissection, which removes only corneal tissue, 
(guarded anterior fistula) is associated with a significantly 
lower incidence of postoperative bleeding. This suggests 
that the vascular components of sclera and the ciliary body 
are the most likely sources of hyphaema. This coincides with 
the occasional postoperative observation during the course of 
this study of blood streaming from the fistula site into the 
aqueous. It is also conceivable that in the dissection of 
the posterior block the peripheral iridectomy may be closer 
to the iris root. This study can not, however, identify with 
certainty the source of postoperative hyphaema.
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Exfoliation glaucoma and hyphaema
It is interesting to note that although exfoliation glaucoma 
cases are known to have a varied degree of iris vasculopathy 
(Vannas 1969, Ringvold 1969, Laatikainen 1971, Ringvold & 
Davanger 1981, Brooks & Gillies 1987 and chapter 6 of the 
present work) this did not result in a higher frequency of 
bleeding. The number of exfoliation glaucoma patients is too 
small for valid statistical analysis, but the overall 
incidence of hyphaema and the protective effect of anterior 
dissection were similar to that for the POAG patients. It 
remains to be known whether exfoliation vasculopathy may be 
decreasing the propensity for hyphaema in patients with 
exfoliation glaucoma.
Postoperative IOP control
The IOP attained with both methods of inner block dissection 
was similar and within the range quoted in the literature 
(Ridgway 1974, Jerndal & Lundstrom 1977, Mills 1981, Migdal & 
Hitchings 1986, Jay & Murray 1988, Lavin et al 1990). The 
present study confirms that varying the size and site of the 
fistula does not affect the final IOP (Duzanec & Krieglstein 
1981, Starita et al 1984). Reduction of the filtration area 
(anterior guarded fistula) did not influence the final 
outcome. It is considered unlikely that the shape of the 
outer scleral flap would influence the result. The use of 
triangular flaps has gradually increased in this Department 
over the last 10 years, without alteration in the rate of 
either IOP control or complications, including hyphaema and 
shallow anterior chamber (Jay 1991).
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Hyphaema and drainage
It has been suggested that hyphaema might affect drainage 
(Zaidi 1980). It is also conceivable that suboptimal 
drainage may influence the severity and speed of resolution 
of postoperative hyphaema. Nevertheless, in the present 
study, no significant difference was found in the surgical 
outcome (untreated mean IOP approximately four months after 
surgery) between patients with hyphaema and those without.
It is conceivable that if with a larger sample size and 
longer follow up a difference would have been detected.
Advantages of anterior dissection
The main advantage of a modified dissection of the inner 
block is the lower incidence of postoperative hyphaema.
This complication sometimes can cause alarm to the patient 
and the surgeon and can influence the duration of hospital 
stay of the patient. In the present study, hyphaemas (grades 
2 and 3) were associated with a significantly longer hospital 
stay and so following the anterior dissection method (guarded 
anterior fistula) should reduce costs. The extra cost of 
longer hospital stay after a trabeculectomy has recently been 
quantified (Ainsworth & Jay 1991).
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11.4 Summary
The effect of varying the position of a trabeculectomy 
fistula on the rate of postoperative hyphaema was studied in 
a prospective randomised trial. One eye of each of 78 
consecutive patients with POAG and exfoliation glaucoma was 
allocated to one of two groups. In group A the fistula was 
fashioned anterior to the scleral spur, entirely in corneal 
tissue. In group B the fistula included cornea and sclera 
with trabecular meshwork and scleral spur.
Seven out of thirty-nine eyes (18%) in group A developed a 
postoperative hyphaema with detectable blood level, compared 
with twenty-two out of thirty-nine eyes (56%) for group B 
(p<0.001). In addition, the severity of the bleeding was 
greater in group B and the three cases of recurrent bleeding 
were all in this group. Exfoliation glaucoma patients did 
not exhibit a higher incidence of postoperative bleeding. 
Group B patients remained in haspital for an average of 3.9 
days, which was significantly longer (p=0.004) than the 
average of 2.9 days for group A. This difference was related 
to the frequency and severity of the hyphaema. The type of 
dissection, or the occurence of hyphaema did not influence 
the IOP at four months after surgery.
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CHAPTER 12 FINAL DISCUSSION AND FUTURE STUDIES
The purpose of this chapter is to provide a concise 
discussion of selected data which have been presented in this 
thesis and to provide suggestions for further investigations.
12.1 Morphological studies
12•1.1 Final discussion
Basement membranes and exfoliation
The hypothesis that basement membrane constituents comprise 
part of the biochemical framework of exfoliation material is 
not novel. Numerous investigators have speculated on the 
relationship between the biosynthesis and degradation of 
ageing basement membranes and exfoliation syndrome (section 
1.5). The present investigation has found an intimate 
relationship between iridic vascular basement membranes and 
exfoliation material (chapter 4). Therefore, it is in favour 
of the view that ageing cells which form basement membranes 
are involved in the synthesis of exfoliation material.
The present study was the first to investigate the role of 
two prominent basement membrane components (laminin and 
collagen type IV) in normal controls and patients with 
exfoliation syndrome. Laminin, a principal basement membrane 
component, was found to be a component of exfoliation 
material. Collagen type IV was not. Therefore the current 
study has produced evidence to suggest an association between 
exfoliation syndrome and basement membranes.
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With regard to the elastosis theory advanced by Streeten and 
coworkers (1986a? 1986b) on the basis of ultrastructural 
studies on conjunctival tissue, the present study did not 
find evidence of elastosis in the exfoliative iris. This is 
not surprising as elastic tissue is absent from the iris 
(Ringvold 1970a). If Streeten's hypothesis is correct and 
exfoliation syndrome is a type of elastosis with elastic 
microfibrills forming the basis for the exfoliative fibres, 
this process does not apply in the exfoliative iris.
Laminin and exfoliation material
The significance of laminin localisation in the exfoliation 
material is open to speculation. The present study suggests 
that in the iris vessels, laminin is incorporated into the 
exfoliation structural framework by basement membrane 
producing cells. It is also conceivable that exfoliation 
material may comprise a different morphological form of 
laminin, but with the same epitopes for the antibody employed 
in the present study? for example a substance representing 
either a precursor, or a breakdown product of laminin.
Altered levels of synthesis and turnover of laminin in 
periods of rapid growth and tissue remodelling have been 
recently documented (section 2.5). However, the mechanisms 
which control the synthesis of laminin and the complex 
modulation of the amount present in ocular tissues remains 
unknown.
Collaaens and exfoliation material
It has been shown in the present investigation that neither 
collagens I-V, nor any antigenic homologues comprise integral
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constituents of exfoliation material. What may be of more 
relevance to exfoliation syndrome is the associated 
quantitative collagen changes observed in the iris vascular 
matrix (chapter 7). An inverse relationship appears to exist 
between the quantity of collagens type I and IV in the iris 
vascular basement membranes and the evolution of the 
disorder. From the evidence presented, it is suggested that 
exfoliation syndrome affects the biosynthesis of collagen 
types I and IV in the vascular matrix of the iris. It is not 
clear why at an early stage of the so called exfoliation 
vasculopathy, type I and IV collagen labelling increases. It 
is conceivable that exfoliation syndrome disturbs the 
synthesis, or degradation of the collagens associated with 
the vascular matrix in the iris. This lends weight to the 
hypothesis that local basement membrane-producing cells are 
involved in the synthesis of exfoliation material.
12•1.2 Future studies
Immunocvtochemical studies
Current concepts suggest that qualitative and quantitative 
variations in numerous ECM components occur in relation to 
disease processes (chapter 2). It is not known however, 
whether these changes are primary or secondary to a disease 
process. Considering exfoliation syndrome, it remains to be 
elucidated how the changes in the laminin content affect 
other basement membrane components not investigated herein 
(e.g. nidogen, fibronectin, thrombospondin and heparan 
sulphate proteoglycan). The influence of ageing on the ECM 
of the affected tissues requires further studies.
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The study of other integral or trapped basement membrane 
and ECM components that are not normally related with 
basement membranes will provide more information concerning 
the pathogenesis of the disease. ECM changes in the 
exfoliation syndrome can subsequently be associated with 
concomitant alterations in the morphology and behaviour of 
the ocular cells that synthesise the diseased ECM.
In view of the advanced changes observed in the exfoliation 
glaucoma specimens, early disease (exfoliation syndrome) 
should in the future be targeted by immunocytochemistry. The 
use of fresh post-mortem eyes with early disease (exfoliation 
syndrome, or even preclinical disease) will provide a 
profitable line of future investigation.
Studies on other body tissues
It has been recently suggested that exfoliation syndrome may 
be a systemic condition (Streeten et al 1990). However, 
there is no information on other basement membranes in the 
body. A future study of kidney tissue (especially glomerular 
basement membranes) from exfoliation patients undergoing 
renal surgery would be a promising line of future research.
Other approaches
Advances in tissue culture will permit the use of more 
sophisticated models to study the synthesis of exfoliation 
material in vitro. A study of this nature should ideally be 
carried out on various ocular tissues from the same eye.
This strategy may identify the tissues that play a major role 
in the synthesis of exfoliation material. Other possible
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approaches to the problem include 1) separation of 
exfoliation material from affected ocular tissues and aqueous 
humour of exfoliation patients (e.g. gel electrophoresis and 
Western blot analysis). This could then lead to potential 
determination of molecular weight and ultimately biochemical 
characterisation. 2) Genetic studies on blood from patients 
with exfoliation syndrome for location of the gene that 
determines the disorder.
Preventative studies
Laminin has been found to bind heparin and other structurally 
similar heparan sulfates (Sakashita et al 1980), but recently 
an important function was discovered confined to heparin. 
Heparin was shown to induce a specific alteration of laminin 
polymerisation in which self-assembly was accelerated 
(Yurchenco 1990). Future studies in exfoliation patients 
could conceivably utilise this effect in order to intervene 
and reverse, or alter laminin polymerisation in affected 
ocular basement membranes. As yet, the factors that modulate 
the synthesis of laminin in vivo remain unknown. However, a 
recent in vitro study on cultured bovine trabecular meshwork 
cells has revealed that ascorbic acid promotes laminin 
production. This key component of the aqueous humour 
stimulated laminin synthesis in all concentrations tested 
(Yue et al 1990). Future studies could conceivably test this 
in vitro observation by systemic administration of ascorbic 
acid in exfoliation patients. It is conceivable that 
ascorbic acid may increase the production of laminin from 
iris cohort cells and bring about a reversal of laminin 
depletion seen in exfoliative vasculopathy (section 7.3).
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12.2 Clinical studies
12.2.1 Final discussion
Prevalence of exfoliation glaucoma
The present study has established that exfoliation glaucoma 
is relatively common (26%) in those Scottish patients coming 
to surgery in the Tennent Institute of Ophthalmology in 
Glasgow. The clinico-morphological diagnostic methodology 
employed herein probably ensures that the figure reflects the 
'true' prevalence of the condition in the group studied. It 
is possible however, that a proportion of the 14 patients 
with possible exfoliation glaucoma (group II) who were 
exfoliation negative on electron microscopic examination 
might develop exfoliation glaucoma in the future.
The present study supports the view that the degeneration of 
the pigment epithelium of the iris in exfoliation glaucoma 
and the consequent release of pigment granules into the 
aqueous circulation probably precede the clinically obvious 
disease. This view however, can only be confirmed by 
sequential studies. The present study has dealt only with 
exfoliation glaucoma patients deemed to warrant surgery. It 
is reasonable to assume that pigmentary signs are of even 
greater importance in patients at an earlier stage of the 
development of exfoliation syndrome.
Exfoliation glaucoma vs POAG
Certain impressions of previous workers concerning 
exfoliation glaucoma have been confirmed in the present
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study. In agreement with previous studies, patients with 
exfoliation glaucoma were older than their POAG counterparts. 
Exfoliation glaucoma was confirmed in this study to be a 
hypertensive glaucoma, characterised by higher untreated and 
treated IOP in comparison with age matched POAG. Despite the 
the more frequent use of more medications and acetazolamide 
the IOP was less amenable to medical therapy in the 
exfoliation glaucoma group. Consequently, the principal 
indication for surgery for the exfoliation glaucoma group was 
unacceptably high IOP. In contrast to other retrospective 
studies, the higher IOP levels did not result in greater 
visual field loss at diagnosis, or at the time of surgery for 
patients with exfoliation glaucoma. From the evidence of the 
present investigation it is clear that exfoliation glaucoma 
differs from POAG. It is hoped that the results of the 
present study will allow a more thorough and critical 
evaluation of the clinical features of the disorder.
Patients with exfoliation glaucoma were found to have a 
significantly lower final IOP (at approximately 6 months 
after surgery) in comparison with suitably matched POAG 
patients. This may be accounted for by the different 
pathogenesis of exfoliation glaucoma. Surgery may alleviate 
the mechanical obstruction of the outflow system caused by 
exfoliation material and pigment deposition in the cribriform 
layer. Alternatively, it could be somehow related to the 
shorter duration of medical therapy in the exfoliation 
glaucoma group. A significantly lower IOP level has been 
reported by Lavin and coworkers (1990) for a group of 
patients with POAG who underwent primary trabeculectomy,
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compared with a group of patients who had received at least 
one year of multiple topical glaucoma therapies before 
undergoing trabeculectomy. Longer term studies are needed to 
confirm and quantify the long term duration of this 
favourable IOP response.
Management of exfoliation glaucoma
For POAG there is considerable evidence from clinical trials 
on which to base our choice of therapy: medical therapy, 
argon laser trabeculoplasty, or trabeculectomy. An informed 
decision can be made for the appropriate form of therapy 
depending on the stage of the disease, level of IOP, 
patients' life expectancy and the probability of satisfactory 
compliance. Such controlled data is currently lacking for 
exfoliation glaucoma.
The results of the present study together with recent reports 
in the literature on POAG (reviewed by Jay 1991? 1992) 
suggest that early surgery (described as a brief trial of 
medical therapy with one medication, or primary ALT followed 
by surgery if the IOP is not satisfactory controlled) is the 
rational choice in the management of exfoliation glaucoma.
In some countries and some social circumstances long term 
medical therapy is impractical and therefore primary surgical 
treatment (trabeculectomy at diagnosis) may be the best 
strategy for exfoliation glaucoma. This study suggests that 
even where there are optimum conditions of glaucoma care, a 
careful choice should be made depending on the severity of 
the disorder and the level of untreated IOP.
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Primary trabeculectomy may be indicated in the management of 
exfoliation glaucoma patients with advanced glaucomatous 
damage. There is now evidence that eyes with advanced optic 
nerve damage caused by POAG require an IOP well below the 
arbitrary top level of 20-22 mm Hg, if further field loss is 
to be avoided (Jay 1991). Increased vulnerability to an IOP 
in the high 'normal' range may be explained by morphological 
changes in the region of the lamina cribrosa or diurnal 
variation in IOP (Stewart 1990, Jay 1991). Odberg (1987) has 
shown in a retrospective study that the best prognosis in 
advanced glaucoma (in a mixed group of POAG and exfoliation 
glaucoma patients) was associated with an IOP less than 15 mm 
Hg. This level of IOP can in most cases be achieved with 
drainage surgery.
Conclusion
The results of the first clinical investigation suggest that 
1) topical anti-glaucoma therapy is less effective in 
controlling IOP in exfoliation glaucoma? 2) earlier surgical 
treatment is more successful in terms of IOP lowering effect 
in exfoliation glaucoma than in age matched POAG and 3) imply 
that properly treated exfoliation glaucoma does not carry a 
worse prognosis than age matched POAG of comparable severity.
The anterior guarded fistula operation 
In the second study a modification of 'Cairns type' 
trabeculectomy with the anterior fistula entirely in corneal 
tissue significantly reduced the incidence of postoperative 
hyphaema. The anterior dissection, termed 'guarded anterior 
fistula' differed from the method described by Cairns (1968)
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in that it did not involve excising angle structures and did 
not disturb the scleral spur. In the posterior group the 
incidence and severity of postoperative bleeding was 
significantly higher. The posterior dissection (Watson's 
modification of Cairns method) proved equally successful in 
terms of IOP control. Nevertheless, patients who underwent a 
posterior trabeculectomy stayed in hospital longer. This was 
due first, to the higher frequency and increased severity of 
postoperative bleeding and second to the appearance of 
recurrent bleeding (3 cases, all in the posterior group).
The anterior dissection probably diminishes the average cost 
of surgery in these patients.
Evidence from this study indicates that patients with 
exfoliation glaucoma do not exhibit a higher frequency of 
postoperative bleeding. Indeed, it is possible that the 
reverse may be the case. Although statistical analysis did 
not demonstrate a significant difference it is possible that 
the present study did not have the required sample size to 
have the power to detect a genuine difference.
12.2.2 Future clinical studies
There is much scope for further research on the clinical 
attributes of exfoliation syndrome/glaucoma. Issues that 
remain ambiguous include the mode and rate of 'conversion' of 
the normotensive exfoliation patients to the ocular 
hypertensive state and subsequently to exfoliation glaucoma. 
At the present time, our knowledge concerning the clinical 
attributes of exfoliation syndrome/glaucoma is incomplete.
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Long term controlled studies are needed to delineate these 
parameters. Aspects of the present study which could be 
extended in the future include the diagnostic methodology 
(clinical examination followed by ultrastructural assessment) 
and the clinical examination and analysis of the results in 
other ethnic groups. This will allow proper assessment of 
the prevalence and importance of exfoliation glaucoma 
worldwide. The author has set up a similar protocol 
investigating the prevalence of exfoliation glaucoma in a 
surgical cohort in Freiburg, Germany. It is interesting to 
note that the morphological prevalence established in the 
German study is similar to that recorded in the present 
investigation, but the clinical prevalence was significantly 
lower. A similar study will be set up in Thessaloniki, 
Greece.
For proper controlled studies first, a random epidemiological 
survey should be carried out on a homogeneous urban, or rural 
population. This study ideally would involve screening for 
exfoliation syndrome/glaucoma, POAG and other ocular 
disorders to provide information on the 'true' prevalence of 
the condition, detect ocular pathology at an early stage and 
lay foundations for a number of subsequent clinical studies. 
Longer term clinical studies can be performed on suitable 
cohorts of individuals drawn from this population survey.
This strategy would ensure the representative nature of the 
material under investigation. Such an approach will be 
pursued in Greece by the author.
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ADDENDUM
Since this thesis was submitted another group of research 
workers has convincingly confirmed that a)laminin is a 
component of exfoliation material and b)have also identified 
a number of other basement membrane components (nidogen and 
proteoglycans) in exfoliation material. In agreement with 
the current study they suggest that exfoliation syndrome is 
an aberration of extracellular matrix synthesis (Schlotzer- 
Schrehardt et al: Current Eye Research, 1992; 11: 343-355).
In addition, two groups of research workers have demonstrated 
that exfoliation material is widely distributed in many 
tissues in the body (Schlotzer-Schrehardt et al: Archives of 
Ophthalmology, 1992? 110: 1752-1756, Streeten et al:
Archives of Ophthalmology, 1992? 110: 1757-1762).
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APPENDIX I
[TAILS OF CONTROL TISSUE USED IN PART I
AGE SEX DIAGNOSIS FIXATION 
PFA 4% plus 
glutaraldehyde
TISSUE USED IN STUDY OF 
COLLAGEN TYPES 
AND LAMININ
r
68 M CM 0.2% CB Iris I-V
| 64 F CM 0.5% CB Iris I-V
6 2 M CBM 0.4% PB Iris I-V
64 M CM PFA only Iris I-V
64 M CM 0.2-1% PB Iris I-V
65 M CM 0.5% CB Iris Laminin,I-V
69 M CM 0.25% CB Iris Laminin,I,IV
52 M CM 0.1% PB Iris Laminin,I,IV
81 F SG 0•2%-l% CB Iris,cornea Laminin,I,IV
) 63 F CM 0%, 0.5% CB Iris,cornea Laminin,I, IV
t 78 F CM 1% CB Iris Laminin,I,IV
f 7 6 M CM 0.5% 1% CB Iris,cornea Laminin,I,IV
b 64 F Lac Ca 1% CB Trabeculum I
r 75 F CBM 0.2% PB Cornea I-V
p 73 M CM 0.25% PB Cornea I-V,laminin
5 78 M CM 1% PB Cornea I-V,laminin
»y: A: male? F: female; CM: choroidal melanoma; CBM: ciliary body melanoma; 
SG: secondary glaucoma? Lac Ca: lacrimal gland carcinoma? PFA: 
paraformaldehyde? PB: phosphate buffer? CB: cacodylate buffer.
APPENDIX II
jgTAlLS OF EXFOLIATIVE TISSUE USED IN PART I
<p AGE SEX DIAGNOSIS FIXATION PFA 4% plus 
glutaraldehyde
TISSUE USED IN STUDY OF 
COLLAGEN TYPES 
AND LAMININ
79 F EXS 0.5% CB Iris I-V
80 F EXG 0.7% CB Iris I-V
J 82 M EXS PFA only PB Iris I-V,laminin
If 69 M EXG 0.4% CB Iris I-V,laminin
168 M EXG 0.5% PB Iris I-V,lamininf
0' '? 69 M EXG 0.25% PB Iris,trabeculum I-V,laminin
t
! 74 M EXG 0.25% CB Iris laminin
i 77 F EXS 0.1% CB Iris laminin
65 M EXG 1% CB Iris laminin
85 F EXG 0.2% CB Iris I,IV,laminin
70 M EXG 0.3% CB Iris,trabeculum I,IV,laminin
71 M EXG 0.5% CB Iris I,IV,laminin
3
:
71 F EXG 0.2% PB Iris I,IV,laminin
14> 72 M EXG 0.5% CB Iris I,IV,laminin
|j:
15 75 M EXG 1% CB Iris I,IV,laminin
16 79 M EXG 0.25% CB Trabeculum I-V
17 65 M EXG 0.2% PB Trabeculum I
1
68 F EXG 0.5% CB Trabeculum I,laminin
79 F EXG PFA only PB Trabeculum I,laminin
) 74 F EXG 0.5% CB Trabeculum I,laminin
* s M: male; glaucoma; 
buffer.
F: female; EXS: exfoliation 
PFA: paraformaldehyde; PB:
syndrome; EXG: exfoliation 
phosphate buffer; CB: cacodylate
jgTAILS of patients from whom
APPENDIX III
HISTOLOGY WAS DEMONSTRATED IN THE STUDY
pJGURE NUMBER EM NO NEGATIVE NUMBER
CHAPTER 4
t.4 309/90 LM
i. 5 309/90 LM
|.6 321/89 LM
J.7 321/89 LM
1.8 141/90 LM
1.9 43/91 LM
1.10 76/90 LM
i.ll 76/90 LM
4.12 131/89 42318
4.13 131/89 42310
4.14 174/90 351 (Jeol)
H.15 143/90 322 (Jeol)
1.16 150/90 48237
4.17 270/89 336 (Jeol)
4.18 270/89 331 (Jeol)
4.19 308/89 48260
4.20 308/90 48262
1.21 18/89 47888
1.22 156/90 48221
4.23 189/90 48247
1.24 189/90 48253
1.25 309/90 48244
1.26 145/90 47891
1.27 174/90 47269
1.28 270/89 47934
1.29 355/90 47941
1.30 309/90 48271
1.31 25/90 47939
1.32 191/89 47896
1.33 270/89 47822
CHAPTER 5
>.1 24/89 42838
5.2 101/88 42452
5.3 24/89 42839
5.4 100/88 42456
5.5 24/89 42836
5.6 100/88 42455
5.7 157/89 42464
*8 157/89 42851
1.9 101/88 42602
1.10 6/89 42482
s. 11 6/89 42478
5.12
5.13
5.14
5.15
5.16
5.17
150/89 46632
207/89 43902
209/89 43889
150/89 46639
314/89 46710
319/89 46703
lPTER
M 24/89 44322Is.3 101/88 44321
6.4 101/88 44816
g.5 6/89 44389
6* 6 101/88 44240
6.7 190/89 44001
6.8 207/89 43870M 190/89 44014g.10 145/90 44341
6.11 264/89 44339
6.12 264/89 44242
6.13 276/89 46677
CHAPTER 7
7.1 150/89 46270
7.2 264/89 44334
|7.3 207/89 47265
7.4 157/90 46629
7.5 207/89 43901
7.6 150/89 46656
7.7 314/89 46664
7.8 207/89 43896
7.9 150/89 46635
7.10 150/89 46280
7.11 314/89 46669
7.12 6/90 47653
7.14 276/89 46678
7.15 276/89 46724
7.16 157/89 43211
7.17 24/89 43238
A
